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ABSTRACT 
Arabinoxylan (AX) is a plant polysaccharide which consists of a xylan backbone on 
which arabinose is substituted. Thirty structurally different wheat arabinoxylan hydrolyzates 
(AXH) were prepared by means of different combinations of xylanase (Cellvibrio japonicas 
xylanase (CJX) and Aspergillus niger xylanase (ANX)) and arabinofuranosidase 
(Bifidobacterium adolescentis arabinofuranosidase (BAF) and Clostridium thermocellum 
arabinofuranosidase (CAF)). The AXH were analyzed using GC-FID, GC-MS, 1H-NMR and 
SEC-MALS techniques. In general, the AXH had high proportion of unsubstituted xylose and 
lesser amount of di- or mono-substituted xylose. The average molecular weights of the AXH 
varied between 0.78-5.64 million Da. Between the two xylanases, ANX might be an enzyme of 
choice for the production of arabinoxylan hydrolyzates with simple structural details while the 
enzyme CJX might be selected for the production of arabinoxylan hydrolyzates with more 
complex structural features. Addition of BAF followed by CAF was more effective in generating 
AXH with higher amount of unsubstituted xylose as well as lesser amount of disubstituted 
xylose. The structural contribution to the immunomodulatory properties of the AXH was also 
evaluated using LPS induced macrophage cell line. The AXH being tested exhibited both pro- 
and anti-inflammatory properties. Structure-function relationship of arabinoxylan hydrolyzates 
as immunomodulators was further assessed using LPS induced colon cancer cell lines: Caco-2 
and HT-29. Fine structural details had a strong correlation with the immunological properties of 
the AXH.  The influence of the fine structural details of AXH on the growth of human gut 
Bacteroides strains was also evaluated. In general, B. cellulosilyticus DSM 14830 had the highest 
growth while B. eggerthii DSM 20697 had the lowest growth on AXH. Interestingly, B. 
cellulosilyticus DSM 14830, B. ovatus 3_1_23, B. ovatus ATCC 8483 and B. xylanisolvens 
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XB1A displayed clearly distinguishable phase shifts along the growth curves indicating their 
ability to tune in their gene expressions to overcome the hindrances to growth exerted by 
structural details on the substrate polysaccharide. This research confirmed the ability of 
Bacteroides to utilize structurally diverse arrays of polysaccharides. Overall, the current study 
indicates that there might be a structure- function relationship between AXH and their 
immunomodulatory properties as well as prebiotic properties. 
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GENERAL INTRODUCTION 
In wheat grain, the major polymer of the cell wall is arabinoxylan (AX) (Saulnier et al., 
2007). AX consists of a backbone of β-(1,4)-linked xylose residues, which are substituted with 
arabinose residues on the C(O)-2 and/or C(O)-3 position (Dornez et al., 2009). Endo-xylanases 
are the major enzymes involved in AX degradation. They cleave AX by internally hydrolyzing 
the 1,4- β-D-xylosidic linkage between xylose residues in the xylan backbone in a random 
manner (Collins et al., 2005; Dornez et al., 2009). α-L-arabinofuranosidase is an exo-enzyme 
that hydrolyzes terminal nonreducing α-arabinofuranose from arabinoxylans (Saha, 2000). Xylan 
is the most abundant polysaccharide in cell walls of cereals, and cereals being a large proportion 
of the human diet, large quantities of xylan are introduced to the gastro intestinal tract. However, 
large proportion of these polysaccharides are indigestible by the human gut enzymes and their 
degradation relies on the gut microbiome. In the case of xylans, the genus Bacteroides are adept 
with a wide repertoire of genes that target xylan degradation (Zhang et al., 2014). A shift in the 
Bacteriodates population in the gut with respect to disease conditions has been reported (Ley et 
al., 2005; Ley et al., 2006) indicating an important contribution from these bacteria to 
maintenance of health. Previous work has demonstrated the influence of structural differences of 
cereal polysaccharides such as AX on their fermentation profiles by bacteria.  Rose et al. (2010) 
indicated differences among the fermentation profiles for AX from different cereals (maize, rice 
and wheat), which consists of different structural features. Xu (2012) concluded that specific 
molecular regions of dietary fibers differentiate gut bacteria. 
Apart from being fermented by the gut bacteria, the ingested polysaccharides interact 
directly with the intestinal tract. Thus, these polysaccharides, depending on their structure might 
exert stimulatory or inhibitory signals in the immune system of the gut acting as 
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immunomodulators.  The immunomodulatory effects of AX have been demonstrated by several 
researchers in the recent years (Cao et al., 2011; Hromádková et al., 2013; Monobe et al., 2008; 
Zhou et al., 2010). Due to the structural heterogeneity of the enzymatic products (arabinoxylan 
hydrolyzates, AXH) obtained by hydrolysis of AX by enzymes, we hypothesized that the fine 
structural details affect the biological activity of these AXH as substrate for gut bacteria and as 
immunomodulators. 
Overall Objectives 
The current research was carried out with four specific objectives in mind.  
i Production and characterization of structurally different arabinoxylan hydrolyzates 
(AXH) using xylanases and arabinofuranosidases with different substrate specificity 
ii Evaluate the immunomodulatory properties of enzymatically derived AXH using cell 
culture models derived from the immune system cells 
iii Evaluate the immunomodulatory properties of enzymatically derived AXH using cell 
culture models derived from the intestinal cells 
iv Understand the effect of enzymatically derived AXH on human gut bacteria 
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CHAPTER 1. LITERATURE REVIEW 
Wheat is one of the dominant grains produced in the world. It is a grass, which belongs to 
the family Poaceae (syn. Gramineae). It is considered a “cereal” as it is grown primarily for its 
grain (or caryopsis) (Gooding, 2009). Although the term ‘wheat’ describes a number of species 
and subspecies in the genus Triticum, the most important are the hexaploid common wheat (T. 
aestivum subsp. aestivum), also known as the bread wheat, which account for more than 90% of 
world wheat production. However, within this subspecies not all varieties are equally suitable for 
bread making. Some genotypes have been shown to possess more desirable qualities than others. 
Mostly, these qualities are inherited and have led to common wheat being generally classified on 
the basis of their seed coat color, endosperm texture, dough strength and sowing season. The 
longitudinal and cross sectional view of the wheat kernel is shown in Figure 1.1.  
 
Figure 1.1. Wheat grain showing its component tissues. Reprinted from Saulnier et al (2007). 
During cereal milling, the starchy endosperm is reduced in particle size to produce flour 
(Delcour and Hoseney, 2010a). The outer layers of the grain from the pericarp to aleurone layer 
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are removed to produce bran. The germ is also separated from the endosperm and usually 
collected in the bran fraction. The general composition of wheat bran can be summarized as in 
Table 1.1.  
Table 1.1. General composition of wheat bran. Adapted from Apprich et. al (2014). 
Compound Amount (%) 
Water 12.1 
Protein 13.2-18.4 
Fat 3.5-3.9 
Total carbohydrates 56.8 
     Starch 13.8-24.9 
     Arabinoxylan 10.9-26.0 
     Cellulose 11.0 
     Beta-glucan 2.1-2.5 
Phenolic acids 1.1 
     Ferulic acid 0.02-1.5 
     Phytic acid 4.2-5.4 
Ash 3.4-8.1 
 
 
The bran is the most important by-product of wheat flour milling and it accounts for 
about 25% of the grain weight (Neves et al., 2006). Many health benefits associated with whole 
grain foods are traced back to compounds in bran. The ability of bran or whole grain to modulate 
hunger and satiety moods, influence the glycemic, lipidic and inflammatory status of consumer, 
or the prebiotic activity has been under extensive research in the recent years. Wheat bran is rich 
in dietary fibers as well as many other compounds that are biologically active such as 
antioxidants and phytoestrogens or lignans (Pruckler et al., 2014).  A concise summary of 
different components of the wheat bran and their beneficial health effects are given in Table 1.2. 
 5 
 
1.1. Arabinoxylans 
In wheat grain, the major polymer of the cell wall is arabinoxylan (Saulnier et al., 2007). 
Even though they occur as a minor constituent  of the grain, their unique physico-chemical 
properties allow them to have a considerable effect on the cereals food industry, including bread 
making (Courtin and Delcour, 2002), gluten-starch separation (Frederix et al., 2004), refrigerated 
dough syruping (Courtin et al., 2005; Simsek and Ohm, 2009) and in animal feeds (Bedford and 
Schulze, 1998). Furthermore, AX has been associated with beneficial health effect in patients 
with impaired glucose tolerance (Garcia et al., 2006). AX consists of a backbone of β-(1,4)-
linked xylose residues, which are substituted with arabinose residues on the C(O)-2 and/or C(O)-
3 position (Dornez et al., 2009). Since AX is mainly composed of pentose sugars xylose and 
arabinose, they are commonly referred to as pentosans. Phenolic acids such as ferulic acid can be 
ester linked on the C(O)-5 position of arabinose. Under oxidative conditions, these ferulic acid 
residues undergo oxidative cross-linking forming inter/intra chain diferulic acid bridges 
(Geissman and Neukom, 1973). Ferulic acid can also function as a radical scavenger, thus it has 
a potential health benefit as an antioxidant (Mpofu et al., 2006). The structure of AX and 
enzymes involved in its degradation are shown in Figure 1.2. 
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Table 1.2. Components of wheat bran and their beneficial health effects. Adapted from Pruckler et al (2014). 
Component          
 
Beneﬁcial action                             Advantages/limitation                            Mechanism 
Soluble dietary 
fiber (SDF) 
Improves gut health 
 
Stimulating the growth of potentially beneﬁcial bacteria/only partially elucidated 
mechanism depending on individual gut  flora 
Prebiotic action 
 
 Control glycemic index  “Food, not drug” concept/investigated in whole wheat Only partially elucidated 
 Reduces plasma cholesterol 
level 
 
“Food, not drug” concept/2-10 g/d are hard to reach with bran bread, triacylglycerols 
and HDL cholesterol were not significantly influenced, increasing soluble fiber 
contributes only to a small extend on dietary therapy 
 
Only partially elucidated 
Dietary fiber  Prolongs bowel transition time Multiple gastrointestinal effects/investigated in rye 
 
SCFA decrease the gastric tone 
 Increases stool volume  Multiple gastrointestinal effects/investigated in rye 
 
Increased mucin production 
Alkylresorcinol  
 
Reduces human colon cancer 
cell growth 
 
Wheat bran oil has shown cancer reduction in mice/multifactorial impact of cereal 
bran 
 
Only partially elucidated cytotoxic 
effects on cancer cells 
Ferulic acid  
 
Antioxidant, anti-microbial, 
anti-inflammatory, antithrombosis 
and anticarcinogenic 
activities 
Fiber-antioxidant complex preserving antioxidants from gastric degradation/bound in 
cell wall matrix 
Inhibits oxidation of LDL, does not 
initiate a chain reaction 
Beta-glucan  
 
Lower/reduce blood cholesterol Lower cholesterol may reduce the risk of heart disease/health claim just given for 
oats and barley 
Increases the synthesis of bile acids 
from cholesterol and the fecal 
excretion of neutral sterols 
 Beneficial role in insulin 
resistance, dyslipidemia, 
hypertension, and obesity 
 
No human adverse effects have been reported/extraction of pure b-glucan is 
relatively costly, in wheat just 2.5% in wheat bran, hard to provide 3 g/d beta-glucan 
 
Only partially elucidated 
Arabinoxylan  
 
 
Reduction of postprandial 
glycemic response 
Reduce the risk of developing type 2 diabetes/health claim just given for 
arabinoxylan from wheat endosperm 
 
Cross-linked arabinoxylans maintain 
their viscosity within the gastrointestinal 
tract, blunting the 
postprandial glucose response 
Lignans  
 
Protection against hormone 
related breast and prostate 
cancer 
 
Consumption of 30 g DF/d results in a significantly reduced odds ratio (0.57), 
matairesinol is a direct precursor to enterolactone/conversion occurs by gut 
microflora, oilseeds have 40 times higher amount per 100 g than cereal bran 
 
Estrogenic effect after transformation 
into enterodiol and enterolactone 
Sterols  
 
 
Reduces total cholesterol “Food, not drug” concept/use of wheat bran resulted in a non-significant 4% 
reduction in serum cholesterol, application of 3-9 g/d sitosterol can be achieved only 
with concentrates 
Lowering of serum cholesterol level by 
inhibiting cholesterol absorption 
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Figure 1.2. Structure of arabinoxylan (AX) and the sites of attack by xylanolytic enzymes 
involved in its degradation (adapted from Grootaert et al. (2007)). The backbone of AX is 
composed of β-(1,4)-linked xylose residues, which can be substituted with arabinose residues on 
the C(O)-2 and/or C(O)-3 position. Ferulic acid can be esterified on the C(O)-5 position of 
arabinose. Endo-β-(1,4)-d-xylanases (EC 3.2.1.8) cleave the xylan backbone internally, β-d-
xylosidases (EC 3.2.1.37) remove xylose monomers from the non-reducing end of xylo-
oligosaccharides, α-l-arabinofuranosidases (EC 3.2.1.55) remove arabinose substituents from the 
xylan backbone, and ferulic acid esterases (EC 3.1.1.73) remove ferulic acid groups from 
arabinose substituents (Dornez et al., 2009). 
 
Even though AX can be described using a general structure, two different classes of AX 
exist in wheat. They are the water-extractable AX (WE-AX), which account for about 25-30% of 
AX in wheat flour and water-unextractable AX (WU-AX), which account for the remainder of 
AX in wheat flour (Meuser and Suckow, 1986). WE-AX are loosely bound to the cell wall 
surface (Mares and Stone, 1973). In contrast, WU-AX are retained in the cell wall by covalent 
and non-covalent interactions with AX and protein, lignin and cellulose (Iiyama et al., 1994).   
1.2. Endo-β-(1,4)-d-xylanases (xylanases) 
Xylanases were originally termed pentosanases (Collins et al., 2005) and were given the 
official name endo-β-(1,4)-D-xylanases with the enzyme code EC 3.2.1.8. However, commonly 
used synonyms include endoxylanase, 1,4-β-d-xylan-xylanohydrolase, endo-1,4-β-d-xylanase, β-
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1,4-xylanase, β-xylanase and xylanase (here after referred to as xylanase). Xylanases are the 
major enzymes involved in AX degradation. They cleave AX by internally hydrolyzing the 1,4- 
β-D-xylosidic linkage between xylose residues in the xylan backbone (Figure 1.2) (Collins et al., 
2005; Dornez et al., 2009). The complex and diverse nature of xylan has given rise to various 
xylanases. Thus, classification of xylanase is not simple and straight forward. Wong et al., 
(1988) classified xylanases based on their physicochemical properties. They classified xylanases 
into two groups: those with low molecular weights (<30 kDa) and basic pI, and those with higher 
molecular weight (>30 kDa) and acidic pI. However, this classification was having drawbacks as 
xylanases of properties opposing to this classification were discovered. Later a more complete 
classification system was introduced, which was based on primary structure comparisons of the 
catalytic domain of the enzymes (Henrissat et al., 1989; Henrissat and Coutinho, 2001). This 
classification not only covers xylanase but covers all glycosidase in general, and has come to 
wide spread use. Initially, cellulases and xylanases were classified into six families A to F 
(Henrissat et al., 1989). However, this was updated to 77 families in 1999 (1-77) (Henrissat and 
Coutinho, 2001). At the time of this writing, 133 Glycoside hydrolases (GH) (EC 3.2.1.x) 
families exist (Lombard et al., 2014).  
Over 290 xylanases have been identified (Fierens, 2007), which have been grouped into 
different glycoside hydrolase (GH) families (5, 7, 8, 10, 11 and 43) (Collins et al., 2005; Dornez 
et al., 2009). Most of these xylanases are from fungal or bacterial origin. All plant xylanases 
identified so far belong to GH family 10, while most of the microbial xylanases are of GH family 
10 or 11 (Simpson et al., 2003). Thus, within our research only xylanases of GH 10 and 11 are 
being discussed. Xylanases of family 10 are characterized by a (beta/alpha)-8 –fold conformation 
and molecular masses that exceed 30 kDa, while xylanases of family 11 contain a jelly roll 
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conformation and molecular masses of around 20 kDa (Biely et al., 1997; Kulkarni et al., 1999). 
The differences of xylanases of GH family 10 and 11 are shown in Table 1.3. 
Table 1.3. Basic comparison between the xylanases of GH 10 and 11 with respect to 
their origin, molecular mass, conformation, and products. Adapted from Mendis 
(2012).  
 Xylanase 
 GH family 10 GH family 11 
Origin All plant xylanase 
Microbial 
Microbial 
Molecular 
mass 
Higher molecular mass (>30 
kDa) 
Lower molecular mass (~20 kDa) 
Conformation (β/α)8 barrel fold  β-jelly roll  
Products Smaller oligosaccharides Larger oligosaccharides 
 
The general retaining mechanism for glycoside hydrolase family 10 and 11 has been 
described by many authors (Collins et al., 2005; McCarter and Stephen Withers, 1994; Rye and 
Withers, 2000; Zechel and Withers, 1999). Xylanase of both family 10 and 11 catalyze the 
hydrolysis of the xylosidic linkage with retention of anomeric configuration (Rye and Withers, 
2000).The general reaction mechanism for this reaction is given in Figure 1.3. The reaction 
proceeds through a double displacement mechanism (Collins et al., 2005; McCarter and Stephen 
Withers, 1994; Rye and Withers, 2000; Zechel and Withers, 1999). Two carboxylic acid residues 
in the active site are involved in formation of the enzyme-substrate intermediate; one acts as an 
acid by protonating the substrate, while other performs a nucleophilic attack. With the departure 
of the leaving group, a covalent glycosyl-enzyme intermediate is formed (inversion from β to α). 
In the second step, the first carboxylic acid acts as a base and abstracts a proton from a water 
molecule upon, which the nucleophilic water molecule attacks the anomeric carbon of the xylan. 
This leads to the formation of the second intermediate state in which the anomeric carbon 
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undergoes an oxocarbonium-ion-like transition state (inversion from α to β). This proceeds with 
the release of the substrate with retention of the original conformation at the anomeric center. 
Hydrolysis of AX by xylanase causes a decrease in the degree of polymerization in the AX and 
produce AX oligosaccharides, xylobiose and xylose with retention of their conformation (Dekker 
and Richards, 1976; Delcour and Hoseney, 2010b; Reilly, 1981).  
1.2.1. GH10 xylanases 
Most of the glycoside hydrolases that are classified in GH10 are endo-β-1,4-xylanases 
(e.g. endo-1,4-β-xylanase from Cellvibrio japonicus) while only a few are endo-β-1,3-xylanases 
(Pollet et al., 2010). GH10 xylanases have broad substrate specificity and attack both linear 
substrates as well as decorated heteroxylans. They attack the glycosidic linkage next to a single 
or double substituted xylose toward the non-reducing end and require two unsubstituted xylose 
residues between branched residues (Figure 1.4). As a result, GH10 xylanases can even degrade 
AX with high degree of substitution (DS) into smaller fragments.  The catalytic domain of GH10 
xylanases has a (β/α)8- barrel fold, called a triosephosphate isomerase (TIM)-barrel fold which 
consists of a shape of a salad bowl (Figure 1.5.) 
 
 11 
 
 
Figure 1.3. General mechanism for catalytic hydrolysis of xylan backbone by xylanases of GH 
10 and 11 (cited from Rye and Withers (2000)). 
 
 
Figure 1.4.  Hydrolytic activity of GH 10 and GH 11 xylanase on arabinoxylan (cited from Pollet 
et al (2010)).  
1.2.2. GH11 xylanases 
GH11 xylanases (e.g. endo-1,4-β-xylanase M4 from Aspergillus niger) exclusively 
consist of true endo-β-1,4-xylanases that cleave internal β-1,4-xylosidic bonds (Pollet et al., 
2010). GH11 xylanase preferably cleaves unsubstiuted regions of the backbone. GH11 cannot 
attack the xylosidic linkage toward the non-reducing end next to a branched xylose and in 
contrast to GH10 xylanase, require three unsubstituted consecutive xylose residues for hydrolysis 
(Figure 1.4). Hence, GH11 xylanases have a low activity on heteroxylans with a high DS.  
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Figure 1.5. Overall structure of xylanase of two glycoside hydrolase families.  (a) Structure of 
GH10 xylanase. The catalytic domain has a (β/α)8-barell fold. (b)  Structure of GH11 xylanase. 
The catalytic domain has a β-jelly roll fold (cited from Pollet et al. (2010)). 
The catalytic domain of GH11 xylanase consists of a β-jelly roll structure that resembles 
the shape of a partially closed right hand and consists of two twisted antiparallel β-sheets and a 
single α-helix (Figure 1.5). The two β-sheets constitute the fingers while the twisted part of β-
sheet B and the α-helix form the palm of the hand. The active site is situated at the concave side 
of the palm.  
1.3. Arabinofuranosidases 
α-L-arabinofuranosidase (α-L-arabinofuranosidase arabinofuranohydrolase, EC 3.2.1.55, 
arabinofuranosidase) is an exo-enzyme that hydrolyzes terminal nonreducing α-arabinofuranose 
from arabinoxylans (Saha, 2000). Based on their amino acid sequence similarities α-L-
arabinofuranosidases have been classified into seven glycoside hydrolase families (GH2, 3, 10, 
43, 51, 54 and 62) (Lombard et al., 2014).  
 
 
a 
b 
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1.3.1. α-L-arabinofuranosidase from Bifidobacterium adolescentis (GH43) 
Arabinoxylan arabinofuranohydrolase-D3 (AXHd3) from Bifidobacterium adolescentis 
releases only C3-linked arabinose residues from double-substituted xylose residues (Van den 
Broek et al., 2005). Laere et al. (1997) isolated two different arabinofuranosidases from B. 
adolescentis able to release arabinose residues from arabinoxylan. These enzymes were named 
arabinofurano-hydrolase-D3 (AXHd3; which hydrolyzed only C3-linked arabinose residues from 
double-substituted xylose residues) 
1.3.2. α-L-arabinofuranosidase from Clostridium thermocellum (GH51) 
This enzyme catalyses the hydrolysis of “α-1,5-linked arabino-oligosaccharides and the 
α-1,3 arabinosyl side chain decorations of xylan with equal efficiency” (Taylor et al., 2006). It 
was also highly active on small soluble oligosaccharides, notably α-1,5-linked 
arabinobiose/arabinotriose and the α-1,3-linked arabinoside of xylobiose which reflect the 
natural limit dextrin products of the action of arabinanases on arabinan and xylanases on wheat 
arabinoxylan. Indeed, it is also highly efficient in the removal of the α-1,3-linked arabinoside 
decorations of polymeric wheat arabinoxylan itself (Taylor et al., 2006). According to the 
existing literature, the substrate specificity of α-L-arabinofuranosidase from Clostridium 
thermocellum is specified with respect to arabinose substitutes to monosubstituted xylose (Taylor 
et al., 2006) and whether or not this specific enzyme acts on 1,3-linked arabinose when linked to 
disubstituted xylose is currently unknown. However, based on what was observed for other 
arabinofuranosidases belonging to GH51, since they hydrolyze the 1,3-linked arabinose from 
monosubstituted xylose and not disubstituted xylose (Sorensen et al., 2006), we speculate that 
this arabinofuranosidase also prefers monosubstituted xylose. 
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Based on the literature available on the two xylanases and arabinofuranosidases discussed 
above, the substrate specificity of these four enzymes could be illustrated as in Figure 1.6. 
1.4. Human Gut Microbiota 
The intestine is an important organ that consists of a huge surface area and permits vital 
interactions with the external world, including the gut microbiota (Cani et al., 2013). The 
microbiota refers to “the microbial life forms within a given habitat or host” while the 
microbiome refers to “the microbial life forms inhabiting a living host, their combined genomes, 
and their interactions with the host” (Walter and Ley, 2011). The gut microbiota exerts a 
significant impact on host physiology, impacting the control of energy homeostasis, the immune 
system, digestion and vitamin synthesis (Cani et al., 2013) and inhibition of pathogen 
colonization (Wardwell et al., 2011).  
The human digestive tract is colonized by a large array of microbes. However, the 
digestive tract has evolved in such a way that the host has the first shot at dietary substances. 
Most of the host digestive enzymes act on the dietary substances along the way from mouth to 
the small intestine. It is then in the large intestine that the saccharolytic bacteria extract 
additional energy from the dietary substances that are resistant to digestion by the human 
enzymes (Walter and Ley, 2011). The distribution of microbial biomass along the human 
digestive track varies in an ascending order with the highest microbial load occurring in the large 
intestine (1011 cells/mL) (Walter and Ley, 2011). This distribution is well summarized in the 
review by Walter and Ley (2011). 
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Figure 1.6. Simplified illustration of hydrolysis specificities of two different xylanases and two 
different abinofuranosidases along the arabinoxylan molecule. Endo-1,4-β-xylanases from 
Cellvibrio japonicus (GH10) attack the glycosidic linkage next to a single or double substituted 
xylose toward the non-reducing end and require two unsubstituted xylose residues between 
branched residues (Pollet et al., 2010). As a result, GH10 xylanases can even degrade AX with 
high degree of substitution into smaller fragments. GH11 xylanases (e.g. endo-1,4-β-xylanase 
M4 from Aspergillus niger) (GH11) exclusively consist of true endo-β-1,4-xylanases that cleave 
internal β-1,4-xylosidic bonds (Pollet et al., 2010) and preferably cleave unsubstituted regions of 
the backbone. It cannot attack the xylosidic linkage toward the non-reducing end next to a 
branched xylose and require three unsubstituted consecutive xylose residues for hydrolysis. 
Hence, GH11 xylanases have a low activity on heteroxylans with a high DS. α-L-
arabinofuranosidase from Bifidobacterium adolescentis (GH43) releases only C3-linked 
arabinose residues from double-substituted xylose residues (Van den Broek et al., 2005). α-L-
arabinofuranosidase from Clostridium thermocellum (GH51) catalyzes the hydrolysis of C3-
linked arabinosyl side chain of xylan  (Taylor et al., 2006).  
The human diet is rich with plant and animal derived glycans. However, there is a large 
array of glycans that are resistant to digestion by human enzymes and rely on microbial enzymes 
for their digestion. The fermentation of these glycans by microbes yield energy for the microbial 
growth, and the end products such as short chain fatty acids (SCFA), mainly acetate, propionate 
and butyrate which have profound effects on the health of the host (Tremaroli and Backhed, 
2012). Butyrate acts mainly as the energy substrate for the colonic epithelium because it is the 
preferred energy source of colonocytes (Hamer et al., 2008; Koropatkin et al., 2012). Acetate and 
propionate are absorbed into the blood stream and travel to the liver where they get incorporated 
into lipid and glucose metabolism, respectively (Rombeau and Kripke, 1990). Thus, acetate and 
propionate act as energy source to peripheral tissue cells.  In addition to that, SCFA have an 
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important effect on the host immune system as well. Low levels of butyrate modify the cytokine 
production profile of TH cells (Kau et al., 2011),  promote intestinal epithelial barrier integrity 
and  has also been associated with colonic tumor suppression (Hamer et al., 2008). In addition to 
being absorbed by the host, acetate is linked to maintaining the intestinal barrier function (Kau et 
al., 2011), and preventing colonization of some enteric pathogens (Fukuda et al., 2011). The 
functional association among the intestinal microbiota, intestinal epithelial cells and the host 
immune system helps maintain the balance between tolerance and immunity to a particular 
pathogenic or non pathogenic microbe or food ingredient. Figure 1.7 illustrates this fragile 
balance among intestinal epithelial cells, microbiota and immune cells.  
Xylan is the most abundant polysaccharide in cell walls of cereals and cereals being a 
large proportion of the human diet, large quantities of xylan are introduced to the gastro 
intestinal tract (GIT).  Healthy adult gut microbiota is composed primarily of members of two 
bacterial phyla, the Bacteroidetes and Firmicutes (McNulty et al., 2013). However, the most 
expanded glycolytic gene collection that target xylan degradation is possessed by genus 
Bacteroides (Zhang et al., 2014). The members of the genus Bacteroides are adept at utilizing 
plant and host derived polysaccharides (Koropatkin et al., 2012). These Bacteroides are rich in 
genes involved in the acquisition and metabolism of various glycosides including glycoside 
hydrolases and polysaccharide lyases which are organized into polysaccharide utilization loci 
(PULs) that are distributed throughout the genome (Koropatkin et al., 2012). 
In the phylum Bacteroidetes, the metabolism of starch from the external environment is 
achieved via the starch utilization system (Sus) (Koropatkin et al., 2012). There have been 
similar systems unique to the phylum Bacteroidetes identified in the Bacteroidetes genome that 
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function by a similar mechanism as Sus but harbor enzymes that target glycans other than starch, 
thus these systems are termed Sus-like systems (Koropatkin et al., 2012). 
 
Figure 1.7. The association among intestinal microbiota, intestinal epithelial cells (IECs) and 
host immune system (Adapted from Xu et al (2013). Intestinal microbiota activates the Pattern 
Recognition Receptors (PRRs) and ER stress signals in IECs, resulting in IECs proliferation, 
integrity barrier function, production of anti-microbial peptides (AMPs) and mucus, and the 
secretion of cytokines such as IL-1β, IL-18, IL-25. The commensal bacteria, together with the 
signals from IECs activate the tolerance responses by the immune system. On the other hand, 
pathogenic bacteria triggers TH1/TH17 responses, which will drive the immune system to 
eliminate these pathogens. Thus the careful balance among the intestinal microbiota, IECs and 
immune system is vital for the health of the host and any disruption of this homeostasis may 
result in uncontrolled inflammation leading to tissue damage, inflammatory bowel disease (IBD), 
colonic cancer, and metabolic diseases. TLRs: Toll-like receptor; NLRs: Nod-like receptor. 
These Sus-like systems are involved in metabolism of many other glylans by the 
Bacteroidetes. The molecular mechanisms used to utilize xylan have been suggested to be 
analogous to the Sus-like paradigm (Dodd et al., 2011; Martens et al., 2009). A gene cluster that 
was highly induced during growth of Bacteroidetes on wheat AX was identified and termed the 
xylan utilization system (Xus) (Dodd et al., 2011). A schematic model predicting the utilization 
of xylan by Xus is given in Figure 1.8. The system consists of a set of polysaccharide binding 
proteins, glycolytic enzymes that hydrolyze large polysaccharides into smaller oligosaccharides 
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and TonB-dependent transporters that transport these oligosaccharides into the periplasm (Zhang 
et al., 2014). These oligosaccharides are then converted to smaller monosaccharides by an array 
of glycolytic enzymes before being transported to the cytosol (Martens et al., 2009).  
The biochemical pathway for xylose metabolism is the pentose phosphate pathway (PPP) 
(Jeffries, 2006). There are two main routes of how xylan enters the PPP; xylose isomerase 
pathway, which is common among bacteria, and the redox pathway, which is common among 
eukaryotes. In the bacterial pathway, xylose gets converted to xylulose by the action of xylose 
isomerase and then phosphorylated to xylulose-5-phosphate by xylulokinase and xylulose-5-
phosphate may enter the PPP (Dodd et al., 2011; Jeffries, 2006).  
1.5. Immunological Effects of Polysaccharides 
1.5.1. Overview of the immune system 
Immunity is the resistance to disease by the body (Abbas and Lichtman, 2011). The cells, 
tissues, organs and the molecules that collectively function to maintain immunity constitutes the 
immune system. The immune system consists of innate immunity (natural or native immunity) 
which mediates the initial resistance against infection and the adaptive immunity (specific or 
acquired immunity) which develops more slowly and comes into play later during infection and 
is more specific and effective defense. The principal components of the innate and adaptive 
immunity are illustrated in Figure 1.9.   
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Figure 1.8. Predicted model for binding of xylan, cleavage and transport of xylan fragments 
across the outer membrane by components of the Xus cluster (adapted from Dodd et al., (2011). 
The proteins, XusA and XusC, are homologues of the SusC TonB-dependent receptor, which is 
involved in oligosaccharide transport across the outer membrane. XusB and XusD are 
homologues of SusD, which binds polysaccharides on the outer leaflet of the outer membrane. 
XusE has no homology to other characterized proteins.In the predicted model, XusE, Xyn10C 
and the XusB/D proteins bind to extracellular xylan polymers. Xyn10C then catalyses the endo-
cleavage of these polymers and XusB/D facilitates transport of these fragments across the outer 
membrane and into the periplasm through the TonB-dependent receptors XusA and XusC. 
1.5.1.1. Innate immunity  
The cells of the innate immune system are first line of defense against microbes and 
infectious agents that are encountered by the body (Delcenserie et al., 2008). Since these initial 
defense mechanisms are always present in a healthy individual, this form of immunity is named 
innate immunity (Abbas and Lichtman, 2011). The components of the innate immune system 
consist of epithelial barriers, phagocytes (neutrophils, monocytes and macrophages), dendritic 
cells, natural killer (NK) cells, complement proteins, cytokines and other types of proteins. The 
two principle reactions of the innate immunity are inflammation and antiviral defense.  
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The cells of the innate immune system consist of receptors that recognize structures that 
are non-self and that are not present in the host cells (Abbas and Lichtman, 2011). Specific 
molecules present at the surface of microbes are targeted by the innate immune system and are 
termed microbe-associated molecular patterns (MAMPs) or pathogen associated molecular 
patterns (PAMPs). The receptors of the innate immune system that recognize these foreign 
components are called pattern recognition receptors and include receptors of the toll like receptor 
(TLR) family and mannose receptors. TLRs are involved in the recognition of many bacterial 
lipopolysaccharides. Recognition of PAMPs by receptors of the innate immune system results in 
a cascade of cellular events that bring about effector functions to eliminate the threat. For 
instance, activation of TLRs by PAMPs involves cellular processes such as recruitment and 
activation of protein kinases which leads to the activation of transcription factors such as nuclear 
factor кB (NF-кB) and interferon response factor-3 (IRF-3), which direct the gene transcription 
of inflammatory cytokines (e.g. interleukin (IL)-1, IL-8), enzymes and proteins involved in 
eliminating the microbial infection. Cytokines are secreted proteins that mediate inflammatory 
reactions. However, innate immunity is not restricted to the initial defense against infection. 
They play a vital role in instructing the adaptive immunity to activate its response. 
1.5.1.2. Adaptive immunity 
Adaptive immunity is the second line of defense in the body against infection. Although 
it comes into play much later that innate immunity, it is very efficient and specific, diverse and 
constitutes the ‘memory’ of the immune system (Abbas and Lichtman, 2011). It consists of two 
types of immunity: humoral immunity and cell-mediated immunity. Humoral immunity is 
specialized in defense against extracellular microbes while cell mediated immunity provides 
defense against intracellular microbes. Lymphocytes and their products such as antibodies 
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constitute the adaptive immune system. Lymphocytes are the only cells in the immune system 
that are capable of producing specific receptors for the specific antigen. Lymphocytes of the 
adaptive immunity are mainly B-lymphocytes and T-lymphocytes (although NK cells are 
lymphocytes they are involved in the innate immune response). Only B-lymphocytes are capable 
of producing antibodies and thus mediate the humoral immunity. The cell-mediated immunity is 
achieved via T-lymphocytes.  
1.5.1.3. Gut associated lymphoid tissue (GALT) 
The immune response of the intestinal mucosa is mediated by the specialized immune 
system features associated with the intestinal mucosa. It consists of the Peyer’s patches, isolated 
lymphoid follicles (ILFs) and mesenteric lymph nodes (MLNs) (Maynard et al., 2012) (Figure 
1.10). Peyer’s patches are lymphoid follicle aggregates which contain T and B lymphocytes, 
plasma cells, macrophages and dendritic cells ((Langkamp-Henken et al., 1992). M-cells 
(microfold cells) are specialized epithelial cells that overlie the Peyers patches (Kagnoff, 1993; 
Schley and Field, 2002). M-cells are involved in endocytose and transport of antigens from the 
intestinal lumen to the Peyer’s patches where they are presented to T- and B-lymphoctes which 
gets activated (Kagnoff, 1993; Langkamp-Henken et al., 1992). The activated B-lymphocytes 
lead to the production of antibodies. Also, the activated immune cells exit and Peyer’s patches 
and enter the systemic circulation. Thus, Peyer’s patches act as main sampling sights for ingested 
antigens (Schley and Field, 2002). T- and B-lymphocytes, plasma cells, mast cells and 
macrophages are distributed throughout the lamina propria (Langkamp-Henken et al., 1992). 
Interepithelial lymphocytes are spread on the interstitial spaces of the epithelial cells and are in 
direct contact with intestinal antigens suggesting that they might be the first cells of the immune 
system that interact with and respond to ingested antigens (Schley and Field, 2002). MLNs 
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comprise of the immune cells entering and leaving the gut (Schley and Field, 2002). ILFs are 
similar to Peyer’s patches but they mainly consist of B-cells, dendritic cells and the overlying 
epithelium comprising of M cells. (Lamichhane et al., 2014; Tsuji et al., 2008). They are 
proposed to be involved in the production of T cell independent IgA production (Tsuji et al., 
2008). 
1.5.2. Plant polysaccharides as immunomodulators 
A possible mode of action of dietary polysaccharides, apart from being fermented by 
intestinal microbiota, is associated with its immunological effects. Evidence suggests that 
addition of fiber to the diet alters the structure and function of the gut, and modifies the gut-
derived hormones and production of cytokines (Mikkelsen et al., 2014; Schley and Field, 2002). 
Most of the research on this area has been performed with beta-glucans while other cereal 
polysaccharides such as arabinoxylans are starting to gain interest as possible 
immunomodulators. Immunomodulators or biologic response modifiers are compounds that 
interact with the host immune system and bring about upregulation or downregulation of specific 
immune responses (Tzianabos, 2000). Some of the immunomodulatory effects of different fibers 
are summarized in a review by Schley and Field (2002). Experimental work performed in vitro 
with monoculture cell lines have suggested that these polysaccharides are capable of directly 
stimulating the intestinal epithelial cells and monocytes, thereby bringing about immunological 
outcomes (Chan et al., 2009; Mikkelsen et al., 2014; Rieder and Samuelsen, 2012; Volman et al., 
2008; Xu et al., 2013).  
Inflammation is an adaptive response that is triggered by noxious stimuli and conditions, 
such as infection and tissue injury (Medzhitov, 2008). Under healthy physiological conditions 
inflammation is a defense response that serves a protective function in the body. Although the 
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exact mechanism of how the dietary fibers affect the immune response and inflammation is not 
well understood, several mechanisms have been studied to explain this effect (Schley and Field, 
2002). Depending on their structure, dietary fibers can be uptaken by M-cells in the Peyer’s 
patches and be transported to underlying immune cells and other cells which results in local 
cytokine production (Volman et al., 2008). This in turn will influence T-cells, B-cells, antigen 
presenting cells and other immune cells. Fibers may also be up taken by intestinal macrophages 
and dendritic cells and transported to lymph nodes, spleen and bone marrow. Moreover, direct 
interaction of fibers with colonic epithelial cells or leukocytes may induce changes in immune 
reactions related to inflammation and development of cancer (Samuelsen et al., 2011; Volman et 
al., 2008).  
Figure 1.9. The principal components of the innate and adaptive immunity. The innate immunity 
is the first line of defense against infection. Epithelial barriers prevent entrance of microbes and 
infectious agents while their elimination is via cells such as phagocytes and natural killer (NK) 
cells and components such as complement proteins. The adaptive immunity develops much later 
and is mediated by lymphocytes (B/T). The B lymphocytes results in the production of 
antibodies against microbes and infectious agents. T lymphocytes mature into effector T cells 
which lead to the elimination of infected cells. Cited from Abbas and Lichtman (2011). 
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Figure 1.10. The gut associated lymphoid tissue (GALT). Intestinal epithelial cells maintain a 
barrier between the contents of the intestinal lumen and the underline immune cells. APC: 
antigen presenting cells; M-cells: microfold cells; IgA: immunoglobulin A.  Cited from Aimutis 
(2011). 
According to one reviewer (Mälkki, 2004) it is still too early to draw full conclusions on 
the effect of dietary fibers on the immune system. However, animal studies have clearly 
demonstrated that dietary fiber type and content can modulate measures of immune function. AX 
extracted from wheat bran has been shown to have potent effects on innate and acquired immune 
response in mice (Cao et al., 2011). Thus, it has been suggested that AX extracted from wheat 
bran by alkaline or enzymatic procedures could be a good source of natural immunomodulation. 
Studies have suggested that the antitumor activity of AX is mainly due to its immunostimulatory 
properties (Cao et al., 2011). AX significantly increases the activation potential of T and B cells 
and enhances the humoral and cell-mediated immunity in tumor bearing mice. Akhtar et al. 
(2012) demonstrated that wheat bran derived AXs have the potential to stimulate the antibody 
mediated immune response in chickens. Thus, AX has the potential as immuno-enhancing and 
antioxidant additives in functional foods (Hromádková et al., 2013). 
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AXs are ingested as part of cereal and non-cereal foods from our diet. AX is a complex 
plant polysaccharide that relays on many different enzymes for its hydrolysis into smaller 
oligosaccharides. Many gut microbes have evolved to contain enzymes, receptors and 
transporters that achieve efficient degradation and utilization of these complex AX molecules.  
The enrichment of different AX utilizing bacteria in the gut upon the consumption of AX rich 
diet could have beneficial health effects to the host. Furthermore, AXs and their hydrolyzates, as 
well as microbial fermentation by-products could contribute towards the immune stimulation of 
the consumer. Due to their variation in degree of polymerization, degree of arabinose 
substitution, and ferulic acid substitution AX hydrolyzates are considerably diverse and complex 
molecules compared to many other prebiotic compounds. Thus, AXs and their hydrolyzates 
should be closely evaluated for their structurally driven biological properties especially related to 
their effect on gut bacteria and immunomodulatory aspects.  
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CHAPTER 2. PRODUCTION OF STRUCTURALLY DIVERSE WHEAT ARABINOXYLAN 
HYDROLYZATES USING COMBINATIONS OF XYLANASE AND 
ARABINOFURANOSIDASE 
2.1. Abstract 
Arabinoxylan (AX) is the predominant polysaccharide in the cell wall of wheat grain. It 
consists mainly of a xylan backbone on which arabinose side groups are substituted on some 
xylose. Xylanase and arabinofuranosidase are the main enzymes involved in hydrolysis of AX.  
The current research was carried out to generate thirty structurally different wheat arabinoxylan 
hydrolyzates (AXH) by means of different combinations of xylanases (Cellvibrio japonicas 
xylanase (CJX) and Aspergillus niger xylanase (ANX)) and arabinofuranosidases 
(Bifidobacterium adolescentis arabinofuranosidase (BAF) and Clostridium thermocellum 
arabinofuranosidase (CAF)). The AXH were grouped into four groups based on the initial 
enzymatic treatment (ANX, CJX, CAF and BAF series). The AXH were analyzed using GC-
FID, GC-MS, 1H-NMR and SEC-MALS techniques to elucidate composition and structural 
details. In general, the AXH had high proportion of unsubstituted xylose and lesser amount of di- 
or mono-substituted xylose. The average molecular weights of the AXH varied between 0.78-
5.64 million Da. Between the two xylanases, ANX might be an enzyme of choice for the 
production of arabinoxylan hydrolyzates with simple structural details while, CJX might be 
selected for the production of arabinoxylan hydrolyzates with more complex structural features. 
Addition of BAF followed by CAF is more effective in generating AXH with higher amounts of 
unsubstituted xylose as well as lesser amounts of disubstituted xylose. The CJX series resulted in 
lower molecular weights compared to ANX series. CAF series yielded larger polysaccharides 
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compared to the BAF series. Overall, the BAF series gave the lowest polydispersity index values 
followed by CAF series while the ANX and CJX series had higher polydispersity index values.  
The enzymatic treatments applied in the current research effectively generated thirty 
different arabinoxylan hydrolyzates. The information derived about the capabilities of the two 
xylanases and two arabinofuranosidase could provide important information in choices made 
regarding enzymes used to generate arabinoxylan hydrolyzates with specific structural details. 
Also, these hydrolyzates could be useful as substrate for future research exploring the effect of 
fine structural details in arabinoxylan hydrolyzates on their biological and physical properties. 
2.2. Introduction 
Arabinoxylan (AX) is the predominant polysaccharide in the cell wall of wheat grain 
(Saulnier et al., 2007). It consists of a backbone of β-(1,4)-linked xylose residues, which are 
substituted with arabinose residues on the C(O)-2 and/or C(O)-3 position (Dornez et al., 2009). 
Since AX is mainly composed of xylose and arabinose, it is commonly referred to as pentosans. 
Phenolic acids such as ferulic acid can be ester linked on the C(O)-5 position of arabinose 
(Figure 1.2). Due to the complex structure of AX it is evident that the degradation of the 
molecule requires a diverse array of enzymes with varying substrate specificities. Endo-β-(1,4)-
d-xylanases (EC 3.2.1.8, xylanase)  are the major enzymes involved in AX degradation. They 
cleave AX by internally hydrolyzing the 1,4- β-D-xylosidic linkage between xylose residues in 
the xylan backbone (Collins et al., 2005; Dornez et al., 2009) giving rise to arabinoxylan 
hydrolyzates (AXH) of different degree of polymerization (DP). The enzyme α-l-
arabinofuranosidases (EC 3.2.1.55) remove arabinose substituents from the xylan backbone 
(Dornez et al., 2009) yielding AX of different degree of arabinose substitution (DS). Thus, 
treatment of AX polysaccharide with various xylanase and arabinofuranosidase can yield AXH 
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with variable DP and DS.  Most of the glycoside hydrolases that are classified in Glycoside 
hydrolase family 10 (GH10) are endo-β-1,4-xylanases (e.g. endo-1,4-β-xylanase from Cellvibrio 
japonicus) (Pollet et al., 2010). GH10 xylanases attack both linear substrates as well as 
substituted heteroxylans. They attack the xylosidic linkage next to a single or double substituted 
xylose toward the non-reducing end and require two unsubstituted xylose residues between 
branched residues (Figure 2.2). Thus, it can hydrolyze AX with high degree of substitution (DS) 
into smaller fragments. GH11 xylanase (e.g. endo-1,4-β-xylanase M4 from Aspergillus niger) 
exclusively consist of true endo-β-1,4-xylanases that cleave internal β-1,4-xylosidic bonds and 
preferably cleave unsubstiuted regions of the backbone (Pollet et al., 2010). GH11 cannot attack 
the xylosidic linkage toward the non-reducing end next to a branched xylose and require three 
unsubstituted consecutive xylose residues for hydrolysis (Figure 1.6). Hence, GH11 xylanases 
have a low activity on heteroxylans with a high DS. Only C3-linked arabinose residues from 
double-substituted xylose residues are hydrolyzed by Arabinoxylan arabinofuranohydrolase from 
Bifidobacterium adolescentis (GH 43) (van den Broek et al., 2005) while α-L-
arabinofuranosidase from Clostridium thermocellum (GH51) catalyses the hydrolysis of “α-1,5-
linked arabino-oligosaccharides and the α-1,3 arabinosyl side chain decorations of xylan with 
equal efficiency” (Taylor et al., 2006).  Thus, it is also highly efficient in the removal of the α-
1,3-linked arabinoside substitutions from wheat arabinoxylan itself (Taylor et al., 2006). 
 There is a growing awareness for the production of dietary fibers and prebiotics with 
health benefits. The production of structurally defined fibers from plant polysaccharides such as 
wheat AX is highly encouraged. Thus, based on the enzymatic specificities, we wanted to 
investigate how these enzymes could be utilized to produce hydrolysis products of desired 
characteristics. Similar approaches to produced enzymatically tailored AX hydrolyzates from 
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corn AX had been previously reported (Xu, 2012). However there are significant structural 
differences between wheat AX and corn AX (Rose et al., 2010). Alkaline extractable AX from 
wheat bran has large proportion of unsubstituted xylose regions compared to corn and rice bran 
AX (Rose et al., 2010). Thus, the objective of this research was to produce structurally different 
arabinoxylan hydrolyzates (AXH) derived from wheat AX by means of enzymatic treatments. 
The insight we get about the capabilities of the enzymes used in the current study might benefit 
many industries (Beg et al., 2001; Clarke et al., 1997; Falck et al., 2013; Spagna et al., 1998) that 
employ different xylanases and arabinofuranosidases. 
2.3. Materials and Methods 
2.3.1. Materials  
Wheat samples were of variety Glenn grown in Casselton, ND in 2011. Heat stable α-
amylase from Bacillus licheniformis (Termamyl ® 120, 1186 units/mg protein; 19.8 mg protein/ 
mL; A-3403-1MU) and protease from Bacillus amyloliquefaciens (P-1236-50 ML) were 
purchased from Sigma-Aldrich Inc. (Saint Louis, MO). Endo-1,4-β-xylanase (Cellvibrio 
japonicus) (EC 3.2.1.8; CAZY Family: GH10; Cat. No: E-XYNACJ), endo-1,4-β-xylanase M4 
(Aspergillus niger)( EC 3.2.1.8; CAZY Family: GH11; Cat. No: E-XYAN4), α-L-
arabinofuranosidase (Clostridium thermocellum) EC 3.2.1.55; CAZy family: GH51; Cat. No: E-
ABFCT) and α-L-arabinofuranosidase (novel specificity) (Bifidobacterium adolescentis) (EC 
3.2.1.55; CAZy Family: GH43; Cat. No: E-AFAM2) were purchased from Megazyme 
International Ireland, Wicklow, Ireland. All the other chemicals were of analytical grade. 
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2.3.2. Procedure for arabinoxylan hydrolyzate preparation  
2.3.2.1. Preparation of wheat bran for arabinoxylan extraction 
Wheat variety Glenn was used to extract arabinoxylans from wheat bran. The whole grain 
was milled in a Bühler MLU-202 mill (Bühler Industries Inc., Uzwil, Switzerland) and bran 
fraction was collected. The bran was then sieved on No 35 (500 micrometer mesh) sieve (100 g 
each for four minutes). This was done to further remove any flour remaining with the bran. The 
sieved bran was stored at 4 oC until further treatment. The bran was then ground using a hammer 
laboratory mill 3100 equipped with a 0.8 mm screen (Perten Instruments North America, Inc.) 
The ground bran was stored at 4 oC.  
2.3.2.2. Production of partially defatted wheat bran 
Ground wheat bran (500 g) was extracted with hexane (2 L) for two hours on a Orbit 
shaker (Lab-Line instrumnts Inc. Melrose Park, IL, USA). The material was then filtered through 
Watmann No 1 filter paper using vacuum and dried under the hood for two days until no hexane 
smell was detected. The resulting material was called partially defatted bran (PDB) and was 
stored at 4 oC until further treatment. 
2.3.2.3. Production of destarched and deprotinized bran 
Preparation of destarched deprotinized bran was carried out according to the method 
described by Rose et al., (2010) with some modifications. Partially defatted bran (250 g) was 
mixed with deionized water (2 L) and pH was adjusted to pH 7.0 using 1M NaOH. The solution 
was then boiled for 20 min. to inactivate the endogenous enzymes. Then 250 µL of heat stable α-
amylase from Bacillus licheniformis was added. Starch was hydrolyzed at 90-95 oC for 2 h, and 
then cooled in an ice bath to 50 oC. The pH was adjusted to 6.0 using 1 M HCl, and 10 mL of 
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protease was added and protein was hydrolyzed at 50 oC for 4 h with shaking (200 strokes/min) 
in a water bath (Type: 89032, VWR International, PA, USA). Next, the enzymes were 
inactivated by boiling the mixture for 30 min. and were cooled in an ice bath to room 
temperature and pH was adjusted to 7.0. The slurry was centrifuged at 3000g for 15 min. The 
residue was termed destarched, deprotenized wheat bran (DSDPB) and stored in freezer (-4 oC) 
until further purification. 
2.3.2.4. Alkaline-hydrogen peroxide extraction 
Alkaline hydrogen peroxide extraction of the DSDPB was carried out as previously 
described by Rose et al., (2010) with some modifications. Destarched deprotinized bran (half of 
the slurry: ~100g) was suspended in 1L of 1M sodium hydroxide using a conical flask of 4L, 
allowing space for foam generation during hydrogen peroxide addition. Under constant mixing at 
60 oC, 42 mL of 30% hydrogen peroxide was slowly added to the mixture and was stirred for 4 h 
at 60 oC using magnetic stir bars. The resulting slurry was centrifuged at 3000g for 15 min at 20 
oC.  The pellet was discarded and three volumes of ethanol (95% v/v) were added to the 
supernatant. The mixture was held overnight at 4 oC, and then the aqueous ethanol portion, 
containing the liberated ferulic acid, was siphoned off as much as possible and discarded. When 
separation of precipitate and supernatant was difficult the remainder of the mixture was 
centrifuged at 3000g for 15 min at 20 oC.  The precipitated material was collected on to a 
Buchner funnel and washed with ethanol (80% v/v), anhydrous ethanol and acetone. The 
resulting material was air-dried until no solvent could be detected by odor. The material was 
termed alkaline extractable arabinoxylans (AE-AX). 
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2.3.2.5. Further purification of alkaline extractable arabinoxylans 
To further purify the AE-AX, treatments with alpha amylase, protease, ethanol 
precipitation and washing were repeated. In detail, AE-AX (125g) was dissolved in 1L of 
deionized water. The pH was adjusted to 7 and boiled for 20 min to bring the internal 
temperature to 90-95 oC. Then 125 µL of heat stable α-amylase (Termamyl ® 120, 1186 
units/mg protein; 19.8 mg protein/ mL; A-3403-1MU, Sigma-Aldrich Inc. Saint Louis, MO) was 
added. Starch was hydrolyzed at 90-95 oC for 2 h, and then mixture was cooled in an ice bath to 
50 oC. The pH was adjusted to 6.0 using 1 M HCl, and 5 mL of protease was added and protein 
was hydrolyzed at 50 oC for 4 h with shaking (200 strokes/min) in a water bath. Next, the 
enzymes were inactivated by boiling the mixture for 30 min. the mixture was cooled in an ice 
bath to room temperature and pH was adjusted to 7.0. The slurry was centrifuged at 3000g for 15 
min and the pellet was collected. The pellet was termed destarched deprotinized AE-AX. Then 
1.25 L of 1M NaOH was added to the pellet and mixed for 30 min at 60 oC. The resulting slurry 
was centrifuged at 3000g for 15 min at 20 oC.  The pellet was discarded and three volumes of 
ethanol (95% v/v) were added to the supernatant. The mixture was held overnight at 4 oC, and 
then the aqueous ethanol portion, containing the liberated ferulic acid, was siphoned off as much 
as possible and discarded. When separation of precipitate and supernatant was difficult the 
remainder of the mixture was centrifuged at 3000g for 15 min at 20 oC.  The precipitated 
material was collected on to a Buchner funnel and washed with ethanol (80% v/v), anhydrous 
ethanol and acetone. The resulting material was air-dried until no solvent could be detected by 
odor. The air-dried material was ground in a small electrical blender (Model 51BL30, Waring 
Commercial, Torrington, CT, USA) to produce a powder. The resulting powder was the purified 
wheat arabinoxylan (WAX) and was used in the preparation of different arabinoxylan 
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hydrolyzates. A schematic representation of the process involved in the production of 
arabinoxylan hydrolyzates is given in Figure. 2.1. 
2.3.2.6. Preparation of arabinoxylan hydrolyzates (AXH) 
Wheat arabinoxylan hydrolyzates were prepared by the methods described by Verwimp 
et al., (2007), Xu, (2012) and Sorensen et al., (2003) with some modifications. Each AXH was 
prepared using different combinations of xylanase and arabinofuranosidases enzyme. WAX (1 g) 
was mixed with sodium acetate buffer (50 mL, 25mM, pH 5.5) and homogenized using a 
homogenizer (Polytron PT10-35 by Kinematica AG, Switzerland) for few minutes. Endo-1,4-β-
Xylanase (Cellvibrio japonicus) (CJX) (4µL) was added to the mixture and immediately boiled 
for 15 min. to inactivate the enzymes and centrifuged at 10,000g for 30 min. The residue was 
discarded. Four volumes of absolute ethanol was added to the supernatant under continuous 
stirring and allowed to sit for 15 min. for arabinoxylan hydrolyzate to precipitate. The precipitate 
was collected by centrifuging at 10,000g for 15 min. The pellet was air dried until no ethanol 
smell was detected and freeze dried to obtain the first arabinoxylan hydrolyzate called CJX-1-P. 
The procedure was repeated using endo-1,4-β-Xylanase M4 (Aspergillus niger) (ANX) (2µL) as 
the starting enzyme to produce ANX-1-P.  
In a similar way WAX (1 g) was mixed with sodium acetate buffer (50 mL, 25mM, pH 
5.5) and homogenized using a homogenizer for few minutes. Endo-1,4-β-Xylanase (Cellvibrio 
japonicus) (CJX) (4µL) was added to the mixture and incubated at 50 0C with continuous 
shaking at 150 rpm in a water bath for 3 hours. The mixture was boiled for 15 min. to inactivate 
the enzymes and centrifuged at 10,000g for 30 min. The residue was discarded. Four volumes of 
absolute ethanol was added to the supernatant under continuous stirring and allowed to sit for 15 
min. for arabinoxylan hydrolyzate to precipitate. The precipitate was collected by centrifuging at 
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10,000g for 15 min. The pellet was air dried until no ethanol smell was detected and freeze dried 
to obtain arabinoxylan hydrolyzate called CJX-2-P. Similarly, a series of AXH was prepared.  In 
CAF series the first enzyme treatment was with α-L-Arabinofuranosidase (Clostridium 
thermocellum) (CAF) (8 µL) followed by other enzymes while in BAF series the first enzymes 
treatment was with α-L-Arabinofuranosidase (novel specificity) (Bifidobacterium adolescentis) 
(BAF) (10 µL). A summary of the treatments and the abbreviation given to the resulting AXH is 
given in Table 2.1. 
 
 
 
 
 
 
 
Figure 2.1. Schematic representation of the process involved in the production of arabinoxylan 
hydrolyzates. DSDP-B, destarched deprteinized bran; AE-AX, alkaline extractable arabinoxylan; 
DSDP-AE-AX, destarched deproteinized alkaline extractable arabinoxylans; WAX, wheat 
arabinoxylan; AXH, arabinoxylan hydrolyzates. Each treatment indicated on the arrows was 
applied consecutively in the order of listing. 
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2.3.3. Chemical analysis 
2.3.3.1. Determination of sugar composition and arabinose to xylose ratio (A/X) of arabinoxylan 
hydrolyzates using gas chromatography (GC)  
Sugar composition and the ratio between arabinose to xylose in arabinoxylans in AXH 
were determined following acid hydrolysis and preparation of alditol acetates as described by 
Blakeney et al., (1983).  
2.3.3.1.1. Hydrolysis 
To hydrolyze the polysaccharide to its monomeric constituents (Fox et al., 1989), 
samples (7 mg) were hydrolyzed with Trifluoroacetic acid (TFA) (2 M, 250 µL) for 1 h at 121 
oC. Myo-Inositol (75 µL of 10 mg/mL solution) was added to the hydrolyzed samples as an 
internal standard and dried under nitrogen (Gys et al., 2003). The excess acid was neutralized by 
adding NH4OH (1 M, 100 µL). The resulting mixture contains the hydrolyzed products. 
2.3.3.1.2. Reduction 
The hydrolyzed samples were reduced by adding sodium borohydride (NaBH4) in a 
dimethylsulfoxide (DMSO) solution (20 mg/mL, 500 µL) (Blakeney et al., 1983). In this step, 
the aldose form of the sugars is reduced to an alditol by NaBH4 (Fox et al., 1989). If this 
reduction is not carried out the acetylation of ring form of aldose complicates the chromatogram 
(in aqueous solution aldoses exist in equilibrium between ring form and open chain but alditols 
only occur as open chain). After reduction to alditols, excess NaBH4 was decomposed by the 
addition of glacial acetic acid (ca. 300 µL).  
2.3.3.1.3. Acetylation 
Alditol acetates were prepared according to the method described by Blakney et al., 
(1983) for the preparation of alditol acetates for monosaccharide analysis. 1-methylimidazol (100 
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µL) was added as a catalyst for the acetylation reaction (Blakeney et al., 1983; Fox et al., 1989). 
Acetic anhydride (500 µL) was added to the reduced monosaccharides and the contents were 
mixed.  The reaction was stopped with the addition of 4 mL of H2O. The acetylated 
monosaccharides were extracted twice with methylene chloride (1 mL). The methylene chloride 
was evaporated under N2. The residue was dissolved in acetone (1 mL) and transferred to vials 
for analysis in GC. Arabinose and xylose were used as monosaccharide standards in the analysis. 
Myo-inositol was used as the internal standard. The derivatized alditol acetate samples were 
analyzed on a Hewlet Packard 5890 series II GC system with a flame ionization detector (FID) 
(Agilent Technologies, Inc. Santa Clara, CA). 
Supelco SP-2380 fused silica capillary column (30 m × 0.25 mm × 2 µm) (Supelco 
Bellefonte, PA) was used in the GC system. The system parameters were as follows: flow rate of 
0.8 mL/min, 82737 Pa flow pressure, oven temperature of 100 oC, 250 oC of detector 
temperature, and 230 oC of injector temperature. The carrier gas was Helium.  
2.3.3.2. Determination of weight average molecular weight of arabinoxylan hydrolyzates using 
HPLC-MALS-RI system 
The weight average molecular weight (Mw) and polydispersity index, defined by the ratio 
Mw/Mn, where Mw represents the weight average molar mass and Mn the number average molar 
mass, of arabinoxylan hydrolyzates were determined according to the method of Storsley et al., 
(2003), with some modifications. 
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Table 2.1. Summarized information about the sequence of treatments and the 
abbreviation given to each AXH. 
Treatment1 Abbreviation of the AXH 
ANX-Series  
ANX  0 h ANX-1 
ANX  3h ANX-2 
ANX  6 h ANX-3 
ANX  12h ANX-4 
ANX  24 h ANX-5 
ANX  24 h  BAF  6 h ANX-6 
ANX  24 h  BAF  6 h  CAF  6 h ANX-7 
ANX  24 h  CAF  6 h ANX-8 
ANX  24 h  CAF  6 h  BAF  6 h ANX-9 
CJX- Series  
CJX  0 h CJX-1 
CJX  3h CJX-2 
CJX  6 h CJX-3 
CJX  12h CJX-4 
CJX  24 h CJX-5 
CJX  24 h  BAF  6 h CJX-6 
CJX  24 h  BAF  6 h  CAF  6 h CJX-7 
CJX  24 h  CAF  6 h CJX-8 
CJX  24 h  CAF  6 h  BAF  6 h  CJX-9 
BAF-Series  
BAF  6 h BAF-1 
BAF  6 h  CJX  24 h BAF-2 
BAF  6 h  ANX  24 h BAF-3 
BAF  6 h  CAF  6 h BAF-4 
BAF  6 h  CAF  6 h  CJX  24 h  BAF-5 
BAF  6 h  CAF  6 h  ANX  24 h BAF-6 
CAF-Series  
CAF  6 h CAF-1 
CAF  6 h  CJX  24 h CAF-2 
CAF  6 h  ANX  24 h CAF-3 
CAF  6 h  BAF  6 h CAF-4 
CAF  6 h  BAF  6 h  CJX  24 h  CAF-5 
CAF  6 h  BAF  6 h  ANX  24 h CAF-6 
1Enzymatic treatments were carried out using the following enzymes: ANX, endo-1,4-
β-Xylanase M4 (Aspergillus niger); CJX, Endo-1,4-β-Xylanase (Cellvibrio 
japonicus); BAF, α-L-Arabinofuranosidase (novel specificity) (Bifidobacterium 
adolescentis); CAF, α-L-Arabinofuranosidase (Clostridium thermocellum). 
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Arabinoxylan hydrolyzate (4 mg) was dissolved in deionized water (filtered via 0.1 µm 
filter) by heating at 40 oC with continuous stirring for few minutes. The sample solution was then 
filtered via 1.5 µm filter.  Analysis was done on an Agilent 1200 high performance liquid 
chromatograph (HPLC) with refractive index detector (RI) and a Wyatt Dawn Helios-II multi-
angle light scattering (MALS) detector. 300 kDa pullulan was used for normalization of the 
MALS detector. Shodex OHpak guard column and Shodex SB 806-HQ column were used. 
Water at 0.5ml/ml flow rate was used as the mobile phase. The calculation of Mw and 
polydispersity index (Mw/Mn) were performed by Astra 6.0.5 software (Wyatt Technology), 
based on the Debye plot with a second-order polynomial fit. Water at 0.5mL/min flow rate was 
used as the mobile phase. Values of dn/dc, defined as the proportional change in refractive index 
with change in polymer concentration were assumed to be 0.146 for arabinoxylans, as determine 
by Dervilly et al., (2000).  
2.3.3.3. Determination of arabinose substitution pattern using proton nuclear magnetic resonance 
(1H-NMR) spectroscopy  
Arabinoxylan hydrolyzate polysaccharides (5 mg) were dissolved in D2O (600 µL) by 
heating at 40 oC with continuous stirring on a heating/ stirring module (Reacti-therm III #18823, 
Thermo Scientific, USA). The samples were then freeze-dried. The dissolving and freeze-drying 
steps were repeated two more times and the final freeze dried sample was dissolved in D2O (650 
µL) and used for NMR analysis. The spectra were recorded on a 400 MHz spectrometer (Bruker 
AV3 HD 400 MHz NMR with a 5 mm PABBO BB/19F-!H/D Z-GRD Z probe) at 80 oC. Data 
were analyzed using the TopSpin 3.2 software (Bruker BioSpin Corporation, Billerica, MA. 
Partial structural assignment of peaks was made by comparison with previously published data 
(Hoffmann et al., 1992; Rose et al., 2010).  
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2.3.3.4. Linkage analysis of arabinoxylan hydrolyzates using GC-MS     
Linkage analysis was performed according to the method described by Carpita and Shea 
(1989) with some modifications: Dried samples (3 mg) were dissolved in anhydrous DMSO (250 
µL), and methylated. The methylated samples were hydrolyzed using 2N trifluoroacetic acid 
(250 µL) at 121 oC for 1 h. The hydrolyzed samples were dried under N2 and dissolved in 
ammonium hydroxide (1M, 100 µL) and 500 µL of DMSO containing 20 mg/mL of sodium 
borodeuteride was added and incubated at 40 oC for 90 min. Six to nine drops of glacial acetic 
acid were added to the mixture to stop the reduction reaction following incubation. 1-
methylimidazole (100 µL) and acetic anhydride (500 µL) were added for acetylation. Partially 
methylated alditol acetates in acetone were quantified by GC-MS (Model no 6890N Network GC 
System and 5973 Mass Selective detector, Agilent technologies, Inc., Santa Clare, CA) using a 
Restek™ RTX™-35 MS (Thermo Fisher Scientific Inc. MA, USA) capillary column (injector 
volume, 2µL;  injector temperature, 250 oC; detector temperature, 250 oC; carrier gas, Helium; 
rate,1.0 mL/min; split ratio10:1; temperature program 170 oC for 2 min., 3 oC/min. to 250 oC, 
250 oC for 2 min.; run time 30.67 min.). Data processing was carried out using Enhanced 
ChemStation software (MSD Chem Station D.01.00, Agilent technologies, Inc., Santa Clare, 
CA).  
2.3.4. Statistical analysis 
  The data are presented as the means ± SE and were subjected to one way ANOVA using 
LSD test procedure employing Statistical Analysis System software package version 9.4 (SAS 
Institute, Cary, NC). A least significant difference (LSD) with a 5 % significance level was used 
to declare differences. Differences were considered significant when the probability value p was 
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lower than 0.05. Pearson's correlation analysis was conducted to evaluate relationships between 
AXH composition/structural details.  
The 30 AXH samples were grouped into four groups (ANX series, CJX series, CAF 
series and BAF series) according to the first hydrolysis enzyme applied to generate each series. 
Canonical discriminant analysis (CDA) was performed on data expressing chemical/fine 
structural details (e.g. total AX %, A/X ratio, resonance integration results from 1H-NMR, 
linkage analysis data from GC-MS) in each AXH (independent variables), in order to classify 
different types of AXH (grouping variable): ANX, CJX, CAF and BAF. The statistical analysis 
of the data was performed using ‘CANDISC’ procedure in SAS (V. 9.2, SAS Institute, Cary, 
NC). 
2.4. Results and Discussion 
2.4.1. Sugar composition  
The sugar composition and the A/X ratio of the WAX and the resulting AXH are given in 
Table 2.2. A sample chromatogram obtained for the AXH after GC-FID analysis is shown in 
Appendix A. The samples consisted predominantly of xylose (14.36-38.77%), followed by 
arabinose (8.26-18.79%). Glucose was found to a lesser amount (2.26-4.85%) and traces of 
galactose (0.18-0.83%) were also detectable. The wheat AX (WAX) which was the starting 
substrate for the rest of the AXH had low amount of total AX and A/X ratio compared to the rest 
of the arabinoxylan hydrolyzate (AXH) samples. The treatment of WAX with the xylanase and 
arabinofuranosidase enzymes and the subsequent treatments could have yielded a much purer 
arabinoxylan sample compared to the starting material, WAX because the AXH samples have 
undergone an extra ethanol precipitation step compared to WAX and this extra step results in 
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much more pure AX. This could be the reason behind the apparent increase in the total AX % in 
the AXH compared to the WAX.  
In the ANX series, as expected most of the AXH samples that underwent treatment with 
arabinofuranosidase, the enzymes that hydrolyze the arabinose substitution from xylose 
backbone (ANX-6, ANX-7 and ANX-8) resulted in lower A/X ratio compared to treatments 
receiving only xylanase treatment (ANX-5) due to the removal of arabinose by the debranching 
enzymes. Surprisingly, ANX-9 which was treated with ANX; followed by CAF; followed by 
BAF resulted in higher A/X ratio compared to the rest of the samples in ANX series. However, 
upon a closer look, it could be noted that the higher A/X ratio is not due to higher arabinose 
content but rather due to reduced xylose content. 
In the CJX series, treatment with BAF in CJX-6 gave higher A/X ratio compared to CJX-
5 (the treatment that didn’t undergo hydrolysis by arabinofuranosidase). However, here again a 
lower xylose content could be responsible for the higher A/X ratio. But rest of the debranched 
treatments gave similar or lower A/X ratios (CJX-7, CJX-8 and CJX-9) as expected due to the 
removal of arabinose from the xylose backbone. 
Overall in both ANX and CJX series the debranching with CAF gave lower A/X 
compared to debranching with BAF: ANX-6 vs. ANX-8 and CJX-6 vs. CJX-8. Thus, CAF might 
be the better enzyme choice to debranch AX that has already undergone depolymerization by 
xylanase. 
When the CAF and BAF series were compared, treatment of WAX with CAF (CAF-1) 
gave slightly higher A/X ratio (0.53) compared to treatment of WAX with BAF (BAF-1) (0.52). 
Also, the arabinose content in CAF-1 (14.24%) was higher than that for BAF-1 (11.02%). This 
indicates that BAF removed more arabinose side groups from WAX compared to CAF. When 
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the substrate specificity of the two enzymes are considered, BAF  releases only C3-linked 
arabinose residues from double-substituted xylose residues (van den Broek et al., 2005) while 
CAF catalyzes the hydrolysis of C3-linked arabinosyl side chain of xylan  (Taylor et al., 2006). 
Also, this hydrolysis of C3-linked arabinose by CAF might be on monosubstituted xylose as 
observed for other similar arabinofuranosidases belonging to same GH family as CAF (Sorensen 
et al., 2006). Based on fine structural details of wheat bran AX, it is suggested that it possess 
large proportion of disubstituted xylose regions (Rose et al., 2010). Thus, the BAF might have an 
advantage over CAF because higher proportion of disubstituted xylose might provide BAF with 
higher substrate to act upon. Since CAF did seem to have this advantage coming from 
disubstituted xylose, we suggest that CAF has a higher possibility of being an rabinofuranosidase 
that only hydrolyze C3 linked arabinose from monosubstituted xylose falling into place with 
other GH51 arabinofuranosidases. The discrepancies observed with some of the expected 
outcomes and the results obtained for the A/X ratio might also be due to the heterogeneous 
distribution of arabinose along the xylan backbone in wheat AX (Beaugrand et al., 2004).    
2.4.2. Weight average molecular weight and polydispersity index of AXH 
The average molecular weights of the AXH varied from 0.78 to 5.64 million Da for the 
AXH (Table 2.3). An example of the superimposed chromatograms of refractive index and light 
scattering detector outputs for AXH is shown in Appendix 1. The starting material WAX had an 
average molecular weight of 5.61 million Da. In general, as the WAX was subjected to more 
enzymatic treatments, the molecular weight decreased as expected.  
The CJX series resulted in lower molecular weights compared to ANX series which is in 
agreement with the substrate specificity of the each of the two xylanases. GH10 xylanases such 
as CJX can even degrade AX with high degree of substitution (DS) into smaller fragments 
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(Pollet et al., 2010). GH11 xylanases such as ANX on the other hand preferably cleave 
unsubstituted regions of the xylan backbone (Pollet et al., 2010) and due to such restrictions 
yield much larger fragments. 
BAF series AXH yielded larger polysaccharides compared to the corresponding CAF 
series AXH. Treatment with CJX following arabinofuranosidase treatment yielded higher 
molecular weight AXH (BAF-2 and CAF-2) compared to treatment with ANX following 
arabinofuranosidase treatment (BAF-3 and CAF-3) in both BAF and CAF series. Adding the 
arabinofuranosidase treatments in sequence of CAF followed by BAF (CAF-5 and CAF-6) was 
more effective in producing smaller molecular weight polysaccharides compared to adding BAF 
followed by CAF (BAF-5 and BAF-6). 
Generally, the xylanases are known to prefer unsubstituted xylose and the presence of 
arabinose exert a hindrance to xylanase activity on AX (Remond et al., 2008). Overall, as 
expected, initial hydrolysis of arabinose from the AX with arabinofuranosidase prior to 
hydrolysis by xylanase as in BAF and CAF series yielded AXH with much smaller average 
molecular weights comparted to initial hydrolysis by xylanase followed by arabinofuranosidase.  
The polydispersity index of a polysaccharide gives an indication about the molecular 
weight distribution of the polysaccharide (Agilent Technologies, 2011). Large polydispersity 
index values thus indicate that the polymer has a broad molecular weight distribution. A 
monodispersed polymer where all the chain lengths are equal has a polydispersity index of 1. 
However, biological polymers such as polysaccharides have a wide chain length distribution. 
The polydispersity index of the WAX used in the current study had a polydispersity index of 1.6. 
This indicates that most of the molecules in WAX were somewhat similar in weight. Overall, the 
polydispersity index values ranged from 1.4-2.4 for the AXH.   
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2.4.3. 1H-NMR of the AXH  
A sample 1H-NMR resonance spectrum of arabinoxylan is given in Figure 2.2. The spectrum 
consists of two distinct groups of resonances. The resonates at δ 5.90 to 5.73 ppm represents the 
anomeric protons of terminal arabinose units (α-L-arabinofuranosyl (α-Araf)) linked to xylose 
main chain (Hoffmann et al., 1992) (Rose et al., 2010). The resonates at δ 5.00 to 5.20 ppm can 
be attributed to the anomeric protons of β-D-xylopyranosyl residues (β-Xylp) (Hoffmann et 
al., 1992). The anomeric proton of arabinose linked to the monosubstituted xylose at O-3 
position corresponds to the resonance at δ5.90 ppm (Resonance 1). 
The resonance at δ5.81 and 5.80 ppm corresponds to anomeric proton of arabinose 
residue linked to the disubstituted xylose at O-3 position (Resonance 2) and resonance atδ5.75 
to 5.73 ppm accounts for anomeric proton of arabinose residue linked to the di-substituted xylose 
at O-2 position (Resonance3). The anomeric proton of di-substituted xylose accounts for the 
resonances atδ5.18 to5.17 ppm (Resonance 4). The anomeric proton mono-substituted xylose 
corresponds to resonances at δ5.04 to 5.03 ppm (Resonance 5) and anomeric proton of 
unsubstituted xylose residues corresponds to resonances at δ5.00 ppm (Resonance 6). The 
quantitative integration of the resonances for each of the AXH was carried out (Table 2.4). The 
samples had high proportion of unsubstituted xylose (Resonance 6) and lesser amount of di- or 
mono-substituted xylose. A distinct difference among the AXH for the resonance integrations for 
the disubstituted xylose (Resonance 4) was evident. However, it was difficult to relate the 
observed results with the expected outcomes with respect to enzymatic substrate specificities. 
Except for resonance 4 integration values, all the other resonance integration values varied 
between a very narrow range and this also made it difficult to identify significant differences 
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among samples.  During the experimental procedure, AXH seemed to precipitate at the bottom of 
the NMR tube and this could have influenced the final outcomes.  
2.4.4. Glycosidic linkage profiles of the AXH   
To further understand the structural details of the AXH, linkage analysis was carried out 
using GC-MS. The fragment identification was based on the online data base of University of 
Georgia, complex carbohydrate resource center (2014), Carpita and Shea (1989) and personal 
communications with Dr. Brad L. Reuhs (Department of Food Science, Purdue University, West 
Lafayette, IN). The results are depicted in Figure 2.3. The total ion chromatogram (TIC) and the 
mass spectrum of the corresponding peak in the TIC is shown in Appendix B. As expected, 
structural heterogeneity was observed with respect to linkage types present in each arabinoxylan 
hydrolyzate. After extensive enzymatic treatments, most of the AXH consists largely of 
unsubstituted xylose, indicating that the debranching enzymes were effective in removing the 
substituted arabinose. In the ANX series, the as the reaction time was increased from 0 h (ANX-
1), 3 h (ANX-2), 6 h (ANX-3) and 12 h (ANX-4) the enzymes successively hydrolyzes more 
xylosidic bonds. The hydrolysis by ANX seems to result in highly unsubstituted AX. Among 
ANX-1, ANX-2, ANX-3 and ANX-4, as the enzyme reaction time increased, the unsubstituted 
xylose content increased and the structural complexity such as disubstituted xylose content and 
substituted arabinose content decreased. However, this trend was reversed with CJX series. 
In CJX series as enzymatic reaction time increased from 0 h (CJX-1) to 3 h (CJX-2) to 12 
h (CJX-3) the amount of unsubstituted xylose decreased and the disubstituted xylose content and 
substituted arabinose content increased. This indicate that between the two xylanases, ANX 
might be an enzyme of choice for the production of arabinoxylan hydrolyzates with simple 
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structural details while CJX might be selected for the production of arabinoxylan hydrolyzates 
with more complex structural features. 
Hydrolysis of the sample with BAF (ANX-6), BAF and CAF (ANX-7), and CAF (ANX-
8) in the ANX series resulted in AXH with apparently similar linkage profiles. Thus, initial 
depolymerization of WAX with ANX might result in hydrolyzates that are not easily accessible 
for the arabinofuranosidase. The arabinose substitution on the xylan backbone contributes to the 
solubility of the AX. The presence of arabinose in AX prevent the aggregation of unsubstituted 
xylose regions and help maintain the rod-like structure of AX in solution, making it soluble 
(Andrewartha et al., 1979).  
It has been suggested that partial removal of such arabinose residues from the xylan 
backbone results in intermolecular insoluble aggregates of the molecule (Andrewartha et al., 
1979). The initial hydrolysis of WAX by ANX might result in highly unsubstituted arabinoxylan 
hydrolyzates as seen in ANX-6, ANX-7 and ANX-8. Thus, these hydrolyzates might form 
aggregates and become partially insoluble. This might render a physical barrier for the 
arabinofuranosidase to bring about its action. Treatment of WAX with CJX resulted in a 
decrease in unsubstituted xylose proportion in the AXH as seen in CJX-6, CJX-7, CJX-8 and 
CJX-9. This was contradictory to what was expected. The expectation was that the subsequent 
arabinofuranosidase treatment would remove arabinose from the AX and yield a less complex 
highly unsubstituted AXH. One possible explanation is that once arabinofuranosidase removed 
the arabinose, CJX was still acting upon that hydrolysis product and cleaved off fractions of 
much of the easily accessible unsubstituted regions of the molecule off to the solution as 
oligomers. Thus, after the ethanol precipitation of the hydrolysis products the products with 
much complex structures are left to precipitate and constitute the AXH.  
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Table 2.2. Sugar composition of wheat AX (WAX) and its enzymatic products. 
AXHa Sugar composition % (w/w) A/X ratio 
 Arabinose Xylose Galactose Glucose 
 
WAX 8.46 26.58 0.26 2.56 0.32 
ANX-1 12.62 31.09 0.50 4.48 0.41 
ANX-2 12.74 26.87 0.55 4.36 0.47 
ANX-3 13.72 28.37 0.65 4.06 0.48 
ANX-4 13.99 24.66 0.57 4.05 0.57 
ANX-5 14.47 25.24 0.73 3.73 0.57 
ANX-6 16.13 29.20 0.73 4.54 0.55 
ANX-7 15.51 28.32 0.83 4.06 0.55 
ANX-8 11.12 22.00 0.40 2.82 0.51 
ANX-9 11.40 17.11 0.37 2.57 0.67 
CJX-1 13.03 28.86 0.68 4.58 0.45 
CJX-2 12.50 25.08 0.26 4.98 0.50 
CJX-3 14.53 29.38 0.81 3.90 0.49 
CJX-4 8.26 14.36 0.21 2.26 0.58 
CJX-5 15.95 29.61 0.69 4.61 0.54 
CJX-6 11.39 19.88 0.47 3.03 0.57 
CJX-7 11.01 20.51 0.52 3.29 0.54 
CJX-8 13.01 26.32 0.56 3.37 0.49 
CJX-9 13.51 25.60 0.18 4.02 0.53 
CAF-1 14.24 26.96 0.51 4.01 0.53 
CAF-2 15.80 32.09 0.20 3.56 0.49 
CAF-3 18.05 35.43 0.23 3.87 0.51 
CAF-4 16.40 27.33 0.65 4.42 0.60 
CAF-5 14.69 28.00 0.21 3.61 0.52 
CAF-6 18.79 38.77 0.21 4.47 0.48 
BAF-1 11.02 21.36 0.46 3.64 0.52 
BAF-2 12.29 19.81 0.30 2.62 0.62 
BAF-3 15.49 27.68 0.68 3.25 0.56 
BAF-4 13.93 24.62 0.31 4.85 0.57 
BAF-5 12.76 24.22 0.46 4.10 0.53 
BAF-6 15.16 28.60 0.25 3.35 0.53 
LSD 0.84 1.4 0.03 0.02 0.01 
LSD = least significant difference (P < 0.05) 
aEnzymatic treatments were carried out using the following enzymes: ANX, 
endo-1,4-β-Xylanase M4 (Aspergillus niger); CJX, Endo-1,4-β-Xylanase 
(Cellvibrio japonicus); BAF, α-L-Arabinofuranosidase (novel specificity) 
(Bifidobacterium adolescentis); CAF, α-L-Arabinofuranosidase (Clostridium 
thermocellum); each sample name starting with corresponding enzyme 
abbreviation received that specific enzyme treatment first.  
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Table 2.3. Weight average molecular weight and polydispersity index of AXH. 
AXHa Weight average molecular 
weight (million Da) 
Polydispersity index (Mw/Mn) 
WAX 5.61 1.6 
ANX-1 5.56 2.2 
ANX-2 4.54 1.5 
ANX-3 4.03 2.2 
ANX-4 3.68 1.5 
ANX-5 3.64 1.8 
ANX-6 3.58 1.5 
ANX-7 3.33 1.4 
ANX-8 2.91 1.8 
ANX-9 2.06 1.8 
CJX-1 5.64 1.8 
CJX-2 4.02 1.7 
CJX-3 2.25 1.6 
CJX-4 1.84 1.7 
CJX-5 1.81 1.6 
CJX-6 1.53 1.8 
CJX-7 1.27 1.6 
CJX-8 1.22 1.7 
CJX-9 1.11 1.9 
CAF-1 3.31 2.3 
CAF-2 1.28 1.5 
CAF-3 1.11 1.3 
CAF-4 1.89 1.6 
CAF-5 0.93 1.8 
CAF-6 0.78 1.4 
BAF-1 3.35 2.0 
BAF-2 1.64 1.9 
BAF-3 1.33 2.1 
BAF-4 2.31 1.6 
BAF-5 1.14 1.8 
BAF-6 1.28 2.0 
LSD 0.04 0.4 
LSD = least significant difference (P < 0.05) 
aEnzymatic treatments were carried out using the following enzymes: ANX, endo-
1,4-β-Xylanase M4 (Aspergillus niger); CJX, Endo-1,4-β-Xylanase (Cellvibrio 
japonicus); BAF, α-L-Arabinofuranosidase (novel specificity) (Bifidobacterium 
adolescentis); CAF, α-L-Arabinofuranosidase (Clostridium thermocellum); each 
sample name starting with corresponding enzyme abbreviation received that 
specific enzyme treatment first.  
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Figure 2.2. Example 1H-NMR resonance spectrum of arabinoxylan.  
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Table 2.4. 1H-NMR resonance integrations for WAX and AXH.  
 Resonance integration as % of total resonance 
AXH Resonance 1 Resonance 2 Resonance 3 Resonance 4 Resonance 5 Resonance 6 
WAX 11 7 11 20 12 39 
ANX-1 14 11 10 11 18 35 
ANX-2 11 8 10 9 14 48 
ANX-3 11 10 10 10 15 44 
ANX-4 13 14 9 14 12 38 
ANX-5 14 12 10 14 12 37 
ANX-6 14 13 10 11 14 38 
ANX-7 15 11 10 9 14 40 
ANX-8 10 13 11 11 14 42 
ANX-9 13 14 11 5 13 43 
CJX-1 12 11 10 12 13 42 
CJX-2 10 13 10 10 15 42 
CJX-3 13 12 12 10 12 41 
CJX-4 13 13 11 7 13 43 
CJX-5 14 12 10 8 15 42 
CJX-6 13 12 11 6 13 45 
CJX-7 14 11 11 8 14 43 
CJX-8 11 10 9 14 13 43 
CJX-9 13 11 11 11 13 42 
CAF-1 14 12 11 5 13 44 
CAF-2 13 11 9 8 13 46 
CAF-3 14 12 10 11 12 42 
CAF-4 13 11 11 9 13 43 
CAF-5 14 11 10 9 12 44 
CAF-6 13 9 9 11 13 44 
BAF-1 13 11 9 11 13 43 
BAF-2 14 10 10 11 14 40 
BAF-3 13 10 9 11 13 44 
BAF-4 14 10 9 11 13 44 
BAF-5 13 11 9 7 13 47 
BAF-6 15 11 10 9 13 43 
Each resonance corresponds to the following anomeric protons: Resonance 1, 
Anomeric proton of O-3 linked arabinose linked to monosubstituted xylose; 
Resonance 2, Anomeric proton of O-3 linked arabinose linked to disubstituted 
xylose; Resonance 3, Anomeric proton of O-2 linked arabinose linked to 
disubstituted xylose; Resonance 4, Anomeric proton of disubstituted xylose; 
Resonance 5, Anomeric proton of monosubstituted xylose; Resonance 6, Anomeric 
proton of unsubstituted xylose 
aEnzymatic treatments were carried out using the following enzymes: ANX, endo-
1,4-β-Xylanase M4 (Aspergillus niger); CJX, Endo-1,4-β-Xylanase (Cellvibrio 
japonicus); BAF, α-L-Arabinofuranosidase (novel specificity) (Bifidobacterium 
adolescentis); CAF, α-L-Arabinofuranosidase (Clostridium thermocellum); each 
sample name starting with corresponding enzyme abbreviation received that 
specific enzyme treatment first.  
 
When CAF-1 and BAF-1 was considered, as expected the CAF-1 consisted with lesser 
linkages corresponding to 3-substituted xylose compared to BAF-1. This is in agreement with the 
substrate specificity of the CAF enzyme which preferentially hydrolyzes the O-3-substitutes 
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arabinose from monosubstituted xylose (Taylor et al., 2006). On the other hand, BAF-1 contains 
slightly lesser proportion of disubstituted xylose compared to CAF-1. This is in agreement with 
the substrate specificity of BAF enzyme which hydrolyzes the O-3 linked arabinose from 
disubstituted xylose (Van den Broek et al., 2005). These indicate that the two 
arabinofuranosidases used in the current research can be effectively used for the specific 
hydrolysis of desired arabinose side groups to produce hydrolysis products with intended 
properties. According to the GC-FID results between BAF-1 and CAF-1, BAF enzyme was 
shown to be better equipped for the removal of arabinose as evident by the low A/X ratio for 
BAF-1 compared to CAF-1. However, this observation was not supported by the linkage analysis 
results. Both BAF-1 and CAF-1 had linkage profiles with close resemblance. 
Between BAF-1 (hydrolysis with BAF only) and BAF-4 (hydrolysis with BAF followed 
by CAF), BAF-4 as expected, consists of high proportion of unsubstituted xylose indicating that 
the two enzymes considerably removed the arabinose side groups from the xylan backbone 
resulting in a less complex structure. Between CAF-1 (hydrolysis with CAF only) and CAF-4 
(hydrolysis with CAF followed by BAF) also a similar increase in unsubstituted xylose 
proportion was observed. However, this change was more prominent for the BAF series. 
Between BAF-4 and CAF-4, BAF-4 had higher amount of unsubstituted xylose as well as lesser 
amount of disubstituted xylose indicating that although both BAF-4 and CAF-4 received similar 
enzymatic treatments the sequence of each enzyme addition (BAF followed by CAF vs CAF 
followed by BAF) is important. 
2.4.5. Canonical discriminant analysis of the AXH   
Canonical discriminant analysis (CDA) was performed on the chemical/ structural detail 
to classify the 30 AXH into four groups according to the first hydrolysis enzyme applied. Total 
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AX %, A/X ratio, resonance integration results from 1H-NMR (resonance 1-6), linkage analysis 
data from GC-MS (9 linkage types and product of total AX% × O-3 substituted xylose 
proportion)  were considered in the CAD. Two canonical variables in the form: 
CS = b1x1 + b2x2 + ⋯ + bnxn + c  
were created, where CS is the canonical score formed by the canonical function; the b’s are 
canonical coefficients that reflect the unique contribution of each chemical/structural detail to the 
classification of AXH, the x’s are individual chemical/structural parameters, and c is a constant. 
Two canonical variables accounted for 75.7 % of variance (44.6% for canonical variable 1 and 
31.0 % for canonical variable 2).  A scatterplot (Figure 2.4) relative to two canonical variables 
shows a good separation among different types of AXH indicating that there were chemical/ 
structural similarities in AXH belonging to a specific series. 
2.5. Conclusions 
The current research was carried out to generate structurally different arabinoxylan 
hydrolyzates (AXH) by means of using different combinations of xylanase and 
arabinofuranosidase enzymes. The AXH consisted predominantly of xylose (14.36-38.77%), 
followed by arabinose (8.26-18.79%). The average molecular weights of the AXH varied 
between 0.78-5.64 million Da. The starting material WAX had an average molecular weight of 
5.61 million Da.The CJX series resulted in lower molecular weights compared to ANX series 
which is in agreement with the substrate specificity of each of the two xylanases. BAF series 
AXH yielded larger polysaccharides compared to the corresponding CAF series AXH. Treatment 
with CJX following arabinofuranosidase treatment yielded higher molecular weight AXH 
compared to treatment with ANX following arabinofuranosidase treatment in both BAF and 
CAF series. Adding the arabinofuranosidase treatments in sequence of CAF followed by BAF 
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was more effective in producing smaller molecular weight polysaccharides compared to adding 
BAF followed by CAF. 
In general, the AXH had high proportion of unsubstituted xylose and lesser amount of di- 
or mono-substituted xylose as indicated by 1H-NMR and GC-MS data. In the ANX series, as the 
reaction time was increased from 0-12 h the proportion of unsubstituted xylose increased and 
structural complexity such as disubstituted xylose content and substituted arabinose content 
decreased.
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Figure 2.4. 2D scatterplot of canonical scores. Scatterplot relative to two canonical variables 
(Can 1 and Can 2) showed separation among different types of AXH. The two canonical 
variables accounted for 75.7 % of variance (44.6% for canonical variable 1 and 31.0 % for 
canonical variable 2) indicating that there were chemical/ structural similarities in AXH 
belonging to a specific series. Can 1: canonical variable 1; Can 2: canonical variable 2; Series 1: 
ANX series; Series 2: CJX series; Series 3: CAF series; Series 4: BAF series.  
Thus, ANX seems to result in highly unsubstituted AXH. However, this trend was 
reversed with CJX series. In CJX series as enzymatic reaction time increased from 0-12 h (CJX-
3) the amount of unsubstituted xylose decreased and the disubstituted xylose content and 
substituted arabinose content increased. This indicate that between the two xylanases, ANX 
might be an enzyme of choice for the production of arabinoxylan hydrolyzates with simple 
structural details while CJX might be selected for the production of arabinoxylan hydrolyzates 
with more complex structural features. 
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Comparison of BAF-4 and CAF-4 indicating that addition BAF followed by CAF is more 
effective in generating AXH with higher amount of unsubstituted xylose as well as lesser amount 
of disubstituted xylose.  
Overall, the enzymatic treatments applied in the current research effectively generated 
thirty different arabinoxylan hydrolyzates. The information derived about the capabilities of the 
two xylanases and two arabinofuranosidase could be important information in decisions made 
regarding which enzyme to be applied in a process to generate hydrolysis products of desired 
structural features. Also, these hydrolyzates could be useful as substrate for future research 
exploring the effect of each of these fine structural details on different physiological properties. 
Such research could indicate the importance specific composition/structure details have on the 
wheat derived arabinoxylan hydrolyzates as biological functional molecules within the human 
body or as physical functional molecules in wheat based processing industries such as baking.  
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CHAPTER 3. ARABINOXYLAN HYDROLYZATES AS IMMUNOMODULATORS IN 
LIPOPOLYSACCHARIDE-INDUCED RAW 264.7 MACROPHAGES. 
3.1. Abstract 
Inflammation is an important healthy immune response by the body during lesions and 
infection. However, uncontrolled excessive inflammation can be damaging to the cells. The 
specific objective of this research was to evaluate the effect of structural details of enzymatically 
derived wheat arabinoxylan hydrolyzates (AXH) on their immunomodulatory properties. The 
LPS induced macrophage cell line is a model widely used to study inflammation. The AXH 
being tested exhibited both pro- and anti-inflammatory properties. Some of the hydrolyzates 
increased the production of NO compared to the control while some AXH decreased the NO 
production. Out of the 30 AXH, six showed anti-inflammatory properties while four exhibited 
pro-inflammatory properties. ANX-6 displayed the highest anti-inflammatory property while 
CJX-2 showed the highest pro-inflammatory property. The AXH with pro-inflammatory 
properties had higher weight average molecular weights while lower molecular weights were 
seen for AXH with anti-inflammatory properties. Apart from molecular weight, total AX content 
also played a role in governing the anti/pro-inflammatory properties. Anti-inflammatory 
compounds had higher total AX content compared to pro-inflammatory compounds. A strong 
negative correlation was seen between NO production and total AX × amount of 1,4-linked 
xylose with arabinose substituted at O- 3- position.  Thus, AXH with higher AX and substitution 
at O-3 position are favorable candidates to reduce the LPS induced inflammation. These results 
indicate that there might be a structure-function relationship for these AXH as 
immunomodulators. 
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3.2. Introduction 
Arabinoxylan (AX) is the predominant polysaccharide in the cell wall of wheat grain 
(Saulnier et al., 2007). It consists of a backbone of β-(1,4)-linked xylose residues, which are 
substituted with arabinose residues on the C(O)-2 and/or C(O)-3 position (Dornez et al., 2009). 
Since AX is mainly composed of xylose and arabinose, it is commonly referred to as pentosans. 
Phenolic acids such as ferulic acid can be ester linked on the C(O)-5 position of arabinose 
(Figure 1.2). Endo-β-(1,4)-d-xylanases (EC 3.2.1.8, xylanase)  are the major enzymes involved 
in AX degradation. They cleave AX by internally hydrolyzing the 1,4- β-D-xylosidic linkage 
between xylose residues in the xylan backbone in a random manner (Collins et al., 2005; Dornez 
et al., 2009) giving rise to arabinoxylan hydrolyzates (AXH) of different degree of 
polymerization (DP). The enzyme α-l-arabinofuranosidases (EC 3.2.1.55) remove arabinose 
substituents from the xylan backbone (Dornez et al., 2009) yielding AX of different degree of 
arabinose substitution (DS). Thus, treatment of AX polysaccharide with various xylanases and 
arabinofuranosidases can yield AXH with variable DP and DS.  Most of the glycoside hydrolases 
that are classified in Glycoside hydrolase family 10 (GH10) are endo-β-1,4-xylanases (e.g. endo-
1,4-β-xylanase from Cellvibrio japonicus) (Pollet et al., 2010). GH10 xylanases attack both 
linear substrates as well as substituted heteroxylans. They attack the xylosidic linkage next to a 
single or double substituted xylose toward the non-reducing end and require two unsubstituted 
xylose residues between branched residues (Figure 2.2). Thus, they can hydrolyze AX with high 
degree of substitution (DS) into smaller fragments. GH11 xylanases (e.g. endo-1,4-β-xylanase 
M4 from Aspergillus niger) exclusively consist of true endo-β-1,4-xylanases that cleave internal 
β-1,4-xylosidic bonds and preferably cleave unsubstiuted regions of the backbone (Pollet et al., 
2010). GH11 cannot attack the xylosidic linkage toward the non-reducing end next to a branched 
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xylose and require three unsubstituted consecutive xylose residues for hydrolysis (Figure 2.2). 
Hence, GH11 xylanases have a low activity on heteroxylans with a high DS. Only C3-linked 
arabinose residues from double-substituted xylose residues are hydrolyzed by Arabinoxylan 
arabinofuranohydrolases from Bifidobacterium adolescentis (GH 43) (van den Broek et al., 
2005) while α-L-arabinofuranosidase from Clostridium thermocellum (GH51) catalyse the 
hydrolysis of “α-1,5-linked arabino-oligosaccharides and the α-1,3 arabinosyl side chain 
decorations of xylan with equal efficiency” (Taylor et al., 2006).  Thus, it is also highly efficient 
in the removal of the α-1,3-linked arabinoside substitutions from wheat arabinoxylan itself 
(Taylor et al., 2006). 
Inflammation is an adaptive response that is triggered by noxious stimuli and conditions, 
such as infection and tissue injury (Medzhitov, 2008). Under healthy physiological conditions 
inflammation is a defense response that serves a protective function in the body. However, 
inflammation can be detrimental if deregulated. At a basic level, acute inflammatory responses 
triggered by infection and tissue injury involve the organized delivery of blood components to 
the site of injury. This response, when triggered by microbial infections is prompted by receptors 
of the innate immune system such as Toll-like receptors (TLRs)) and NOD (nucleotide-binding 
oligomerization-domain protein)-like receptors (NLRs). Recognition of these triggers by 
macrophages and mast cells lead to the production of inflammatory mediators (chemokines, 
cytokines, vasoactive amines, eicosanoids and products of proteolytic cascades). One outcome of 
this initial inflammatory response is the production of large amount of reactive oxygen species 
(ROS), a process known as respiratory burst (Gwinn and Vallyathan, 2006; Robinson, 2009). 
Toxic compounds such as ROS, reactive nitrogen species, proteinase 3, cathepsin G and elastase 
are released by leucocytes with an attempt to mitigate invading agents. However, these highly 
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reactive compounds do not distinguish between microbial and self-cells leading to unavoidable 
collateral damage.  After a successful elimination of the infection, the recovery phase is initiated. 
This is mainly mediated by macrophages (Medzhitov, 2008). A shift in lipid mediators from pro-
inflammatory prostaglandins to anti-inflammatory lipoxins helps towards recovery. Also, growth 
factors produced by macrophages plays a role in tissue recovery.  An overview of the 
inflammatory outcomes is given in Figure 3.1. Although the mechanisms of infection-induced 
inflammation are understood to a higher extent, knowledge about mechanisms governing other 
forms of inflammation such as systemic chronic inflammation is still at its initial stages.  
Macrophages are tissue-based phagocytic cells derived from blood monocytes (Abbas 
and Lichtman, 2011). They play an important role in innate and adaptive immunity. Upon 
activation by microbial byproducts such as lipopolysaccharides (LPS) and T-cell cytokines such 
as interferon-γ, activated macrophages phagocytose and kill microbes, secrete proinflammatory 
cytokines and present antigens to helper T-cells. Macrophages express inducible isoforms of 
nitric oxide (NO) synthase (iNOS) upon activation by microbial or cytokine stimuli, which leads 
to the production of NO from L-arginine. Nitric oxide functions as a microbicidal agent that kills 
ingested microbes and also acts as a mediator of the immune system (Abbas and Lichtman, 2011; 
Moncada et al., 1991). Thus, LPS induced RAW 264.7 murine macrophages have been widely 
used as a model to study inflammatory responses (Fujihara et al., 2003; Liu et al., 2008; 
MacKenzie et al., 2013; MacKichan and DeFranco, 1999; Xu et al., 2012). Although NO is an 
essential bioregulatory molecule with diverse functions including neural signal transmission, 
immune response, and control of blood pressure, elevated levels of NO can lead to pathological 
inflammatory conditions (Moncada et al., 1991). Thus, mediation of the production of such 
inflammatory effector molecules is beneficial in the treatment of chronic inflammation derived 
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diseases such as rheumatoid arthritis, diabetes, atherosclerosis inflammatory bowel disease and 
cancer (Kim et al., 2012; Moncada et al., 1991).    
Immunomodulators are medications used to help regulate or normalize the immune 
system (American academy of allergy, 2014). The immunomodulatory effects of AX have been 
demonstrated by several researches in the recent years. AX extracted from wheat bran has been 
shown to have potent effects on innate and acquired immune response in mice (Cao et al., 2011). 
AX significantly increases the activation potential of T and B cells and enhances the humoral 
and cell-mediated immunity in tumor bearing mice. Akhtar et al. (2012) demonstrated that wheat 
bran derived AX has the potential to stimulate the antibody mediated immune response in 
chickens. However, there is a scarcity of research on understanding how the fine chemical 
structure of this complex polysaccharide affects its immunomodulatory properties. More so, no 
recent research is available on the immunomodulatory properties of enzymatically derived 
arabinoxylan hydrolyzates from wheat. Thus, we aimed to investigate how the fine chemical 
structure of enzymatically hydrolyzed AXH affects its immunomodulatory properties. 
3.3. Materials and Methods 
3.3.1. Materials  
Materials used for the production of AXH were previously described in section 2.3.1. 
Murine macrophage RAW 264.7 cell line (obtained from the American Type Culture Collection, 
ATCC), was a generous gift from Dr. Estelle Leclerc (Department of Pharmaceutical Sciences, 
North Dakota State University, ND). Dulbecco's Modified Eagle's Medium (DMEM) (ATCC® 
30-2002™) and Fetal Bovine Serum (FBS) (ATCC® 30-2020™) were from ATCC (Manassas, 
VA). Penicillin-Streptomycin solution (10,000 units/mL Penicillin/ 10,000 µg/mL Streptomycin) 
was purchased from HyClone Laboratories, Inc. (Logan, UT).  
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Figure 3.1. Overview of cause, physiological and pathological outcomes of inflammation (adapted from Medzhitov 
(2008)). 
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Lipopolysaccharides (LPS) (Escherichia coli 0111:B4, L4391-1MG, Lot No: 043M4089V) were 
purchased from Sigma-Aldrich (St. Louis MO). The Griess Reagent Kit for Nitrite 
Determination was from Molecular Probes, Inc. (Eugene, OR).  
3.3.2. Procedure for arabinoxylan hydrolyzate preparation  
AXH preparation was carried out as described in section 2.3.2 in a previous chapter. A 
summary of the treatments and the abbreviation given to the resulting AXH is given in Table 2.1. 
3.3.3. Chemical analysis 
The chemical analysis of the AXH was carried out as described in section 2.3.3 using 
GC-FID, SEC-MALS, 1H-NMR and GC-FID techniques. 
3.3.4. Determination of immunomodulatory properties of AXH 
Thirty different arabinoxylan hydrolyzates were evaluated for their immunomodulatory 
properties in LPS induced macrophages. RAW 264.7 macrophages were grown in DMEM media 
supplemented with 10% FBS and 1% Penicillin-Streptomycin solution at 37 oC under a 
humidified atmosphere of 95% air and 5% CO2. 
3.3.4.1. Effect of AXH on NO production in RAW 264.7 cells 
RAW 264.7 cells were plated at 1x105 cells/100 µL cell density (100 µL) in 96 well plate 
wells and incubated overnight. Next day, the AXH (2000 µg/mL) dissolved in serum free-
antibiotic free DMEM were added (50 µL) to each well. Wells receiving serum free-antibiotic 
free DMEM were used as control wells. Indomethacin (50 µL, 80 µg/mL, PHR1247 Fluka, 
Sigma-Aldrich (St. Louis MO)), a nonsteroidal anti-inflammatory drug (NSAID) which brings 
about its anti-inflammatory effects through the inhibition of cyclooxygenase (COX) (Edogawa et 
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al., 2014), in serum free-antibiotic free DMEM was used as the positive control. After 2 h 
incubation with each pre-treatment, 50 µL of LPS dissolved in serum free-antibiotic free DMEM 
(4 µg/mL) was added to each well to induce inflammation at a final concentration of 1 µg/mL. 
Thus, the final concentration of the AXH in a well was 500 µg/mL. The cells were incubated for 
24 h.  Nitric oxide production was determined based on the amount of nitrite, a stable end 
product of NO. Nitrite concentration in media supernatants was determined using the Griess 
reaction. Griess reaction was carried out according to manufacturer’s instructions with some 
modifications: media supernatant (100 µL) was aspired out from each well and transferred to a 
new 96 well plate where the Griess reagent (1% sulfanilamide in 2.5% phosphoric acid and 0.1% 
naphthylenediamine dihydrochloride in water, 100 µL) was added. Nitrite standard solutions 
provided with the kit were used to develop a standard curve for absorbance vs. nitrite 
concentration. The Griess reaction was allowed to take place in the dark for 30 min. Absorbance 
of each well was read at 548 nm using a microplate reader (Molecular Devices, Sunnyvale, CA). 
The amount of nitrite produced in each treatment group was calculated based on the standard 
curve. 
3.3.4.2. Effect of different AXH doses on NO production in RAW 264.7 cells 
 Six AXH (CJX-1, CJX-2, CJX-3, ANX-6, ANX-7 and ANX-8) were further evaluated 
for their effect on NO production at different doses. The experimental procedure was carried out 
as described in section 3.2.4.1. and six different doses (1000, 500, 250, 125, 62.5 and 31.25 
µg/mL final concentration in each well) of each of the six AXH were used in the assay. The 
experiments were conducted in duplicate.  
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3.3.5. Statistical analysis 
 All the cell culture experiments were done in duplicate. The data are presented as the 
means ± SE and were subjected to one way ANOVA using LSD test procedure employing 
Statistical Analysis System software package version 9.4 (SAS Institute, Cary, NC). A least 
significant difference (LSD) with a 5 % significance level was used to declare differences. 
Differences were considered significant when the probability value p was lower than 0.05.  
Pearson's correlation analysis was conducted to evaluate relationships between 
immunological outcomes and AXH composition/structural details.  
3.4. Results and Discussion 
3.4.1. Composition and structural analysis of AXH 
Extensive discussions on the fine structural details of the AXH are discussed in a 
previous chapter (Chapter 2). The sugar composition, total AX % and the A/X ration of the 
WAX and the resulting AXH are given in Table 2.2. The weight average molecular weights and 
polydispersity index of each AXH is presented in Table 2.3.The 1H-NMR resonance integrations for 
WAX and AXH  are in Table 2.4. The linkage analysis results of each AXH are depicted in Figure 2.3.   
3.4.2. Immunomodulatory properties of thirty AXH 
The specific objective of this research was to evaluate the effect of structural details of 
AXH on their immunomodulatory properties. The LPS induced macrophage cell line is a model 
widely used to study inflammation. Thus, the effect of each AX hydrolyzates on altering the LPS 
induced inflammation with respect to NO was evaluated. The cells that were induced with LPS 
but did not receive any AXH was regarded as the control treatment. Indomethacin was used as 
the positive control. The results are illustrated in Figure 3.2. Inflammation is an important 
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healthy immune response by the body during lesions and infection. However, uncontrolled 
excessive inflammation can be damaging to the cells. Excessive inflammation can lead to several 
acute and chronic diseases characterized by excessive production of pro-inflammatory cytokines, 
eicosanoids derived from arachidonic acid, reactive oxygen species and adhesion molecules 
(Kumar et al., 2002; Vernaza et al., 2012). Thus, food components that regulate inflammatory 
and oxidative stress responses are of vital need.  On the other hand, inflammation is not 
necessarily a negative response. A healthy amount of inflammation is necessary for the 
maintenance of health. This fine balance between acute inflammation and chronic inflammation 
lead to health or disease. The AXH being tested exhibited both pro- and anti-inflammatory 
properties. Some of the hydrolyzates increased the production of NO compared to the control 
while some AXH decreased the NO production.  
As shown in Figure. 3.2, the effects of AXH varied from each other. Indomethacin was 
used as a positive control. The treatment of cells with AXH without LPS induction did not result 
in a significant increase in NO production compared to cells that did not receive an AXH 
treatment  which indicates that AXH themselves are not inducing NO production in 
macrophages. This ruled out possible LPS contamination in the AXH. 
Physiologically, NO induces oxidative stress and causes the release of oxygen and 
nitrogen reactive species which are important in the elimination of engulfed microbes by 
macrophages (Vernaza et al., 2012). It also contributes to the killing of tumor cells through 
activated macrophages and mediates a variety of biological functions as an intracellular 
messenger molecule (Palmer et al., 1988). However, enhanced NO production, mainly via 
inducible nitric oxide synthase (iNOS) activity is also associated with colonic inflammation 
(Rodriüguez-Cabezas et al., 2003). Thus, AXH that reduce the production of NO might be 
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beneficial for patients with inflammatory bowel disease (IBD) and need further investigation. 
Rodriüguez-Cabezas et al., (2003) observed that anti-inflammatory effects of dietary fibers were 
associated with a significant inhibition of colonic nitric oxide synthase (NOS) activity.  
Seventeen of the 30 AXH lowered LPS induced NO production in macrophages 
compared to cells that did not receive an AXH treatment. These results indicate some anti-
inflammatory properties among these AXH.  Indomethacin was displaying higher NO 
suppression than the AXH. In a dietary point of view, these polysaccharides are intended to 
enforce immunological outcomes as a result of frequent consumption of these wheat derived 
polysaccharides over a period of time. Thus, consumption of food rich in AXH of this nature 
could be beneficial. Future research on the dose dependent effect of these AXH could provide 
more information about their potency. The rest of the AXH caused an increase in NO production 
in the LPS induced cells. This suggests immune-stimulatory properties of these AXH. Although 
over expression of immune responses are detrimental to the health, immune-enhancing properties 
can be beneficial in terms of NO mediated cytotoxicity properties in macrophages (Moncada et 
al., 1991). Such pro-inflammatory compounds could exert benefits to the immune system by 
stimulating the immune cells. These pro-inflammatory AXH could have potential role as 
immunostimulator which might be beneficial in immune compromised individuals. 
Out of the 30 AXH, ten AXH were identified to contain statistically significant 
differences compared to the control (Table 3.1). Six AXH (ANX-6, CAF-3, ANX-8, CAF-6, 
CAF-2 and ANX-7 in the descending order of activity) showed anti-inflammatory properties 
while four AXH (CJX-2, CAF-1, CJX-1 and CJX-3 in the descending order of activity) exhibited 
pro-inflammatory properties. ANX-6 displayed the highest anti-inflammatory property while 
CJX-2 showed the highest pro-inflammatory property.
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Figure 3.2. Effect of AXH on nitric oxide production in LPS induced NO production in macrophages. Control: cells treated with 
DMEM; positive control: cells treated with Indomethacin; ANX-1 to BAF-6: cells treated with corresponding AXH. Data are 
presented as mean ± SD. LSD, least significant difference (P<0.05). Values differing more than LSD are significantly different from 
each other.
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The AXH with the highest anti-inflammatory properties and those with the highest pro-
inflammatory properties were selected and further evaluated for the contribution of their 
structure to such properties. We compared the structures of CJX-2 and CAF-1 (highest pro-
inflammatory properties) and ANX-6 and CAF-3 (highest anti-inflammatory properties) to 
identify any structure function relationship. Several important differences were evident among 
the two groups of AXH. The AXH with pro-inflammatory properties had higher weight average 
molecular weights (e.g. 5.64 million Da) while lower molecular weights (e.g. 0.78 million Da) 
were seen for AXH with anti-inflammatory properties. This suggests that the weight of the AXH 
polymers seems to have an effect in governing their immunomodulatory properties. This 
contradicts Mikkelsen et al (2014), who evaluated the immunological properties of beta-glucan 
and concluded that the immune response doesn’t depend on molecular mass of the beta-glucan 
polysaccharides. However, Mikkelsen et al. (2014) also stated that these conclusions could have 
been caused by the narrow molecular mass range (130-410 kDa) used in that study. In the 
contrary, the current study employed AXH of a wider range of molecular weights ranging from 
c.a. 0.78 to 5.64 million Da. Thus, the contribution from molecular weight to immunomodulatory 
properties was more detectable in the current study. Even though the molecular weight of a 
polysaccharide does not give an idea about its size in the solution, we could assume that the 
AXH with larger molecular weights were of larger size compared to the AXH with smaller 
molecular weight. Using the Dectin-1 receptor, a receptor for beta-glucan, Goodridge et al 
(2011) showed that unlike some other pattern recognition receptors, such as Toll-like receptors 
(TLRs) which are activated by soluble ligands, Dectin-1 receptors are only activated by 
particulate beta-glucans, (and not soluble beta-glucans) “which cluster the receptor in synapse-
like structures from which regulatory tyrosine phosphatases CD45 and CD148 are excluded” 
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which results in its activation. Mikkelsen et al (2014) also hypothesized a similar model to 
explain his finding regarding soluble and aggregated beta-glucan in solution. In a similar sense, 
the higher molecular weight AXH might have a clustering effect on its receptors due to its larger 
sizes that might result in activation of its receptors, and account for the pro-inflammatory 
properties of AXH with larger molecular weights. In general, to trigger an immune response, the 
polysaccharide must collide with its receptor on the cell surface. The polysaccharides with larger 
molecular weights, and thus, with larger sizes, are more effective in making sufficient collisions 
with their receptors (Leung et al., 2006). Also, polysaccharides with larger molecular weights 
have larger number of repeating units that increases their chances of making effective bonding 
with the receptors (Leung et al., 2006).  
 
 
 
 
 
 
 
Apart from molecular weight, total AX content in each AXH also played a role in 
governing the anti/pro-inflammatory properties of these compounds. ANX-6 and CAF-3 which 
showed the highest anti-inflammatory properties had higher total AX content compared to CJX-2 
and CAF-1 which exhibited the highest pro-inflammatory properties. There were significant 
Table 3.1. AXHa with anti-inflammatory and pro-inflammatory propertiesb. 
Anti-
inflammatory 
properties 
Percent decrease in NO 
production compared to 
control (%) 
Pro-inflammatory 
properties 
Percent increase in NO 
production compared to 
control (%) 
ANX-6 24.1 CJX-2 14.2 
CAF-3 21.7 CAF-1 13.3 
ANX-8 16.0 CJX-1 12.2 
CAF-6 15.4 CJX-3 10.4 
CAF-2 12.4   
ANX-7 11.9   
aEnzymatic treatments were carried out using the following enzymes: ANX, endo-
1,4-β-Xylanase M4 (Aspergillus niger); CJX, Endo-1,4-β-Xylanase (Cellvibrio 
japonicus); CAF, α-L-Arabinofuranosidase (Clostridium thermocellum); each 
sample name starting with corresponding enzyme abbreviation received that 
specific enzyme treatment first.  bThe AXH  are presented in their descending order 
of potency.  
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differences among the fine structural details of these AXH as well. The three anti-inflammatory 
AXH, ANX-6 and CAF-3 had lower amount of terminal xylose residues, higher amount of 1-4-
linked xylose residues and higher amount of 1-4-linked xylose with substitution at O-3- position 
compared to the three pro-inflammatory AXH, CJX-2 and CAF-1. The importance of polymer 
side branching on its immunological properties has also been emphasized by other researches 
(Adams et al., 2008; Mikkelsen et al., 2014). Zhou et al (2010) suggested that “immune-
enhancing function of wheat bran AX is related to the molecular weight, chemical composition 
and substituted degree or branch of arabinose.” Similarly, the fine structural details might play a 
role in governing the immunological properties of the AXH in the current study.  
3.4.3. Effect of different AXH doses on NO production  
Six AXH were further investigated for their dose-dependent effect on LPS induced RAW 
264.7 cells. The cells were treated with different doses of six AXH and NO levels were 
investigated. Although there was a slight increase in NO production in cells treated with each 
AXH at highest concentration (1000 µg/mL) compared to the cells that did not receive any AXH 
treatment, this increased NO production was relatively low compared to NO production in cells 
upon induction with LPS (Figure 3.3). Thus, we could assume that the endotoxin levels in AXH 
used in this study was negligible.  
Overall, all the six AXH dose-dependently increased LPS induced NO production. 
However, CJX-3, ANX-6 and ANX-8 showed prominent dose dependent responses. Previous 
researches had demonstrated dose-dependent suppression of NO production in LPS induced cells 
upon treatment with yeast beta-glucans (Xu et al., 2012). However, other researches had reported 
dose-dependent increase of NO production by mushroom derived beta-glucans (Volman et al., 
2010). In the current research, AXH increased NO production with increasing concentration. 
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This indicates that the AXH being investigated might have pro-inflammatory effects in a dose-
dependent manner. These results make AXH an interesting food component that needs to be 
further investigated as immunomodulators that can be useful to revive depressed states of 
immunity. Activation of macrophages is an important innate immune response that serves a 
defense purpose. Wheat bran AX has been shown to enhance phagocytic activity of macrophages 
in animals (Zhou et al., 2010). Our results also indicate activation of LPS induced macrophages 
by AXH under study. 
3.4.4. Correlation analysis between NO production and chemical properties of thirty AXH  
Correlation analysis of the data indicates that there is a strong negative correlation (-
0.538) between the amount of 1,4-linked xylose with arabinose substituted at O- 3- position and 
the NO production. A stronger negative correlation (-0.616) was seen when the amount of total 
AX was also taken into account (i.e. correlation between NO production and total AX into 
amount of 1,4-linked xylose with arabinose substituted at O- 3- position).  This association is 
shown in Figure 3.4. This indicates that AXH with higher AX and substitution at O-3 position 
are favorable candidates to reduce the LPS induced inflammation. Kim et al (2012) investigated 
the anti-inflammatory activity of hydroxycinnamic acid derivatives isolated from corn bran in 
LPS-stimulated Raw 264.7 macrophages and observed that phenolic amide and ferulic acid 
moieties may be responsible for inhibiting NO production.  
These results support our finding in which higher amount of arabinose substituted at O- 
3- position (GP9) might carry higher phenolic moieties along with it and result in higher 
inhibition of NO production. The exact molecular mechanisms involved in AX uptake by the 
intestinal epithelial cells or the macrophages are not yet clearly understood. However, in the case 
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of beta-glucan, a vastly studied polysaccharide, there is extensive literature identifying the 
specific receptors involved in recognition of beta-glucan by cells.  
There are two main receptors involved in beta-glucan recognition (Hong et al., 2004). 
Dectin-1, a signaling non-TLR pattern recognition receptor is a major receptor involved in beta-
glucan recognition in macrophages (Brown, 2006; Brown et al., 2002; Hong et al., 2004). The 
second receptor, CR3 is less present in macrophages (Hong et al., 2004). While dectin-1 exerts 
its action via phagocytosis, CR3 achieves this function via granulocytes and relies on the 
complement system (Hong et al., 2004). Just as macrophages possesses specific receptors that 
ligate with beta-glucan, it is possible that the macrophages possess other pattern recognition 
receptors that specifically identify AX and that these receptors are involved in bringing about the 
specific immunological outcomes as evident by increased NO production. Lee et al (2008) 
demonstrated that NO production induced by mushroom polysaccharide can be markedly 
suppressed by function blocking antibodies to dectin-1. Though it is still too early to draw such 
conclusions about the molecular mechanism as to how the AXH exhibit its anti-inflammatory 
properties, the possibility of these AXH acting as inhibitory molecules to specific pattern 
recognition molecules in the cell surface can be a potential research area that needs to be 
explored.  
Nuclear factor-κB (NF-κB) is an important transcription factor involved in various 
immunological processes including cytokine production, phagocytosis and respiratory burst 
(Volman et al., 2008).  Mitogen-activated protein kinase (MAPK) phosphorylation is a 
prerequisite for NO and cytokine productions in stimulated macrophages (Dean et al., 1999) and 
NF-κB activation is dependent on activation of MAPK (Olson et al., 2007).
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Figure 3.3. Effect of different doses of six AXH on nitric oxide production in LPS induced NO production in macrophages. Control: 
cells treated with DMEM; positive control: cells treated with Indomethacin; CJX-1 to ANX-8: cells treated with corresponding AXH. 
Data are presented as mean ± SD. LSD, least significant difference (P<0.05). Values differing more than LSD are significantly 
different from each other. 
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Figure 3.4. Association between NO production and total AX (TAX) into amount of 1,4-linked 
xylose with arabinose substituted at O- 3- position (GP9). 
Several researches have demonstrated the involvement of NF-κB in cellular pathways triggered 
by botanical polysaccharides (Lee et al., 2013; Schepetkin and Quinn, 2006; Volman et al., 
2008). Polysaccharides from fermented soybean were shown to increase NO and TNF-α 
production by activating the MAPK and NF-κB signaling pathways in macrophages (Lee et al., 
2013). Reviews by Schepetkin and Quinn (2006) and Volman et al. (2008) describe the 
involvement of pattern recognition receptors such as toll-like receptor (TLR), scavenger receptor 
(SR), complement receptor type 3 (CR3), and mannose receptor (MR) in recognition of botanical 
polysaccharides by cells. “Plant polysaccharides can also be phagocytosed, leading to activation 
of unknown intracellular targets” and it is also “likely that several different receptor types 
cooperate with each other, forming clusters of signaling complexes” (Schepetkin and Quinn, 
2006). A schematic model illustrating potential signaling pathways involved in macrophage 
activation by botanical polysaccharides can be illustrated as follows (Figure 3.5) as reviewed by 
Schepetkin and Quinn (2006). However, there is scarcity of research investigating the 
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underlining molecular mechanisms of how AXH modulate the immune function in cells and this 
area needs to be further investigated. To date, the exact mechanism of processes executed by 
cells upon encounter of arabinoxylans has not been well defined.  
3.5. Conclusions 
Use of plant derived polysaccharides as health promoter has gained immense interest in 
the past few years. The current research aimed to investigate the structure-function relationship 
of enzymatically tailored AXH as immunomodulators using LPS induced RAW 264.7 
macrophage cell line. Our results indicate that under the enzymatic conditions used, structurally 
different AXH could be produced and that these AXH had varying immunomodulatory 
properties. Out of the 30 different AXH, 10 AXH that indicated strong immunomodulatory 
properties were identified. These AXH had either pro-inflammatory properties or anti-
inflammatory properties. The pro-inflammatory AXH had higher molecular weights compared to 
the anti-inflammatory AXH. Fine structural differences were also evident between these two pro- 
and anti- inflammatory groups of AXH. These results indicate that there might be a structure-
function relationship for these AXH as immunomodulators. Further research is needed to 
evaluate the dose dependence of these AXH on immune system cells and also to identify the 
cellular mechanisms involved in exerting the observed outcomes for these compounds.  
 
 
 91 
 
 
Figure 3.5. Schematic model illustrating potential signaling pathways involved in macrophage 
activation by botanical polysaccharides. Polysaccharides can activate macrophages via 
complement receptor 3 (CR3), mannose receptor (MR), scavenger receptor (SR), Dectin-1 and 
Toll-like receptor 4 (TLR4). SR- and CR3-activated signaling pathways lead to activation of 
mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB). Ultimately, these 
pathways lead to induction of gene transcription. MR activation leads to activation of 
macrophage phagocytosis, oxidant production, endocytosis and NF-κB. TLR-4 ligation leads to 
the activation of IL-1R-associated kinase (IRAK) via an adaptor myeloid differentiation protein 
88 (MyD88), with subsequent activation of MAPK and NF-κB. Activation of these transcription 
pathways induces expression of pro-inflammatory cytokines and inducible nitric oxide synthase 
(iNOS). Adapted from Schepetkin and Quinn (2006). 
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CHAPTER 4. ARABINOXYLAN HYDROLYZATES AS IMMUNOMODULATORS IN 
CACO-2 AND HT-29 HUMAN INTESTINAL CELL LINES 
4.1. Abstract 
Use of plant derived polysaccharides as health promoter has gained immense interest in 
the past few years. Arabinoxylans (AX) are the predominant non-starch polysaccharide in cereals 
and grasses including wheat. The current research aimed to investigate the structure-function 
relationship of arabinoxylan hydrolyzates (AXH) obtained by enzymatic hydrolysis of AX using 
xylanase and arabinofuranosidase as immunomodulators using LPS induced colon cancer cell 
lines: Caco-2 and HT-29. Fine structural details had a strong correlation with the immunological 
properties of the wheat AXH.  The immunological properties of the AXH might not be 
dependent on each fine structural detail independently but rather dependent upon a combination 
of structural details. The 12 different AXH being tested showed different immunological 
properties with respect to cell type and the cytokine of interest. These results indicate that there 
might be a structure-function relationship for these AXH as immunomodulators.  
4.2. Introduction 
Arabinoxylan (AX) is the predominant polysaccharide in the cell wall of wheat grain 
(Saulnier et al., 2007). It consists of a backbone of β-(1,4)-linked xylose residues, which are 
substituted with arabinose residues on the C(O)-2 and/or C(O)-3 position (Dornez et al., 2009). 
Since AX is mainly composed of xylose and arabinose, it is commonly referred to as pentosans. 
Phenolic acids such as ferulic acid can be ester linked on the C(O)-5 position of arabinose 
(Figure 1.2).  
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As the human body lack the enzymes required to hydrolyze the β-glycosidic linkages, AX 
are not digested by the human digestive enzymes (Carvalho et al., 2013). Thus, they reach the 
large intestine intact and are considered dietary fibers (under the category of non-starch 
polysaccharides) (Lafiandra et al., 2014). Owing to these properties they are capable of exerting 
the health benefits such as weight management, lowering glycemic response, prevention of 
several non-communicable diseases such as cardiovascular diseases, type II diabetes and cancer 
(Lafiandra et al., 2014; Mendis and Simsek, 2014). Most of these effects are related to the 
viscosity effects of dietary fibers which hinder the mixing and diffusion of enzymes to the 
substrate as well as diffusion of products such as glucose to the enterocytes (Lafiandra et al., 
2014). The anti-cancer effects of dietary fibers are mostly related to the effects of short chain 
fatty acids that are produced by the microbial fermentation of these dietary fibers. However, the 
immunomodulatory properties of dietary fibers are not to be undermined (Mendis and Simsek, 
2014; Tzianabos, 2000; Zhou et al., 2010).  
Inflammation is an adaptive response that is triggered by noxious stimuli and conditions, 
such as infection and tissue injury (Medzhitov, 2008). Under healthy physiological conditions 
inflammation is a defense response that serves a protective function in the body. However, 
inflammation can be detrimental if deregulated. At a basic level, acute inflammatory responses 
triggered by infection and tissue injury involve the organized delivery of blood components to 
the site of injury. This response, when triggered by microbial infections is activated by receptors 
of the innate immune system such as Toll-like receptors (TLRs)) and NOD (nucleotide-binding 
oligomerization-domain protein)-like receptors (NLRs). Recognition of these triggers by cells 
leads to the production of inflammatory mediators (chemokines, cytokines, vasoactive amines, 
eicosanoids and products of proteolytic cascades).  
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The intestinal barrier acts as a first line of defense against many foreign agents that pass 
through the intestinal tract (Figure 1.10). It comprises of the monolayer of intestinal epithelial 
cells that display a number of specialized adaptations to maintain its barrier function (Schenk and 
Mueller, 2008).  These include the formation of tight junctions to seal the paracellular spaces, 
secretion of mucins by globlet cells that form the mucus layer at the apical surface of the 
intestinal epithelial cells, and secretion of antimicrobial agents such as alpha-defensins, and 
secretion of lysozyme and cathelicidins by Paneth cells that hinders the penetration of luminal 
agents and microbes into the intestinal mucosa (Schenk and Mueller, 2008). Thus, intestinal 
epithelial cells play a vital role in contributing to gut immune system, mediating mucosal 
defense, barrier repair and identifying and developing tolerance to commensal microbes (Cario et 
al., 2000).  
 Thus, intestinal epithelial cells maintain a cross talk between the intestinal lumen and the 
underling immune cells (Van De Walle et al., 2010). On one hand, they selectively identify and 
response to luminal content by modulating the barrier permeability and produce inflammatory 
mediators which facilitate immune response by the underling immune cells. On the other hand, 
they respond to various inflammatory mediators secreted by immune cells by altering the barrier 
permeability and cellular secretions and result in amplification or attenuation of the 
inflammatory process. Thus, intestinal inflammation is a natural and protective function of the 
gastro-intestinal tract which helps maintain the health of the individual (Martin and Wallace, 
2006).  However, dysregulation of this inflammatory response can lead to detrimental effects. 
Inflammatory bowel disease (IBD), the collective name for Crohn’s disease and ulcerative 
colitis, is one such outcome (Neuman, 2007). The disease is characterized by “unpredictable 
attacks of inflammation of the intestine”. It affects as many as 1.4 million persons in the United 
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States and about 2.2 million persons in Europe (Loftus Jr, 2004).  The clinical symptoms include 
weight loss, diarrhea accompanied by blood, and abdominal pain (Podolsky, 2002). Although the 
etiology of the disease is not fully understood, a combination of environmental, genetic and 
immunologic factors seem to initiate an uncontrolled immune response in genetically 
predisposed individuals leading to the disease (Karlinger et al., 2000). A defective epithelial cell 
barrier function and elevated immune response leads to a self-amplifying loop, where increased 
epithelial permeability leads to increased introduction of luminal agents to the underlying 
immune cells, resulting in increased inflammatory response (Van De Walle et al., 2010). 
Cytokines are signaling proteins involved in inter-cell communication (Volman et al., 2008). The 
broadly pro-inflammatory cytokines, specifically tumor necrosis factor (TNF) and interleukin 
(IL)-1 and 6, which enhance the inflammatory processes, have been linked to the manifestation 
of the disease (Podolsky, 2002). In vitro, cytokines such as IL-1β, TNF-α, interferon (IFN)-ɣ and 
lipopolysaccharides (LPS) are capable of activating intracellular cascades in intestinal epithelial 
cells, increasing the transcription and secretion of IL-6 (Parikh et al., 1997), prostaglandin (PG)-
E2 (Grishin et al., 2004) (Wright et al., 2004) and nitric oxide (Forsythe et al., 2002).  
The human intestinal cell line, Caco-2 has been extensively used over the last years as a 
model of the intestinal barrier (Cosentino et al., 2010; Guo et al., 2014; Jung et al., 1995; Liboni 
et al., 2004; Morita et al., 2002; Sambuy et al., 2005; Van De Walle et al., 2010; Wang et al., 
2013). The parental cell line, originally obtained from a human colon adenocarcinoma, 
undergoes a process of spontaneous differentiation in culture leading to the formation of a 
monolayer of cells with several morphological and functional characteristics of mature 
enterocytes (Pinto M, 1983; Sambuy et al., 2005).  They grow into monolayer of cells with a 
cylindrical polarized morphology exhibiting microvilli on the apical side, tight junctions between 
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adjacent cells.  The human colorectal adenocarcinoma cell line, HT-29 established in 1964 
(Rousset, 1986) is another widely used model cell line for the study of intestinal features (Gong 
et al., 2014; Guri et al., 2012; Hajiaghaalipour et al., 2015; Huet et al., 1995; Kim et al., 2012; 
Rieder et al., 2011; Rousset, 1986). Under standard culture conditions HT-29 cells are 
undifferentiated and grow as a multilayer of unpolarized cells (Rousset, 1986). However, 
although mainly undifferentiated they contain a small proportion of mucus-secreting cells and 
columnar absorptive cells (Gagnon et al., 2013). These two model cell lines were employed in 
the current research to evaluate the immunomodulatory properties of the different AXH with 
respect to their structure.  
Immunomodulators or biologic response modifiers are compounds that interact with the 
host immune system and bring about upregulation or downregulation of specific immune 
responses (Tzianabos, 2000). The immunomodulatory properties of arabinoxylans and their 
enzymatic products such as xylo-oligosaccharides have been explored in the recent years. 
Immunostimulating activity of wheat bran derived AX was found to be higher than that for AX 
derived from corn husk or rice bran (Monobe et al., 2008). Arabinoxylans from wheat bran exert 
potent effects on innate and acquired immune system (Zhou et al., 2010).  Cao et al. (2011) 
investigated the anti-tumor activity of AX using mice and found that AX from wheat bran were 
significantly effective in inhibiting the growth of transplanted tumors. They classified AX as 
anti-tumor agents with immunomodulatory activity.  Also, AX were shown to have a possible 
effect on stimulating the antibody mediated immune response in chicken (Akhtar et al., 2012). 
As evident as it is, the exact cellular mechanism of how these immunomodulatory effects are 
brought about by the AX are still not well understood. More so, there is a scarcity of research on 
understanding how the fine chemical structure of this complex polysaccharide affects its 
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immunomodulatory properties. No recent research is available on the immunomodulatory 
properties of enzymatically derived arabinoxylan hydrolyzates from wheat. Thus, we aimed to 
investigate how the fine chemical structure of enzymatically hydrolyzed AXH affects its 
immunomodulatory properties. 
4.3. Materials and Methods 
4.3.1. Materials  
Materials used for the production of AXH were previously described in section 2.3.1. 
Human colorectal adenocarcinoma cell line HT-29 with epithelial morphology was a generous 
gift from Dr. Bin Guo (Department of Pharmaceutical Sciences, North Dakota State University, 
ND). The human colorectal adenocarcinoma cell line, Caco-2 was purchased from American 
Type Culture Collection (ATCC) (Manassas, VA). Eagle's Minimum Essential Medium 
(EMEM) (ATCC® 30-2003™), Dulbecco's Modified Eagle's Medium (DMEM) (ATCC® 30-
2002™) and Fetal Bovine Serum (FBS) (ATCC® 30-2020™) were from ATCC (Manassas, 
VA). Penicillin-Streptomycin solution (10,000 units/mL Penicillin/ 10,000 µg/mL Streptomycin) 
was purchased from HyClone Laboratories, Inc. (Logan, UT). Trypsin (1x, 0.25% Trypsin in 
HBSS without Calcium and Magnesium) was from Mediatech Inc. (Manassas, VA). 
Lipopolysaccharides (LPS) (Escherichia coli 0111:B4, L4391-1MG, Lot No: 043M4089V) and 
Indomethacin (PHR1247 Fluka) were from Sigma-Aldrich (St. Louis MO). PARIS™ Kit: 
protein and RNA isolation system (AM1921) was purchased from Ambion® by Life 
Technologies (Carlsbad, CA). The Reverse Transcription System (A3500) used for the 
production of cDNA was from Promega Corporation (Madison, WI). The Brilliant II SYBR® 
Green QRT-PCR Master Mix with Low ROX kit (600835) was purchased from Agilent 
Technologies, USA. 
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4.3.2. Procedure for arabinoxylan hydrolyzate preparation  
AXH preparation was carried out as described in section 2.3.2 in a previous chapter. A 
summary of the treatments and the abbreviation given to the resulting AXH is given in Table 4.1.  
4.3.3. Chemical analysis 
The chemical analysis of the AXH was carried out as described in section 2.3.3 using 
GC-FID, SEC-MALS, 1H-NMR and GC-FID techniques. 
4.3.4. Determination of immunomodulatory properties of AXH 
Enzymatically derived arabinoxylan hydrolyzates were evaluated for their immunomodulatory 
properties using LPS induced intestinal epithelial cell lines Caco-2 and HT-29. Caco-2 cells were 
grown in EMEM media supplemented with 20% FBS and 1% Penicillin-Streptomycin solution. 
HT-29 cells were grown in DMEM media supplemented with 10% FBS and 1% Penicillin-
Streptomycin solution. The cells were grown at 37 oC under a humidified atmosphere of 95% air 
and 5% CO2.  
4.3.4.1. Treatment of cells with AXH 
 Caco-2 cells were plated at 2×106 cells/mL cell density (400 µL) in 24 well plate wells 
and incubated overnight. Next day, AXH (2000 µg/mL) dissolved in serum free-antibiotic free 
EMEM was added (200 µL) to each well. The negative control wells and control wells both 
received serum free-antibiotic free EMEM (200 µL). Indomethacin (200 µL, 80 µg/mL, 
PHR1247 Fluka, Sigma-Aldrich (St. Louis MO)), a nonsteroidal antiinflammatory drug 
(NSAID) which brings about its anti-inflammatory effects through the inhibition of 
cyclooxygenase (COX) (Edogawa et al., 2014), in serum free-antibiotic free DMEM was added 
to the positive control wells. 
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After 2 h incubation with each treatment, 200 µL of LPS dissolved in serum free-
antibiotic free EMEM (4 µg/mL) was added to each well to induce inflammation. However, no 
LPS stimulation was done on the negative control wells, and 200 µL of serum free-antibiotic free 
EMEM was added to them instead of LPS solution. Thus, the final concentration of each 
compound in a well was: AXH (500 µg/mL), or Indomethacin (20 µg/mL) and LPS (1 µg/mL). 
The cells were incubated for 24 h.  The same procedure was carried out using HT-29 cells. The 
cells were plated at 1×106 cells/mL cell density and the media used was DMEM. The EMEM 
media used for dissolving the compounds was replaced with DMEM.  A simplified presentation 
of the AXH treatment procedure carried out on each cell line is given in Figure 4.1. 
Table 4.1. Summarized information about the treatments and the abbreviation given to 
each AXH. 
Treatment1 Abbreviation of the AXH 
ANX  6 h ANX-3 
ANX  12h ANX-4 
ANX  BAF ANX-6 
ANX  BAF  CAF ANX-7 
ANX  CAF ANX-8 
CJX  BAF CJX-6 
CAF  CJX CAF-2 
CAF ANX CAF-3 
CAF  BAF  CJX CAF-5 
CAF  BAF  ANX CAF-6 
BAF  CAF  CJX BAF-5 
BAF  CAF  ANX BAF-6 
1Enzymatic treatments were carried out using the following enzymes: ANX, endo-1,4-β-
Xylanase M4 (Aspergillus niger); CJX, Endo-1,4-β-Xylanase (Cellvibrio japonicus); 
BAF, α-L-Arabinofuranosidase (novel specificity) (Bifidobacterium adolescentis); CAF, 
α-L-Arabinofuranosidase (Clostridium thermocellum) 
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Figure 4.1. Schematic presentations of treatments carried out on cells. Each cylinder represents a 
well in the 24 well plate. AXH, arabinoxylan hydrolyzate; LPS, lipopolysaccharide. 
4.3.4.2. Determination of PG-E2, IL-1β, IL-6, IL-8 and TNF-α using ELISA techniques 
 The extracellular media were collected and centrifuged at 13,000 rpm for 3 min to 
precipitate the cell debris. The supernatants were aliquoted out and stored at -20 oC until further 
analysis. Human Prostaglandin E2 ELISA kit (KHL 1701) and human IL-8 ELISA Kit 
(KHC0081) were purchased from Invitrogen Corporation (Camarillo, CA). Human IL-1β 
Quantikine ELISA kit (DLB50), human IL-6 Quantikine ELISA kit (D6050) and human TNF-α 
Quantikine ELISA kit (DTA00C) were purchased from R&D Systems, Inc. (Minneapolis, MN). 
The amount of PG-E2 and each cytokine in the media were determined using the appropriate 
ELISA kit following the manufacturer’s instructions. The results were quantified using the 
corresponding standard provided with each kit.  
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4.3.4.3. Quantification of human COX-2, TLR-4, TNF-α and IL-8 mRNAs using quantitative 
reverse transcriptase real-time polymerase chain reaction (qRT-PCR) techniques 
In qRT-PCR the initial amount of mRNA of the gene of interest is assessed by indirectly 
using its complementary DNA. Throughout the quantitative PCR reaction the amplified 
transcripts of the gene is responsible for the emission of fluorescence signal and the intensity of 
this signal is indicative of the number of copies of the amplicon produced after each cycle 
(Skrzypski, 2008). The greater the number of amplicons, the greater the fluorescence signal. 
Once a sufficient amount of amplicons are produced after a number of PCR cycles, the 
fluorescence signal reaches a detectable level (threshold cycle, Ct) and result in exponential 
increase in fluorescence. If the initial amount of studied transcript is high in a sample the 
required number of amplicons to produce a detectable fluorescence signal will be produced in 
fewer PCR cycles (Skrzypski, 2008). Thus, lower Ct values are indicative of higher amount of 
gene of interest (and in turn higher amount of mRNA of the gene) and vice versa. 
The cells were detached using a cell scraper and washed with PBS according to the 
manufacturer’s instructions for the total RNA isolation using the PARIS™ Kit: protein and RNA 
isolation system (Ambion® by Life Technologies, Carlsbad, CA).The Reverse Transcription 
System (A3500) (Promega Corporation, Madison, WI) was used for the production of cDNA. 
The cDNA samples were stored at -20 oC until use. The qRT-PCR mixture system was set up as 
follows according to the manufacturer’s instructions with some modifications: 10 µL of 2× 
Brilliant II SYBR® Green QRT-PCR Master Mix with Low ROX (Agilent Technologies, USA), 
2 µL of primer mix (5 µM of forward primer and 5 µM of reverse primer), 1 µL of cDNA (5 
ng/µL) and 7 µL of nuclease free PCR grade water. The primers purchased from The Midland 
Certified Reagent Company, Incorporated (Midland, TX) were as follows: Actin (forward) 
 108 
 
CATGTACGTTGCTATCCAGGC (reverse) CTCCTTAATGTCACGCACGAT; COX-2 
(forward) CAGCAAATCCTTGCTGTTCC (reverse) GTGCACTGTGTTTGGAGTGG; TLR-4 
(forward) ATATTGACAGGAAACCCCATCCA (reverse) TAGAACCCGCAAGTCTGTGC; 
TNF-α (forward) ATGAGCACTGAAAGCATGATCC (reverse) 
GAGGGCTGATTAGAGAGAGGTC; IL-8 (forward) TTTTGCCAAGGAGTGCTAAAGA 
(reverse) AACCCTCTGCACCCAGTTTTC. The reaction protocol was as follows: 95 oC for 10 
min; 40 cycles at 95 oC for 30 s, 60 oC for 1 min, 72 oC for 1 min; 95 oC for 1min; 55 oC for 30 s; 
95 oC for 30 s.  Actin was used as the housekeeping gene and ΔCt values were calculated taking 
LPS induced cells without any AXH treatment as control.  
4.3.5. Statistical analysis 
All the cell culture experiments were done in duplicate. All statistical analyses were 
performed using the Statistical Analysis System software package version 9.4 (SAS Institute, 
Cary, NC) 
The data are presented as the means ± SE and were subjected to one way ANOVA using 
LSD test procedure. A least significant difference (LSD) with a 5 % significance level was used 
to declare differences. Differences were considered significant when the probability value p was 
lower than 0.05.  
Pearson's correlation analysis was conducted to evaluate relationships between 
immunological outcomes and AXH composition/structural details.  
Stepwise multiple linear regression (SMR) was used to identify and quantify the 
relationships of immunological outcomes and AXH composition/structural details. The stepping 
criteria employed for entry and removal were based on the significance level of the F-value and 
set at 0.05. SMR can provide an equation linking immunological outcomes to the structural 
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details of the AXH. Stepwise SMR constructs a multivariate model for the dependent variable, 
Y, based on a few deliberately selected explanatory variables. The best equation is selected on 
the basis of the highest coefficient of determination (R2) of a model. The equation takes the 
following form: 
Y=b0+b1X1+b2X2+⋯+bnXn 
where Y is the dependent variable (i.e. the immunological outcome (e.g. cytokine production); 
X1, X2, …, Xn are the independent variables (descriptive variables, i.e. the composition/structural 
details of AXH such as total AX, unsubstituted xylose %, etc. ); b0 is the constant, where the 
regression line intercepts the Y axis, representing the amount the dependent Y will be when all 
the explanatory variables are 0; bi (1 ≤ i ≤ n) is the regression coefficient, representing the 
amount the response variable Y changes when the explanatory variable changes 1 unit. The 
equation represents a model of the system under study, which can be used to investigate which 
variables influence its response and at what extent, and/or to predict the value of one variable 
when the others are known. 
4.4. Results and Discussion 
4.4.1. Chemical characteristics of the AXH 
The sugar composition, A/X ration of the WAX and the resulting AXH are given in Table 
4.2. The xylose was the predominant sugar in all the AXH samples followed by arabinose. 
Glucose was present to a lesser extent and trace amounts of galactose was also present. The total 
AX ranged between 57.56% in CAF-6 to 31.27% in CJX-6. The arabinose to xylose (A/X) ratio 
ranged from 0.57 in CJX-6 to 0.48 in ANX-3 and CAF-6. Thus enzymatic treatment on WAX to 
produce AXH resulted in products with higher A/X ratio. The enzymatic treatment on WAX 
resulted in AXH products with drastically reduced molecular weights (Table 4.3). The weight 
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average molecular weight of the AXH ranged from from 0.78- 4.03 million Da. ANX-3 had the 
highest molecular weight (4.03 million Da) followed by ANX-4 (3.68 million Da) and ANX-6 
(3.58 million Da). The lowest molecular weight of 0.78 million Da was observed for CAF-6. 
The 1H-NMR results of the different hydrolyzates are summarized in Table 4.4. Each 
AXH has its own pattern of resonances corresponding to different anomeric protons in the 
arabinoxylan molecule. Resonances 1-3 correspond to anomeric protons of arabinose, while 
resonances 4-6 corresponds to anomeric proton in xylose. These fine structural details of the 
AXH were used in correlating the structural details with biological properties later in the chapter. 
Table 4.2. Sugar composition of wheat AX (WAX) and its enzymatic products. 
AXH Sugar composition % (w/w) A/X ratio 
 Arabinose Xylose Galactose Glucose 
 
WAX 8.46 26.58 0.26 2.56 0.32 
ANX-3 13.72 28.37 0.65 4.06 0.48 
ANX-4 13.99 24.66 0.57 4.05 0.57 
ANX-6 16.13 29.20 0.73 4.54 0.55 
ANX-7 15.51 28.32 0.83 4.06 0.55 
ANX-8 11.12 22.00 0.40 2.82 0.51 
CJX-6 11.39 19.88 0.47 3.03 0.57 
CAF-2 15.80 32.09 0.20 3.56 0.49 
CAF-3 18.05 35.43 0.23 3.87 0.51 
CAF-5 14.69 28.00 0.21 3.61 0.52 
CAF-6 18.79 38.77 0.21 4.47 0.48 
BAF-5 12.76 24.22 0.46 4.10 0.53 
BAF-6 15.16 28.60 0.25 3.35 0.53 
LSD 0.84 1.4 0.03 0.02 0.01 
LSD = least significant difference (P < 0.05) 
aEnzymatic treatments were carried out using the following enzymes: ANX, 
endo-1,4-β-Xylanase M4 (Aspergillus niger); CJX, Endo-1,4-β-Xylanase 
(Cellvibrio japonicus); BAF, α-L-Arabinofuranosidase (novel specificity) 
(Bifidobacterium adolescentis); CAF, α-L-Arabinofuranosidase (Clostridium 
thermocellum); each sample name starting with corresponding enzyme 
abbreviation received that specific enzyme treatment first.  
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To further understand the structural details of the AXH, linkage analysis was carried out 
using GC-MS techniques. The results are depicted in Figure 4.2. As expected, structural 
heterogeneity was observed with respect to linkage types present in each arabinoxylan 
hydrolyzate. As a general trend, the amount of linkages corresponding to unsubstituted xylose is 
lower in CAF- and BAF- series compared to ANX- and CJX- series. However, this trend is 
reversed with respect to linkages corresponding to 2,3-disubstituted-1,4,-linked xylose. Thus, the 
structural complexity is lower in ANX- and CJX- compared to CAF- and BAF- series.  
Table 4.3. Weight average molecular weight and polydispersity index of AX 
hydrolyzates (AXH). 
AXHa Molecular weight (Million 
Da) 
Polydispersity index 
ANX-3 4.03 2.2 
ANX-4 3.68 1.5 
ANX-6 3.58 1.5 
ANX-7 3.33 1.4 
ANX-8 2.91 1.8 
CJX-6 1.53 1.8 
CAF-2 1.28 1.5 
CAF-3 1.11 1.3 
CAF-5 0.93 1.8 
CAF-6 0.78 1.4 
BAF-5 1.14 1.8 
BAF-6 1.28 2.0 
LSD 0.04 0.4 
LSD = least significant difference (P < 0.05) 
aEnzymatic treatments were carried out using the following enzymes: ANX, 
endo-1,4-β-Xylanase M4 (Aspergillus niger); CJX, Endo-1,4-β-Xylanase 
(Cellvibrio japonicus); BAF, α-L-Arabinofuranosidase (novel specificity) 
(Bifidobacterium adolescentis); CAF, α-L-Arabinofuranosidase 
(Clostridium thermocellum); each sample name starting with corresponding 
enzyme abbreviation received that specific enzyme treatment first.  
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4.4.2. Immunological activity of AXH 
The specific objective of this research was to evaluate the effect of structural details on 
the immunomodulatory properties of these AXH. The LPS induced colon cancer cell lines Caco-
2 and HT-29 were used in this study.  Thus, the effect of each AX hydrolyzate on altering the 
LPS induced inflammation was evaluated.  
Table 4.4. 1H-NMR resonance integrations for wheat AX (WAX) and AX 
hydrolyzates (AXH ). 
 Resonance integration as % of total resonance 
AXHa 
Resonance 
1 
Resonance 
2 
Resonance 
3 
Resonance 
4 
Resonance 
5 
Resonance 
6 
WAX 11 7 11 20 12 39 
ANX-3 11 10 10 10 15 44 
ANX-4 13 14 9 14 12 38 
ANX-6 14 13 10 11 14 38 
ANX-7 15 11 10 9 14 40 
ANX-8 10 13 11 11 14 42 
CJX-6 13 12 11 6 13 45 
CAF-2 13 11 9 8 13 46 
CAF-3 14 12 10 11 12 42 
CAF-5 14 11 10 9 12 44 
CAF-6 13 9 9 11 13 44 
BAF-5 13 11 9 7 13 47 
BAF-6 15 11 10 9 13 43 
Each resonance corresponds to the following anomeric protons:  
Resonance 1, Anomeric proton of O-3 linked arabinose linked to monosubstituted 
xylose; Resonance 2, Anomeric proton of O-3 linked arabinose linked to 
disubstituted xylose; Resonance 3, Anomeric proton of O-2 linked arabinose linked 
to disubstituted xylose; Resonance 4, Anomeric proton of disubstituted xylose;  
Resonance 5, Anomeric proton of monosubstituted xylose;  
Resonance 6, Anomeric proton of unsubstituted xylose 
aEnzymatic treatments were carried out using the following enzymes: ANX, endo-
1,4-β-Xylanase M4 (Aspergillus niger); CJX, Endo-1,4-β-Xylanase (Cellvibrio 
japonicus); BAF, α-L-Arabinofuranosidase (novel specificity) (Bifidobacterium 
adolescentis); CAF, α-L-Arabinofuranosidase (Clostridium thermocellum); each 
sample name starting with corresponding enzyme abbreviation received that 
specific enzyme treatment first.  
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The cells that were induced with LPS but did not receive any AXH were regarded as the 
control treatment. Indomethacin (20 µg/mL) is a nonsteroidal anti-inflammatory drug (NSAID) 
which brings about its anti-inflammatory effects through the inhibition of cyclooxygenase 
(COX) (Edogawa et al., 2014). Both COX-1 and COX-2 are inhibited by indomethacin with 
selectivity for COX-1 (Sigma-Aldrich, 2014) which results in the inhibition of prostaglandin 
production at inflamed sites. The cells that did not receive any LPS and AXH/Indomethacin were 
also included in the assays to compare with the effect of LPS on the cells.  
4.4.2.1. Effect of AXH on PG-E2 and COX-2 production 
The effect of AXH on LPS induced prostaglandin (PG)-E2 production in Caco-2 and HT-
29 cells were evaluated. PG-E2 is a bioactive lipid that elicits a wide range of biological 
outcomes related to inflammation and cancer (Nakanishi and Rosenberg, 2013). PG-E2 exerts 
diverse effects on cell proliferation, apoptosis, inflammation and immune surveillance. Epithelial 
cells play a key role in maintaining the homeostasis within the gut and inducible formation of 
PG-E2 plays a vital role in achieving this function, specially maintaining epithelial barrier 
function (Montrose et al., 2010). It is involved in epithelial regeneration and reconstitution 
following tissue injury (Iizuka and Konno, 2011) and inducing epithelial cell proliferation 
(Castellone et al., 2005). The effect of AXH on LPS induced PG-E2 production was evaluated 
(Figure 4.3). Contrary to what was expected, induction of cells with LPS (control treatment) 
displayed a reduced PG-E2 production compared to the cells that were not induced by LPS 
(negative control treatment). This trend was observed for both Caco-2 and HT-29 cell lines. In 
Caco-2 cells, Indomethacin (positive control) caused an increase in PG-E2 production compared 
to the control. In the biosynthesis of prostaglandins, phospholipids are converted to arachidonic 
acid by the action of phospholipase A2 (MacKenzie et al., 2013; Nakanishi and Rosenberg, 
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2013). Arachidonic acid is next converted into prostaglandin H2 (PGH2) via the action of 
cyclooxygenases (COX) which is the rate limiting step of PG synthesis. PGH2 is next quickly 
converted into thromboxane, prostacyclin, or prostaglandin D, E, or F via the action of specific 
prostaglandin synthases. In mammalian cells two main isoforms of cyclooxygenase exists, 
cyclooxygenase 1 (COX-1) and COX-2. COX-1 is constitutively expressed in most tissues. 
COX-2 is highly inducible in many cells by pro-inflammatory stimuli. Thus, production of PG-
E2 under no inflammatory stimuli should mainly be due to COX-1 (Surh et al., 2001) and should 
be responsible for the PG-E2 production in negative control treatment. On the other hand, the 
PG-E2 produced in the rest of the treatments should be mediated via COX-1 as well as COX-2 
(Romier-Crouzet et al., 2009). Mitogen and stress activated protein kinase (MAPK) have been 
suggested to exert control on the induction of COX-2 mRNA by Toll-like receptor (TLR) 
agonists (e.g. LPS) (MacKenzie et al., 2013). It was found that MAPK regulated LPS induced 
prostaglandin and COX-2 protein levels in a time dependent manner. While MAPK promoted 
COX-2 mRNA transcription initially, following longer LPS stimulation MAPK inhibit LPS-
induced prostaglandin production via a negative feedback loop involving IL-10 (Figure 4.5). A 
similar cellular mechanism might be responsible for the reduced PG-E2 production observed 
upon LPS stimulation of Caco-2 and HT-29 cells in the control compared to the negative control. 
However, AXH treatments exerted variable effects on the LPS-induced PG-E2 production in 
Caco-2 and HT-29 cells. Some AXH exhibited pro-inflammatory properties while others 
displayed anti-inflammatory properties. However, due to the complex nature of the cellular 
mechanisms involved in PG-E2 regulation by the cells, the current study alone is not sufficient to 
draw solid conclusions about the mechanisms involved in up-regulation or down-regulation of 
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PG-E2 by AXH. A side by side comparison of effect of each of these AXH on cells with and 
without LPS induction would be a potential approach to be explored in the future.   
To further understand the cellular responses involved in immunomodulatory properties of 
AXH in LPS induced intestinal cells, expression of COX-2 at the mRNA level was investigated 
using real time quantitative reverse transcriptase polymerase chain reaction (qRT- PCR). Lower 
Ct values are indicative of higher amount of gene of interest (and in turn higher amount of 
mRNA of the gene) and vice versa. 
Two isoforms of enzyme COX: COX-1 and COX-2 are responsible for prostaglandin 
synthesis (Martinez-Cutillas et al., In press). While high levels of COX-1 is expressed during 
physiological conditions, level of COX-2 remains at low levels (Dey et al., 2006). On the 
contrary, COX- 2 is considered an inducible form of COX and elevated levels are observed 
during inflammation (Porcher et al., 2004). Up-regulation of COX-2 induces production of PG-
E2 which is associated with pathological conditions such as inflammatory bowel disease (Dey et 
al., 2006) and slow transit constipation (Cong et al., 2007). In the presence of endotoxins such as 
LPS, mitogen-activated protein kinase (MAPK) (specifically p38 MAPK) is involved in 
regulation of COX-2 mRNA transcription (Grishin et al., 2004) (Grishin et al., 2006). Also, the 
anti-inflammatory properties of many phytochemicals have been predicted to be achieved by the 
down regulation of COX-2 (via suppression of NF-κB activation) (Surh et al., 2001). The effect 
of different AXH on LPS induced COX-2 gene expression was evaluated by assessing the COX-
2 mRNA levels in Caco-2 and HT-29 cells (Figure 4.4). In Caco-2 the COX-2 mRNA expression 
in LPS induced cells (control) was significantly higher than the none-LPS induced cells 
(negative control).   
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Figure 4.2. Occurrence of each linkage type in each AXH as determined by GC-MS techniques.   
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As expected, the LPS induced cells had lower Ct values compared to the none-induced 
cells, translating to higher COX-2 mRNA in the LPS induced cells. All the treatments except 
CAF-2, ANX-8 and BAF-6 displayed significant differences from the control. Nine of the AXH 
being tested resulted in higher Ct values compared to the control indicating that the treatment 
with these AXH decreased the LPS induced COX-2 mRNA production in Caco-2 cells with 
ANX-6 having the highest inhibitory effect. However, no significant differences were observed 
between the control and negative control with respect to COX-2 mRNA production in HT-29 
cells. Ct values for ANX-4 and BAF-5 were significantly lower than the control indicating 
increased COX-2 mRNA production in LPS induced HT-29 cells upon treatment with these 
AXH.  
Surprisingly, higher COX-2 mRNA expression in the cells did not result in higher PG-E2 
production in the cells for some of the treatments.  However, in the biosynthesis of PG-E2, 
COX-1 and COX-2 are responsible for the conversion of arachidonic acid to PG-G2 and 
conversion of PG-G2 to PG-H2 (Nakanishi and Rosenberg, 2013). PG-H2 is the precursor for 
three different PG: PG-D2, PG-I2 and PG-E2. Therefore, one explanation for the reduced 
production of PG-E2 even under increased COX-2 mRNA might be that once PG-H2 was 
produced via COX-2, the PG-H2 was involved in the production of other PG (PG-D2, PG-I2) 
and PG-E2 was not a predominant product. Also, the production of PG-E2 is catalyzed by 
different set of enzymes whose expression might not have been induced by the treatments under 
the current study. Moreover, the catabolism of the PG-E2 during the incubation period might 
also play a role in eliminating the produced PG-E2 from the system (Nakanishi and Rosenberg, 
2013). Also, with respect to COX-2 mRNA levels in the cell, with longer stimulation with LPS, 
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the COX-2 mRNA degradation is accelerated via IL-10 mediated pathways leading to lesser 
amounts of COX-2 mRNA available for detection (MacKenzie et al., 2013).  
 
Figure 4.3. Immunomodulatory effect of AXH on LPS induced PG-E2 production in (a) Caco-2 
cells and (b) HT-29 cells. Cells only, cells not induced with LPS (negative control); Cells with 
LPS, cells induced with LPS (control); cells treated with indomethacin (Indo) and induced with 
LPS (positive control); ANX-3 to BAF-6, cells treated with corresponding AXH and induced 
with LPS. Data are presented as mean ± SD. LSD, least significant difference (P<0.05). Values 
differing more than LSD between each other are significantly different (P<0.05) from each other. 
Bars with an asterisk are significantly different from the control (P<0.05). 
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Figure 4.4. Immunomodulatory effect of AXH on LPS induced COX-2 mRNA production in (a) 
Caco-2 cells and (b) HT-29 cells. ΔCt= Ct(gene)-Ct(actin). Cells only, cells not induced with LPS 
(negative control); Cells with LPS, cells induced with LPS (control); cells treated with 
indomethacin (Indo) and induced with LPS (positive control); ANX-3 to BAF-6, cells treated 
with corresponding AXH and induced with LPS. Data are presented as mean ± SD. LSD, least 
significant difference (P<0.05). Values differing more than LSD between each other are 
significantly different (P<0.05) from each other. Bars with an asterisk are significantly different 
from the control (P<0.05). 
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Figure 4.5. Regulation of COX-2 mRNA and PG-E2 production via an IL-10 feedback 
mechanism. Initially upon activation of TLR-4 by LPS, MSK 1/ 2 is activated resulting in 
transcription of COX-2 and IL-10 mRNA. Moreover, activation of P38α leads to the inhibition 
of COX-2 mRNA degradation by mRNA degrading proteins. Thus, more COX-2 mRNA is 
available for translation to produce COX-2. COX-2 catalyzes the conversion of AA (arachidonic 
acid) to PG-H2. PG-H2 subsequently gets converted to PG-D2 or PG-E2 or PG-I2. PG-E2 is 
eventually degraded and eliminated. However, with time, more and more IL-10 is produced and 
secreted from the cells. The IL-10 generated a feedback loop (indicated by red dashed arrows). 
The activation of IL-10 receptor by IL-10 lead to downstream pathways that inhibit P38α. Thus, 
the inhibition it had upon COX-2 mRNA degrading proteins gets eliminated and results in 
increased degradation of COX-2 mRNA. Based on (MacKenzie et al., 2013; Nakanishi and 
Rosenberg, 2013). 
Thus, ultimately the higher expression of COX-2 mRNA might not necessarily be reflected with 
higher PG-E2 levels. 
4.4.2.2. Effect of AXH on IL-8 production 
IL-8 is an important cytokine involved initiation and amplification of inflammatory 
responses resulting in tissue damage and injury (Al-Sadi and Ma, 2007). Thus, IL-8 is a primary 
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target for treatment of intestinal inflammation (Sartor, 1994).  The increased production of pro-
inflammatory cytokine IL-8 by Caco-2 and HT-29 cells in response to bacterial invasion has 
been previously shown (Jung et al., 1995). LPS, a bacterial polysaccharide, can activate 
sphingomyelinases SMases which causes an increase in cellular ceramide (MacKichan and 
DeFranco, 1999; Medvedev et al., 1999). Ceramide triggers mitogen-activated protein kinase 
(MAPK), which lead to the expression of several inflammation related genes (Spiegel et al., 
1996). LPS efficiently increases the release of IL-8 from HT-29 intestinal epithelial cells by 
activating SMases and NF-κB in the cells (Sakata et al., 2007). Control of excess cytokine 
production induced by LPS is important because uncontrolled inflammation can be cytotoxic to 
enterocytes and cause systemic inflammatory response syndrome, leading to sepsis, septic shock, 
multiple organ failure, necrotizing enterocolitis and other organ damages (Houdijk et al., 1998; 
Nanthakumar et al., 2000; Wischmeyer et al., 2001). Also, elevated mucosal IL-8 levels were 
observed in patients with acute ulcerative colitis (Murata et al., 1995).  
 We investigated the effect of each AXH on LPS induced IL-8 production on Caco-2 and 
HT-29 cells. In both cell lines, LPS induced IL-8 production compared to the cells that were not 
stimulated by LPS (Figure 4.6). Previous studies have shown that IL-8 secretion by LPS induced 
Caco-2 cells occurred 10-24 h after LPS stimulation (Liboni et al., 2004). We also observed 
increased IL-8 secretion in Caco-2 cells following stimulation with LPS for 24 h. At the present 
seeding density, Caco-2 cells produced small amount of IL-8 compared to the HT-29 cells. 
Similar observations regarding the differences in IL-8 production between these two cell lines 
have also been reported previously (Rieder et al., 2011; Samuelsen et al., 2011). Eight of the 12 
AXH used caused a significant decrease in LPS induced IL-8 production in Caco-2 cells. CJX-6 
lowered LPS induced IL-8 significantly compared to the cells induced with LPS (control). Eight 
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of the AXH been tested lowered IL-8 in Caco-2 cells. However, in the case of HT-29, none of 
the AXH significantly lowered the LPS induced IL-8 production. In the contrary, three of the 
AXH significantly increased LPS induced IL-8 production in HT-29 cells. ANX-8 caused the 
highest increase in IL-8 followed by CAF-3 and ANX-3.  
There was a significant difference observed between the control and the negative control 
in the IL-8 mRNA expression in Caco-2 cells (Figure 4.7). Five of the AXH resulted in 
significantly increased Ct values (indicating significantly reduced IL-8 mRNA expression) 
compared to the control in LPS induced Caco-2 cells. ANX-7 displayed the highest inhibitory 
effect followed by ANX-6, CAF-6, CJX-6 and ANX-4 consecutively.  However, there were no 
statistically significant differences in Ct values observed among the treatments for the HT-29 cell 
line. There were large error bars observed for the IL-8 mRNA expression calculated for HT-29 
cells and this might mask the actual differences between the treatments which might be 
preserved as not being significantly different from each other statistically. 
4.4.2.3. Effect of AXH on TNF-α production  
TNF-α is a pro-inflammatory cytokine produced during acute inflammation leading to a 
wide range of intracellular signaling events (Wang et al., 2013). It is involved in inducing anti-
microbial effects in response to bacterial infection in cells (Andrade et al., 2005; Liu et al., 2008; 
Zakharova and Ziegler, 2005). It also leads to the production of other related chemokines and 
cytokines that directs progression of disease (Liu et al., 2008). In Caco-2, 1µg/mL LPS was 
unable to induce TNF-α production significantly compared to the control (Figure 4.8). However, 
Indomethacin was effective in reducing the TNF-α production significantly. Also, CAF-5, BAF-
4 and ANX-8 were able to reduce TNF-α production significantly compared to the control in 
Caco-2 cells. 
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Figure 4.6. Immunomodulatory effect of AXH on LPS induced IL-8 production in (a) Caco-2 
cells and (b) HT-29 cells. Cells only, cells not induced with LPS (negative control); cells with 
LPS, cells induced with LPS (control); cells treated with indomethacin (Indo) and induced with 
LPS (positive control); ANX-3 to BAF-6, cells treated with corresponding AXH and induced 
with LPS. Data are presented as mean ± SD. LSD, least significant difference (P<0.05). Values 
differing more than LSD between each other are significantly different (P<0.05) from each other. 
Bars with an asterisk are significantly different from the control (P<0.05). 
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Figure 4.7. Immunomodulatory effect of AXH on LPS induced IL-8 mRNA production in (a) 
Caco-2 cells and (b) HT-29 cells. ΔCt= Ct(gene)-Ct(actin). Cells only, cells not induced with LPS 
(negative control); Cells with LPS, cells induced with LPS (control); cells treated with 
indomethacin (Indo) and induced with LPS (positive control); ANX-3 to BAF-6, cells treated 
with corresponding AXH and induced with LPS. Data are presented as mean ± SD. LSD, least 
significant difference (P<0.05). Values differing more than LSD between each other are 
significantly different (P<0.05) from each other. Bars with an asterisk are significantly different 
from the control (P<0.05). 
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The rest of the AXH did not exert a significant effect on the TNF-α production in Caco-2. 
In the case of HT-29, a similar scenario was observed where the TNF-α production in LPS 
induced cells did not show a significant difference from the non-induced cells. Also, there was 
no significant difference among Indomethacin treated LPS induced cells with the non-induced 
cells or only LPS induced cells. However, there was a significant increase in TNF-α production 
in cells treated with CJX-6, ANX-4 and CAF-3 prior to stimulation with LPS compared to the 
control (cells treated with LPS only). The TNF-α mRNA expression was not significantly 
different between the LPS induced and none-LPS induced Caco-2 cells (Figure 4.9). However, 
CAF-2, ANX-6, CAF-6 and CAF-5 treated LPS induced Caco-2 cells displayed a reduction in 
TNF-α mRNA expression in LPS induced cells compared to the control. Similarly, TNF-α 
mRNA expression was not significantly different between the LPS induced and none-LPS 
induced HT-29 cells while BAF-5 treated LPS induced HT-29 cells displayed a significant 
increase in TNF-α mRNA expression compared to the control.  
The effect of AXH on IL-1β and IL-6 production in LPS induced Caco-2 and HT-29 cells were 
also investigated. However, no detectable level of these cytokines was produced by either of the 
cell lines under any of the conditions exerted during the current study that was detectable by the 
ELISA techniques being used.  
4.4.2.4. Effect of AXH on TLR-4 production 
TLR-4 is a pattern recognition receptor that is involved in the recognition of bacterial 
membrane components such as LPS (Liu et al., 2008). TLR-4 along with its intracellular co-
receptor MD88, leads to the activation of NF-κB (Fujihara et al., 2003; Liu et al., 2008). NF-κB 
is an important transcription factor involved in various immunological processes including 
cytokine production, phagocytosis and respiratory burst (Volman et al., 2008). 
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Figure 4.8. Immunomodulatory effect of AXH on LPS induced TNF-α production in (a) Caco-2 
cells and (b) HT-29 cells. Cells only, cells not induced with LPS (negative control); Cells with 
LPS, cells induced with LPS (control); cells treated with indomethacin (Indo) and induced with 
LPS (positive control); ANX-3 to BAF-6, cells treated with corresponding AXH and induced 
with LPS. Data are presented as mean ± SD. LSD, least significant difference (P<0.05). Values 
differing more than LSD between each other are significantly different (P<0.05) from each other. 
Bars with an asterisk are significantly different from the control (P<0.05). 
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Figure 4.9. Immunomodulatory effect of AXH on LPS induced TNF-α mRNA production in (a) 
Caco-2 cells and (b) HT-29 cells. ΔCt= Ct(gene)-Ct(actin). Cells only, cells not induced with LPS 
(negative control); Cells with LPS, cells induced with LPS (control); cells treated with 
indomethacin (Indo) and induced with LPS (positive control); ANX-3 to BAF-6, cells treated 
with corresponding AXH and induced with LPS. Data are presented as mean ± SD. LSD, least 
significant difference (P<0.05). Values differing more than LSD between each other are 
significantly different (P<0.05) from each other. Bars with an asterisk are significantly different 
from the control (P<0.05). 
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Eventually NF-κB triggers the MAPK pathways  (Akira and Takeda, 2004) and  MAPK 
pathways, specifically p38 MAPK pathway is involved in the biosynthesis of LPS induced TNF-
α (Brook et al., 2000), a cytokine that promotes the production of other inflammatory cytokines 
(Liu et al., 2008). Several researches have demonstrated the involvement of NF-κB in cellular 
pathways triggered by botanical polysaccharides (Lee et al., 2013; Schepetkin and Quinn, 2006; 
Volman et al., 2008). In Caco-2 cells, TLR-4 mRNA expression was reduced by ten of the AXH 
being tested compared to the control (LPS induced cells without AXH treatment) with ANX-6 
having the most significant inhibitory effect (Figure 4.10). In HT-29 cells there was no 
significant difference between the control and negative control in TLR-4 mRNA expression. 
However, ANX-4 and BAF-5 displayed an increased TLR-4 mRNA expression in LPS induced 
HT-29 cells compared to the rest of the treatments.  
According to the correlation analysis of the data strong correlations were observed among 
some mRNA expression levels in certain genes. There was a strong positive correlation (0.968) 
between the TLR-4 mRNA expression and COX-2 mRNA expression in Caco-2 cells. A similar 
trend was observed for HT-29 cells with a strong positive correlation of 0.991 between the TLR-
4 mRNA expression and COX-2 mRNA expression. Also, in HT-29, the TNF-α mRNA 
expression was strongly positively correlated with COX-2 mRNA expression (0.871) and TLR-4 
mRNA expression (0.840). To understand the structure function relationship among the AXH 
structure and its immunological properties, correlation was tested among the 
composition/structure properties of AXH with their immunological properties determined by 
ELISA techniques (Table 4.5). Strong negative correlations were observed between PG-E2 
production in Caco-2 and product of A/X ratio and 3 substituted 1,4 linked xylose (-0.725) and 
product of  NMR resonance 1 data and 3 substituted 1,4 linked xylose (-0.727). 
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Figure 4.10. Immunomodulatory effect of AXH on LPS induced TLR-4 mRNA production in (a) 
Caco-2 cells and (b) HT-29 cells. ΔCt= Ct(gene)-Ct(actin). Cells only, cells not induced with LPS 
(negative control); Cells with LPS, cells induced with LPS (control); cells treated with 
indomethacin (Indo) and induced with LPS (positive control); ANX-3 to BAF-6, cells treated 
with corresponding AXH and induced with LPS. Data are presented as mean ± SD. LSD, least 
significant difference (P<0.05). Values differing more than LSD between each other are 
significantly different (P<0.05) from each other. Bars with an asterisk are significantly different 
from the control (P<0.05). 
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Also, strong positive correlations were observed between product of NMR resonance 4 
and 2,3 substituted 1,4 linked xylose (AX24 × AX39)  (+0.715) and product of  1,4- linked 
xylose and 2,3, substituted 1,5-linked arabinose (AX35 × AX38) (+0.73) with PG-E2 production 
in Caco-2 cells. IL-8 production in Caco-2 was negatively correlated with product of terminal 
arabinose and 1,3- linked arabinose (AX31 × AX36) (-0.72) and TNF-α production was 
negatively correlated with the product of NMR resonance 6 and terminal arabinose (AX26 × 
AX31) (-0.763) in Caco-2 cells.  
Correlation was tested among the composition/structure properties of AXH with their 
immunological properties determined by qRT-PCR techniques (Table 4.6). Strong positive 
correlations were observed between the ΔCt values for TNF-α in Caco-2 and product of total AX 
and A/X ratio (AX11 × AX12) (0.735) and product of total AX and NMR resonance 1 (AX11 × 
AX21) (0.735).  
It is suggested that recognition of plant polysaccharides by cells involves pattern 
recognition receptors such as toll-like receptor (TLR) (Schepetkin and Quinn, 2006). TLR 
receptors are expressed in many cell types including epithelial cells (Iwasaki and Medzhitov, 
2004). Out of the ten TLR receptors identified in humans, TLR-2 and TLR-4 are involved in 
recognition of polysaccharides (Brown et al., 2003; Leung et al., 2006; Li et al., 2004). The 
likelihood of several different receptors cooperating with each other to form “clusters of 
signaling complexes” have also been proposed (Schepetkin and Quinn, 2006).  Interestingly, 
although lesser significant correlations were observed among the immunological parameters 
being tested with single structural features being tested, stronger correlations were observed 
when the effect of two structural features were considered in combination for correlation 
analysis. Combining two or more structural features might give a better understanding about the 
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overall structure/ pattern of the AXH being tested because at the cellular level it is the overall 
structure of the molecule that is at play. At the cellular level the recognition of these AXH by the 
cells might be via pattern recognition receptors on the cell surfaces. Thus, overall structural 
features that are better depicted by combined structural properties might display better 
correlations with immunological properties compared to considering these structural features 
individually. Also, there might be a synergistic effect from two different structural properties that 
determine the ultimate immunological property of the AXH.   
Based on the data gathered for the structural properties of each of the AXH, we further 
constructed the prediction equations for each of the parameters being tested using stepwise 
regression analysis (Table 4.7). These equations can be used to identify the different structural 
properties of AXH that had most significant contribution to production of PG-E2, cytokines and 
mRNA expression of specific genes. 
4.5. Conclusions 
Use of plant derived polysaccharides as health promoter has gained immense interest in 
the past few years. The current research aimed to investigate the structure-function relationship 
of enzymatically tailored AXH as immunomodulators using LPS induced colon cancer cell lines: 
Caco-2 and HT-29. Twelve structurally different AXH were prepared from wheat AX, using 
different enzymatic conditions. The importance of polymer side branching on the immunological 
properties of AXH has also been emphasized by others (Adams et al., 2008; Mikkelsen et al., 
2014). Zhou et al (2010) also suggested that the immunological effects of wheat bran AX depend 
on the molecular weight, chemical composition and substituted degree or branch of arabinose. 
Similarly, we demonstrated that the fine structural details had a strong correlation with the 
immunological properties of the wheat AXH.  
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Table 4.5. Correlation coefficients among parameters tested on chemical 
characteristics (using GC-FID, 1H-NMR and GC-MS) and immunomodulatory 
properties (using ELISA). 
 
Caco-2 
PG-E2 
 
Caco-
2 IL-8 
 
Caco-2 
TNF-α 
 
HT-29 
PG-E2 
 
HT-29 
IL-8 
 
HT-29 
TNF-α 
 
NMR resonance 1 
        
-0.700 * 
  3 substituted 1,4 linked 
xylose -0.581 * 
          
AX11 × AX31 
 
-0.632 * -0.647 * 
      
AX11 × AX33 
     
-0.590 * 
    
AX11 × AX34 
     
0.619 * 
    
AX11 × AX38 0.610 * 
          
AX11 × AX39 0.671 * 
          
AX12 × AX21 
       
-0.588 * 
  
AX12 × AX25 -0.665 * 
          
AX12 × AX31 
 
-0.650 * -0.700 * 
      
AX12 × AX33 
     
-0.604 * 
    
AX12 × AX36 
       
-0.596 * 
  
AX12 × AX37 -0.725 ** 
          
AX12 × AX38 0.586 * 
          
AX12 × AX39 0.662 * 
          
AX21 × AX31 
 
-0.671 * -0.669 * 
      
AX21 × AX33 
     
-0.596 * 
    
AX21 × AX36 
       
-0.660 * 
  
AX21 × AX37 -0.727 ** 
          
AX21 × AX39 0.629 * 
          
AX22 × AX31 
   
-0.648 * 
      
AX22 × AX33 
     
-0.623 * 
    
AX22 × AX38 0.611 * 
          
AX22 × AX39 0.690 * 
          
AX23 × AX31 
   
-0.684 * 
      
AX23 × AX37 -0.645 * 
          
AX23 × AX38 0.597 * 
          
AX23 × AX39 0.695 * 
          
AX24 × AX31 
   
-0.614 * 
      
AX24 × AX33 
     
-0.678 * 
    
AX24 × AX34 
     
0.656 * 
    
AX24 × AX38 0.639 * 
          
AX24 × AX39 0.715 ** 
          
AX25 × AX31 
 
-0.619 * -0.672 * 
      
AX25 × AX37 -0.697 * 
          
AX25 × AX39 0.645 * 
          
AX26 × AX31 
 
-0.635 * -0.763 ** 
      
AX26 × AX38 0.614 * 
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Table 4.5. Correlation coefficients among parameters tested on chemical 
characteristics (using GC-FID, 1H-NMR and GC-MS) and immunomodulatory 
properties (using ELISA) (continued). 
 
Caco-2 
PG-E2 
 
Caco-
2 IL-8 
 
Caco-2 
TNF-α 
 
HT-29 
PG-E2 
 
HT-29 
IL-8 
 
HT-29 
TNF-α 
 
AX26 × AX39 0.687 * 
          
AX31 × AX31 
   
-0.605 * 
      
AX31 × AX35 
   
-0.655 * 
      
AX31 × AX36 
 
-0.720 ** -0.653 * 
      
AX31 × AX37 
   
-0.613 * 
      
AX31 × AX39 
 
-0.690 * -0.606 * 
    
-0.651 * 
AX32 × AX34 
     
0.586 * 
    
AX32 × AX38 
 
-0.640 * 
        
AX32 × AX39 
 
-0.639 * 
      
-0.595 * 
AX33 × AX33 
     
-0.634 * 
    
AX33 × AX34 
         
0.577 * 
AX33 × AX35 
     
-0.640 * 
    
AX33 × AX36 
     
-0.609 * 
    
AX33 × AX37 
     
-0.634 * 
    
AX34 × AX37 
     
0.581 * 
    
AX35 × AX38 0.730 ** 
          
AX35 × AX39 0.706 * 
          
AX37 × AX37 -0.631 * 
          
AX37 × AX39 0.652 * 
          
AX38 × AX38 0.601 * 
          
AX38 × AX39 0.680 * 
          *** P-value <0.0001; ** P-value <0.001; * P-value <0.05 
a The abbreviations used for each parameter is as follows: 
Composition data obtained by GC-FID: AX11, Total AX; AX12, A/X ratio. 
Structural data obtained by 1H-NMR: AX21, NMR resonance 1; AX22,NMR 
resonance 2; AX23NMR resonance 3; AX24, NMR resonance 4; AX25, NMR 
resonance 5; AX26, NMR resonance 6. 
Structural data obtained by GC-MS:  AX31, Terminal Arabinose; AX32,Terminal 
Xylose; AX33, 2 substituted 1,4 linked xylose; AX34, 1,5 linked arabinose; AX35, 
1,4- linked xylose; AX36, 1,3- linked arabinose; AX37, 3 substituted 1,4 linked 
xylose; AX38, 2,3, substituted 1,5-linked arabinose; AX39, 2,3 substituted 1,4 linked 
xylose. 
AX11 × AX11, product of AX11 by AX11; AX11 × AX12, product of AX11 by 
AX12; and so on. 
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Table 4.6.Correlation coefficients among parameters testeda on chemical characteristics 
(using GC-FID, 1H-NMR and GC-MS) and immunomodulatory properties (using qRT-
PCR). 
 
Caco-2 
TLR-4 
ΔCt 
 
Caco-2 
TNF-α 
ΔCt 
 
Caco-2 
IL-8 
ΔCt  
 
HT-29 
COX-2 
ΔCt 
 
HT-29 
TLR-4 
ΔCt 
 
HT-29 
TNF-α 
ΔCt 
 
HT-29 
IL-8 
ΔCt 
 
A/X ratio  
            
0.622 * 
NMR resonance 1 
  
0.678 * 
          
NMR resonance 2 
            
0.704 * 
NMR resonance 3 
        
0.615 * 
    2 substituted 1,4 
linked xylose 
  
-0.607 * 
          1,3- linked 
arabinose 
      
-0.645 * -0.640 * 
    
AX11 × AX11 
  
0.715 ** 
          
AX11 × AX12 
  
0.753 ** 
          
AX11 × AX21 
  
0.735 ** 
          
AX11 × AX22 
  
0.657 * 
          
AX11 × AX23 
  
0.596 * 
          
AX11 × AX25 
  
0.624 * 
          
AX11 × AX26 
  
0.698 * 
          
AX11 × AX33 
    
0.642 * 
        
AX11 × AX37 
  
0.585 * 
          
AX12 × AX23 
  
-0.578 * 
          
AX12 × AX25 
    
0.648 * 
        
AX12 × AX33 
    
0.631 * 
        
AX12 × AX36 
    
0.602 * -0.597 * 
      
AX21 × AX33 
    
0.667 * 
        
AX21 × AX36 
    
0.580 * 
        
AX22 × AX33 
    
0.591 * 
        
AX22 × AX36 
    
0.604 * -0.578 * 
      
AX23 × AX23 
  
-0.654 * 
          
AX23 × AX25 
  
-0.594 * 
          
AX23 × AX26 
  
-0.583 * 
          
AX23 × AX33 
    
0.611 * 
        
AX25 × AX33 
    
0.636 * 
        
AX25 × AX36 
    
0.607 * 
        
AX25 × AX39 
            
-0.578 * 
AX26 × AX33 
    
0.630 * 
        
AX26 × AX36 
          
-0.596 * 
  
AX31 × AX33 
    
0.579 * 
        
AX31 × AX36 
    
0.625 * 
        
AX32 × AX34 0.589 * 
            
AX33 × AX33 
    
0.650 * 
        
AX33 × AX36 
    
0.581 * 
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Table 4.6.Correlation coefficients among parameters testeda on chemical characteristics 
(using GC-FID, 1H-NMR and GC-MS) and immunomodulatory properties (using qRT-
PCR) (continued).  
 
Caco-2 
TLR-4 
ΔCt 
 
Caco-2 
TNF-α 
ΔCt 
 
Caco-2 
IL-8 
ΔCt  
 
HT-29 
COX-2 
ΔCt 
 
HT-29 
TLR-4 
ΔCt 
 
HT-29 
TNF-α 
ΔCt 
 
HT-29 
IL-8 
ΔCt 
 
               
AX33 × AX37 
    
0.601 * 
        
AX34 × AX35 0.592 * 
            *** P-value <0.0001; ** P-value <0.001; * P-value <0.05 
a The abbreviations used for each parameter is as follows: 
Composition data obtained by GC-FID: AX11, Total AX; AX12, A/X ratio. 
Structural data obtained by 1H-NMR: AX21, NMR resonance 1; AX22,NMR resonance 2; 
AX23NMR resonance 3; AX24, NMR resonance 4; AX25, NMR resonance 5; AX26, NMR 
resonance 6. 
Structural data obtained by GC-MS:  AX31, Terminal Arabinose; AX32,Terminal Xylose; 
AX33, 2 substituted 1,4 linked xylose; AX34, 1,5 linked arabinose; AX35, 1,4- linked 
xylose; AX36, 1,3- linked arabinose; AX37, 3 substituted 1,4 linked xylose; AX38, 2,3, 
substituted 1,5-linked arabinose; AX39, 2,3 substituted 1,4 linked xylose. 
AX11 × AX11, product of AX11 by AX11; AX11 × AX12, product of AX11 by AX12; and 
so on. 
 
More so, we indicated that there might be a synergistic effect of combination of different 
fine structural details that exert a significant impact on the polysaccharide’s immunological 
properties rather than one single structural detail of the AXH. This might be further explained by 
the cellular mechanisms involved in recognition of these polysaccharides by the cells. The 
pattern recognition receptors that identify specific polysaccharides might identify them based on 
the collective structural features of the polysaccharide vs one specific structural detail. The 12 
different AXH being tested showed different immunological properties with respect to cell type, 
the cytokine of interest, etc. The current research indicates that there is a structure driven 
immunological properties for wheat bran derived AX polysaccharides. However, the exact 
cellular mechanisms involved in recognition of these polysaccharides need to be further 
elucidated. Also, the inflammatory mediator pathways that are triggered upon encounter of each 
of these AXH which might be structure dependent need to be further explored.  
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Table 4.7. Prediction equation for the dependent variables related to immunomodulatory properties. 
Dependent variable Prediction equation Model R2 
Caco-2 PG-E2 Caco-2 PG-E2 = 0.19 - 6.32×10-3 (AX21)- 3.1×10-4 (AX25×AX37) + 6.32×10-5 (AX35×AX38) 0.8604 
Caco-2 IL-8 Caco-2 IL-8 = 16.3 + 6.84×10-3 (AX11×AX38) – 0.55 (AX12×AX39) – 9.63×10-2 (AX31×AX36) 0.9104 
Caco-2 TNF-α Caco-2 TNF-α = 32.5 + 8.96×10-7 MWT – 5.73×10-2 (AX11) – 5.31×10-3 (AX26×AX31) 0.8683 
HT-29 PG-E2 HT-29 PG-E2 = -7.8×10-2 + 2.1×10-2 (AX12×AX25) – 3.74×10-3 (AX24×AX33) – 5.37×10-4 (AX24×AX36) 0.9155 
HT-29 IL-8 HT-29 IL-8 = 307.1 – 17.7 (AX21) +.203 (AX11×AX22) - .87 (AX22×AX36) 0.9548 
HT-29 TNF-α HT-29 TNF-α = 52.39 - .11 (AX11) – 1.7 (AX23) – 1×10-2 (AX31×AX39) 0.9303 
Caco-2 COX (ΔCt) Caco-2 COX (ΔCt) = 20.1 – 1.7 (AX23) + 3.5×10-2 (AX24×AX25) + 0.43 (AX24×AX34) 0.8884 
Caco-2 TLR-4 (ΔCt) Caco-2 TLR-4 (ΔCt) = 7.4 – 0.69 (AX22) + 5.2×10-2 (AX21×AX24) + 9.9×10-2 (AX34×AX35) 0.8091 
Caco-2 TNF-α (ΔCt) Caco-2 TNF-α (ΔCt) = 6.4 – 0.17 (AX31) + 0.29 (AX11×AX12) + 8.8×10-3 (AX22×AX31) 0.8605 
Caco-2 IL-8 (ΔCt) Caco-2 IL-8 (ΔCt) = 4.03 + 1.6 (AX34) + 6.9×10-2 (AX21×AX33) +1.16×10-3 (AX25×AX35) 0.8309 
HT-29 COX-2 (ΔCt) HT-29 COX-2 (ΔCt) = 2.01 + 0.809 (AX23) – 0.76 (AX36) – 0.37 (AX33×AX36) 0.8733 
HT-29 TLR-4 (ΔCt) HT-29 TLR-4 (ΔCt) = -1.02 + 0.96 (AX23) – 0.74 (AX36) – 0.36 (AX33×AX36) 0.9054 
HT-29 TNF-α (ΔCt) HT-29 TNF-α (ΔCt) = 9.7 + 2.4 (AX34) – 2.1×10-2 (AX26×AX36) + 2.1×10-2 (AX31×AX37) 0.7784 
HT-29 IL-8 (ΔCt) HT-29 IL-8 (ΔCt) = -4.8 + 22.8 (AX12) + 0.33 (AX22) – 0.58 (AX36) 0.7344 
*** P-value <0.0001; ** P-value <0.001; * P-value <0.05 
a The abbreviations used for each parameter is as follows: 
MWT, weight average molecular weight; composition data obtained by GC-FID: AX11, Total AX; AX12, A/X ratio; structural data 
obtained by 1H-NMR: AX21, NMR resonance 1; AX22,NMR resonance 2; AX23NMR resonance 3; AX24, NMR resonance 4; 
AX25, NMR resonance 5; AX26, NMR resonance 6; structural data obtained by GC-MS:  AX31, Terminal Arabinose; 
AX32,Terminal Xylose; AX33, 2 substituted 1,4 linked xylose; AX34, 1,5 linked arabinose; AX35, 1,4- linked xylose; AX36, 1,3- 
linked arabinose; AX37, 3 substituted 1,4 linked xylose; AX38, 2,3, substituted 1,5-linked arabinose; AX39, 2,3 substituted 1,4 linked 
xylose. 
AX11 × AX11, product of AX11 by AX11; AX11 × AX12, product of AX11 by AX12; and so on. 
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To date, the exact mechanism of processes executed by cells upon encounter of arabinoxylans 
has not been well defined.  
These results indicate that there might be a structure-function relationship for these AXH 
as immunomodulators. Further research is needed to evaluate the dose dependence of these AXH 
on immune system cells and also to identify the cellular mechanisms involved in exerting the 
observed outcomes for these compounds.  
4.6. Future Research 
In the current study the induction of inflammation in the cells were achieved via 
stimulation with LPS, a commonly used pro-inflammatory agent. However, with respect to some 
cytokine production, the LPS induced cells did not produce significantly higher amounts of 
cytokine compared to the none-LPS induced cells. Many researches have reported using pro-
inflammatory cytokines instead of LPS to induce immunological outcomes in intestinal cell lines 
(Andoh et al., 1995; Kim et al., 2004; Kim et al., 2005; Mukherjee and Biswas, 2014; Rieder et 
al., 2011; Son et al., 2005; Van De Walle et al., 2010). Thus, evaluating the immunomodulatory 
effects of AXH on inflammation induced by some of these cytokines in cells would help mitigate 
the above drawback and also help understand the cellular mechanisms involved in 
immunomodulation by cereal fibers such as arabinoxylan.  
Although changes in production of inflammatory mediators such as PG-E2 and cytokines 
were observed under the current study in response to different AXH these inflammatory 
mediators are regulated by feedback mechanisms in vivo. Thus, further research employing 
animal models would be able to shed better light on the role of AX in animals. 
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CHAPTER 5. ARABINOXYLAN HYDROLYZATES AS SUBSTRATE FOR THE 
BACTEROIDES SPECIES 
5.1. Abstract 
Although the human diet is rich with plant and animal derived polysaccharides, there is a 
large array of polysaccharides that are resistant to digestion by human enzymes and rely on 
microbial enzymes for their digestion. The fermentation of these by microbes yield energy for 
the microbial growth and the end products such as short chain fatty acids has profound effects on 
the host health. The fine structural details of these polysaccharides might have an influence on 
their fermentability by the gut bacteria. The current research was carried out to evaluate how the 
structural differences among arabinoxylan hydrolyzates from wheat influence the growth of 
human gut microbiota using an idealized experimental model employing Bacteroides strains. In 
general, B. cellulosilyticus DSM 14830 had the highest growth while B. eggerthii DSM 20697 
had the lowest growth on arabinoxylan hydrolyzates. Interestingly, B. cellulosilyticus DSM 
14830, B. ovatus 3_1_23, B. ovatus ATCC 8483 and B. xylanisolvens XB1A displayed clearly 
distinguishable phase shifts along the growth curves. This indicates their ability to tune in their 
gene expressions to overcome the hindrances to growth exerted by structural details on the 
substrate polysaccharide. Another explanation for this could be that during growth, the bacteria 
encounter specific structures that reduce growth rate and these cause the shifts. Overall, this 
research confirms the ability of Bacteroides to utilize structurally divers array of 
polysaccharides. The co-existence of these bacteria within the human intestinal tract could lead 
to maximum utilization of plant polysaccharides and in turn contribute to the many health 
benefits associated with plant polysaccharides. 
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5.2. Introduction 
The intestine is an important organ that consists of a huge surface area and permits vital 
interactions with the external world, including the gut microbiota (Cani et al., 2013). The 
microbiota refers to “the microbial life forms within a given habitat or host” (Walter and Ley, 
2011). The gut microbiota exerts a significant impact on host physiology, impacting the control 
of energy homeostasis, the immune system, digestion and vitamin synthesis (Cani et al., 2013) 
and inhibition of pathogen colonization (Wardwell et al., 2011).  
It is then in the large intestine that the saccharolytic bacteria extract additional energy 
from the dietary substances that are resistant to digestion by the human enzymes (Walter and 
Ley, 2011). Although the human diet is rich with plant and animal derived glycans, there is a 
large array of glycans that are resistant to digestion by human enzymes and rely on microbial 
enzymes for their digestion. The fermentation of these glycans by microbes yield energy for the 
microbial growth and the end products such as short chain fatty acids (SCFA), mainly acetate, 
propionate and butyrate has profound effects on the host health (Tremaroli and Backhed, 2012). 
The functional association among the intestinal microbiota, intestinal epithelial cells and the host 
immune system help maintain the balance between tolerance and immunity to a particular 
pathogenic or nonpathogenic microbe or food ingredient.  
Studies of healthy adult gut microbiota have shown that it is composed primarily of 
members of two bacterial phyla, the Bacteroidetes and Firmicutes (McNulty et al., 2013). 
However, the most expanded glycolytic gene repertoires that target xylan degradation is found in 
genus Bacteroides (Zhang et al., 2014). The Bacteroidetes encode more carbohydrate-active 
enzyme (CAZyme) families enzymes and processes more CAZyme-encoding genes than other 
phyla such as Firmicutes,  indicating their enhanced capacity to utilize wide range of 
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polysaccharide substrates (Kaoutari et al., 2013). The members of the genus Bacteroides are 
adept at utilizing plant and host derived polysaccharides (Koropatkin et al., 2012). These 
Bacteroides are rich in genes involved in the acquisition and metabolism of various glycosides 
including glycoside hydrolases and polysaccharide lyases which are organized into 
polysaccharide utilization loci (PULs) that are distributed throughout the genome (Koropatkin et 
al., 2012). In the phylum Bacteroidetes, the metabolism of starch from the external environment 
is achieved via the starch utilization system (Sus) (Koropatkin et al., 2012). There have been 
similar systems unique to the phylum Bacteroidetes identified in the Bacteroidetes genome that 
function by a similar mechanism as Sus but harbor enzymes that target glycans other than starch, 
thus these systems are termed Sus-like systems (Koropatkin et al., 2012). These Sus-like systems 
are involved in metabolism of many other glylans by the Bacteroidetes. The molecular 
mechanisms used to utilize xylan “is analogous to the Sus-like paradigm” (Dodd et al., 2011; 
Martens et al., 2009). A gene cluster that was highly induced during growth of Bacteroidetes on 
wheat AX was identified and termed the xylan utilization system (Xus) (Dodd et al., 2011). A 
schematic model predicting the utilization of xylan by Xus is given in Figure 1.8. The system 
consists of a set of polysaccharide binding proteins, glycolytic enzymes that hydrolyze large 
polysaccharides into smaller oligosaccharides and TonB-dependent transporters that transport 
these oligosaccharides into the periplasm (Zhang et al., 2014). These oligosaccharides are then 
converted to smaller monosaccharides by an array of glycolytic enzymes before being 
transported to the cytosol (Martens et al., 2009).  
With regard to metabolic syndromes, a statistically significant 50% reduction in 
Bacteroidetes was observed in cecal microbiota of obese mice compared to lean mice (Ley et al., 
2005). A similar observation was made on humans, showing that the relative proportion of 
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Bacteroidetes is reduced in obese individuals compared to lean individuals (Ley et al., 2006). 
The beneficial effects of the commensal microbes on human health have been demonstrated by 
numerous studies. Mazmanian et al. (2008) demonstrated that the “human symbiont Bacteroides 
fragilis   protects animals from experimental colitis induced by Helicobacter hepaticus”.  The 
observed protective action was attributed to the microbial polysaccharide, polysaccharide A 
(PSA), produced by Bacteroides fragilis (Mazmanian et al., 2008). Also, administration of PSA 
to mice protected the animals from weight loss and caused decreased levels of proinflammatory 
cytokines such as TNF, IL-17 and IL-23 (Mazmanian et al., 2008). These PSA molecules are 
suggested to be taken up by dendritic cells in the intestine and presented on MHC II to CD4+ T 
cells resulting in activation of these T cells (Round and Mazmanian, 2009). In assessing the 
contribution from intestinal bacteria to development of asthma, Bjorksten (1999) concluded that 
allergic children had lower levels of colonization by Bacteroides spp. compared to non-allergic 
children. Inflammatory bowel disease (IBD) is a chronic remittent or progressive inflammatory 
condition in the gastrointestinal tract (Kaser et al., 2010). It affects nearly 1 million persons in 
North America alone and several million persons worldwide (Bamias et al., 2005). In IBD 
patients a reduced proportion of Bacteroides and Firmicutes and an increase in Escherichia coli 
and Shigella flexneri were observed indicating a possible relationship between these bacteria and 
IBD (Li et al., 2012).  
Previous work has demonstrated the influence of structural differences of cereal 
polysaccharides such as arabinoxylans on their fermentation profiles.  Rose et al. (2010) 
indicated differences among the fermentation profiles for AX from different cereals (maize, rice 
and wheat), which consists of different structural features. Xu (2012) concluded that specific 
molecular regions of dietary fibers differentiate gut bacteria. With such background, the current 
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research was carried out to evaluate how the structural differences among enzymatically tailored 
wheat arabinoxylan hydrolyzates influence the growth of human gut microbiota using an 
idealized experimental model employing Bacteroides strains. 
5.3. Materials and Methods 
5.3.1. Materials 
Materials used for the production of AXH were previously described in section 2.3.1. The 
bacterial fermentation experiments were carried out using six publicly available Bacteroides 
strains belonging to 5 different species kindly provided by Dr Eric Martens (Department of 
Microbiology & Immunology, University of Michigan, Ann Arbor, MI). The strains were: 
Bacteroides cellulosilyticus DSM 14838, Bacteroides ovatus ATCC 8483, Bacteroides ovatus 3-
1-23, Bacteroides eggerthii DSM 20697, Bacteroides intestinalis DSM 17393, Bacteroides 
xylanisolvens XB1A. All strains were originally isolated from human colon or fecal samples, 
representative of the most commonly encountered xylanolytic organisms in the gut. 
5.3.2. Procedure for arabinoxylan hydrolyzate preparation  
AXH preparation was carried out as described in section 2.3.2 in a previous chapter. 
A summary of the treatments and the abbreviation given to the resulting AXH is given in Table 
2.1. 
5.3.3. Chemical analysis 
The chemical analysis of the AXH was carried out as described in section 2.3.3 using 
GC-FID, SEC-MALS, 1H-NMR and GC-FID techniques. 
 
 155 
 
5.3.4. Pure bacterial strain growth experiments 
The bacterial growth experiments were carried out according to the methods described by 
Martens et al. (2011). Each freeze dried arabinoxylan hydrolyzates from all the thirty 
preparations were weighed out (45mg) and dissolved in millipore water (4.5 mL) to prepare 10 
mg/mL stock solutions of each hydrolyzate. Xylose (10 mg/mL) stocks were also prepared as 
standard and for comparisons.  Each substrate was autoclaved at 121 ºC for 20 min. Substrate 
solution was pipetted into one of the designated wells on a 24 × 16 plate assigning three wells for 
each substrate per bacterial strain. Each bacterial strain inoculum was added to each well, 
diluting the final substrate concentration to 5 mg/mL.  
The bacterial inocula were prepared as follows: each bacterium was inoculated into 
custom chopped meat media using sterile wood sticks from glycerol stocks from freezer. These 
cultures for assay inoculations were grown for 24 h at 37 0C  under an anaerobic atmosphere of 
10% H2, 5% CO2, and 85% N2 using an anaerobic chamber (Coy manufacturing, Grass Lake, 
MI). This culture (1 mL) was drawn into 1.5 mL centrifuge tube and was centrifuged at 10 × 
1000g for 1 min. The supernatant was discarded and Bacteroides minimal medium (1 mL) was 
added and the bacterial pellet was re-suspended in it. This was again centrifuged (10 × 1000g for 
1 min) to wash the bacteria. This step was repeated another time. After discarding the second 
washing, the bacterial pellet was re-suspended in 1 mL of Bacteroides minimal medium. This 
was the washed culture. Washed culture was pipetted into Bacteroides minimal medium to 
prepare the “diluted bacterial culture” (1:50 ratio). Diluted bacterial culture was inoculated into 
the previously prepared microplates containing substrate solution in each well inside the 
anaerobic chamber. 
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After inoculation the plates were allowed to equilibrate with the anaerobic conditions for 
about 30 min. Assay plates were sealed under the atmosphere noted above with an optically clear 
gas-permeable polyurethane membrane (Diversified Biotech, Boston, MA). The plates were then 
loaded into a Biostack automated plate handling device coupled to a Powerwave HT absorbance 
reader (both devices from Biotek Instruments, Winooski, VT). Absorbance at 600 nm (A600) 
was measured for each well at 10–15 min intervals. Data were processed using Gen5 software 
(Biotek) and Microsoft Excel. 
Several glycans yielded complicated polyphasic growth profiles rather than a single 
exponential growth phase. Thus, we quantified growth in each assay by first identifying a 
minimum time point (Amin) at which A600 had increased by 10% over a baseline reading taken 
during the first 500 min of incubation. Next, we identified the time point at which A600 reached 
its maximum (Amax) immediately after exponential growth. Total growth parameter was 
generated for each well (Amax - Amin). Cultures that failed to increase density by at least 0.1 
(A600) were scored as no growth. 
5.3.5. Statistical analysis 
 All the experiments were done in duplicate. All statistical analyses were performed using 
Statistical Analysis System software package version 9.4 (SAS Institute, Cary, NC) 
The data are presented as the means ± SE and were subjected to one way ANOVA using 
LSD test procedure. A least significant difference (LSD) with a 5 % significance level was used 
to declare differences. Differences were considered significant when the probability value p was 
lower than 0.05.  
Pearson's correlation analysis was conducted to evaluate relationships between bacterial 
growth and AXH composition/structural details.  
 157 
 
5.4. Results and Discussion 
5.4.1. Chemical characterization of the AXH 
Extensive discussions on the fine structural details of the AXH are discussed in a 
previous chapter (Chapter 2). The sugar composition, A/X ratio of the WAX and the resulting 
AXH are given in Table 2.2. The weight average molecular weights and polydispersity index of 
each AXH is presented in Table 2.3.The 1H-NMR resonance integrations for WAX and AXH are in 
Table 2.4. The linkage analysis results of each AXH are depicted in Figure 2.3.   
5.4.2. Bacterial growth experiments 
Each Bacteroides species growing on the same AXH (CJX-1) had different growth curves 
(Figure 5.1). B. cellulosilyticus DSM 14830 had the highest growth while B. eggerthii DSM 
20697 had the lowest growth on CJX-1. Interestingly, B. cellulosilyticus DSM 14830, B. ovatus 
3_1_23 and B. ovatus ATCC 8483 displayed clearly distinguishable phase shifts along the 
growth curve for growing on CJX-1. B. xylanisolvens displayed a less prominent phase shift. B. 
intestinalis DSM 17393 also displayed phase shifts but this occurred much later in the growth. 
Rose et al. (2010) observed that while the fermentation of maize bran by fecal microbes 
happened in a linear pattern with high production of short chain fatty acids during the 24 hour 
fermentation, the fermentation of the wheat bran followed a two phase mechanism. They 
suggested that the bacteria might utilize the unsubstituted less complex regions initially and upon 
depletion of unsubstituted regions might proceed to subsequently metabolize the substituted 
xylose regions. The phase shifts observed for B. cellulosilyticus DSM 14830, B. ovatus 3_1_23 
and B. ovatus ATCC 8483 might be due to such two phasic fermentation of complex 
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arabinoxylan structures. These phase shifts indicate that the above Bacteroides species have 
evolved in such a way to degrade even complex polysaccharides.  
None of the Bacteroides species under investigation displayed a correlation with the total 
AX in the substrate, AXH. This suggests that it is not merely the content of AX that influences 
the growth but the fine structural complexity that is at play. A strong positive correlation (0.751) 
was seen between the total growth results of B. cellulosilyticus DSM 14830 and B. ovatus 
3_1_23. This correlation between the two strains suggests that these two strains might have 
similar enzymatic abilities to utilize AXH. Also a strong positive correlation (0.641) was 
observed for the total growth results between B. cellulosilyticus DSM 14830 and B. ovatus 
ATCC 8483. However, although of the same species, no significant correlation was evident for 
the growth results between B. ovatus 3_1_23 and B. ovatus ATCC 8483. These indicate the 
diversity of AX fermentation capacity within the B. ovatus species. 
A strong positive correlation (0.707) was also observed between the total growth results 
of B. eggerthii DSM 20697 and B. xylanisolvens XB1A indicating that both species preferred 
similar substrates, thus might have similar enzymes at their disposal. Interestingly, no correlation 
was observed for B. intestinalis DSM 17393 with any other five Bacteroides species employed in 
the current study.  
Overall, B. cellulosilyticus DSM 14830 had the highest growth while B. eggerthii DSM 
20697 had the lowest growth. Except B. eggerthii DSM 20697, all the other strains showed 
significantly lower growth compared to the control, xylose.  
As the name indicates, B. cellulosilyticus DSM 14830 is equipped with enzymes to 
degrade cellulose (Robert et al., 2007). However, the ability of B. cellulosilyticus DSM 14830 to 
ferment other plant cell wall polysaccharides have also been reported (Xu, 2012). The growth 
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curves of B. cellulosilyticus DSM 14830 on different AXH and xylose is given in Figure 5.2. 
Most of the growth curves followed a similar path with distinguishable phase shifts occurring 
along the growth. B. cellulosilyticus DSM 14830 efficiently fermented most of the AXH being 
tested (Figure 5.8). However, highest growth was observed for the control substrate, xylose. Out 
of all the six Bacteroides species used in the current study, B. cellulosilyticus DSM 14830 had 
the highest overall growth on AXH substrates. The overall growth on AXH varied from 0.43 to 
0.59 (ΔOD600) with lowest growth on CJX-4 and highest growth on CJX-1. A negative 
correlation (-0.512) was observed between the arabinose to xylose ratio and B. cellulosilyticus 
DSM 14830 growth. This suggests that the bacteria prefer the unsubstituted xylose regions along 
the AX molecule compared to those having high proportions of arabinose substitution. However, 
in general, B. cellulosilyticus DSM 14830 grew well on all the AXH despite their fine structural 
differences. The human gut Bacteroide, B. cellulosilyticus WH2, a different strain of the same 
species as B. cellulosilyticus DSM 14830, has been shown to contain a genome encoding more 
carbohydrate active enzymes than any other Bacteroidetes species analyzed to date (McNulty et 
al., 2013). B. cellulosilyticus WH2 is exceptionally capable of adapting to different diets rich in 
different polysaccharides (McNulty et al., 2013). Depending on the available dietary source, B. 
cellulosilyticus WH2 is capable of tailoring its carbohydrate utilization strategies to adapt to that 
substrate, with a preference for cereal grain xylans. A similar adaptability might be responsible 
for the ability of B. cellulosilyticus DSM 14830 to grow similarly well on all the AXH under 
investigation despite their structural differences. 
B. ovatus 3_1_23 had similar growth curves upon growth on the 30 different AXH 
substrates except for xylose (Figure 5.3).  Similar to B. cellulosilyticus DSM 14830, B. ovatus 
3_1_23 also indicated phase shifts along its growth curve for the AXH substrates. The total 
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growth on the AXH substrates ranged between 0.28-0.42 (ΔOD600) with lowest growth on ANX-
5 and highest growth on CJX-1 (Figure 5.9). The control, xylose had a growth of 1.54 (ΔOD600). 
When the structural complexity of the AXH were considered, there was a tendency towards 
AXH with high proportion of unsubstituted xylose to result in higher growth compared to AXH 
with lower proportion of unsubstituted xylose. In a similar way, the less complex the structure 
was, that is, less amount of arabinose substitution was observed in the AXH, the bacteria seemed 
to prefer that substrate.  
The growth curves of B. ovatus ATCC 8483 growing on different AXH are given in 
Figure 5.4. It followed a similar growth to B. ovatus 3_1_23 and also displayed a phase shift 
along the growth curve, although less prominent than B. ovatus 3_1_23. The total growth of B. 
ovatus ATCC 8483 on different AXH showed a considerable variation among most of the AXH 
(Figure 5.10). The lowest growth was observed for BAF-2 (0.27) while highest growth showing 
AXH was ANX-1 (0.48). Xylose indicated a growth of 0.87. An apparent negative correlation (-
0.439) was observed between the growth of B. ovatus ATCC 8483 with the arabinose to xylose 
ratio of the AXH. A similar indication that the bacterial growth is negatively correlated (-0.425) 
with the amount of terminal arabinose substitution was supportive of the above statement. Thus, 
B. ovatus ATCC 8483 seemed to display a preference for the less substituted, less structurally 
complex AX.   
B. eggerthii DSM 20697 grew well on xylose (ΔOD600 of 0.61) following the typical 
growth curve in xylan medium (Figure 5.5) (Salyers et al., 1981). No apparent phase shift was 
observed for any of the AXH. Among the AXH substrates, the lowest growth was observed for 
CJX-3 (0.15) (ΔOD600) while the highest growth was on CJX-1 (0.27) (ΔOD600) (Figure 5.11). 
Thus, compared to all rest of the strains used in the current research, the weakest growth on 
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AXH being tested was displayed by B. eggerthii DSM 20697. Xu (2012) also investigated the 
growth of same strains used in the current research and observed that B. eggerthii DSM 20697 
grew the weakest on wheat arabinoxylan.  
The growth curves of B. intestinalis DSM 17393 is given in Figure 5.6. There were phase 
shifts observed for some of the AXH which occurred much later in the log phase compared to 
other species in the current study. The overall growth of B. intestinalis DSM 17393 on AXH was 
in the range of 0.26-0.0.39 (ΔOD600) with lowest growth on CJX-3 and highest growth on CJX-7 
(Figure 5.12). Interestingly, it did not show a drastic growth improvement on xylose (0.39 
(ΔOD600)). Within the current study, we observed that B. intestinalis DSM 17393 had lowest 
growth on the control, xylose while the other two species, B. ovatus ATCC 8483, B. 
xylanisolvens XB1A grew comparably well on xylose. The reduced growth of B. intestinalis 
DSM 17393 on xylose has also been previously reported (Xu, 2012). They observed an apparent 
preference for arabinose branches of the AX by B. intestinalis DSM 17393. According to the 
model predicted by Dodd et al., (2011) for the transport of xylans across the bacterial outer 
membrane, the binding of xylan, cleavage and transport of xylan fragments across the outer 
membrane is achieved via the Xus cluster. XusB/D, XusE, and Xyn10C protein components of 
the Xus cluster bind to extracellular xylan polymers to facilitate its degradation and subsequent 
transport in to the cell. Thus, B. intestinalis DSM 17393 might be better designed to recognize 
and bind substituted arabinoxylans or xylan polymers over the monosaccharide, xylose. Among 
the species B. intestinalis DSM 17393, B. ovatus ATCC 8483, B. xylanisolvens XB1A, B. 
intestinalis DSM 17393 has the highest number of different glycoside hydrolases (GHs) and 
polysaccharide lyases (PLs) families (Kaoutari et al., 2013). This further indicates that B. 
intestinalis DSM 17393 might prefer polysaccharides over monosaccharides as fermentation of 
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polysaccharides would require more enzymes than for monosaccharides. Furthermore, utilization 
of monosaccharide xylose shouldn’t require any GH enzymes, but it does require expression of 
the proper transporter, so these data may indicate that the xylose transporter is controlled by 
xylan/xylooligosaccharide signals and is therefore not properly expressed in just xylose. 
B. xylanisolvens XB1A growth curves are given in Figure 5.7. For most of the AXH, a 
phase shift was observed towards the beginning of the log phase of the growth curve. Thus, the 
bacteria seem to adjust its enzyme expression based on the available substrate and once the 
enzymes are ready, the bacteria seemed to grow exponentially. The total growth on AXH ranged 
from 0.26 to 0.44 (ΔOD600) with lowest growth on CAF-2 and highest growth on ANX-2 (Figure 
5.13). Structural analysis of AXH indicated that there is a negative correlation (-0.471) between 
the substituted arabinose substitution (2,3-substituted 1,5-linked arabinose) and the bacterial 
growth. 
5.5. Conclusion 
When the diversity of glycan cleaving enzymes among the human gut microbiota was 
considered, the phylum Bacteroidetes had the highest number of genes encoding glycoside 
hydrolases (GHs) and polysaccharide lyases (PLs) and highest number of carbohydrate-active 
enzyme (CAZyme) families represented in these genomes compared to the other phyla under 
review (Kaoutari et al., 2013). This indicates that Bacteroidetes are capable of utilizing a large 
range of carbohydrate substrates compared to other phyla such as Firmicutes (Kaoutari et al., 
2013). The ability of different Bacteroides to ferment different polysaccharide substrates has also 
been indicated by others (Salyers et al., 1977). As the human diet consists of large repertoire of 
dietary polysaccharides, presence of these diverse array of CAZymes are of vital importance to 
take maximum benefit from these structurally diverse polysaccharides.
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Figure 5.1. Bacterial growth curves of six Bacteroides species on same AXH (CJX-1). The absorbance was measured at 600 nm over a 
continuous time frame.  
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Figure 5.2. Growth curves of B. cellulosilyticus DSM 14830 on different arabinoxylan hydrolyzates and xylose. CJX-1P to BAF-6P: 
different AXH; XYL: xylose. 
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Figure 5.3. Growth curves of B. ovatus 3_1_23 on different arabinoxylan hydrolyzates and xylose. CJX-1P to BAF-6P: different 
AXH; XYL: xylose. 
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Figure 5.4. Growth curves of B. ovatus ATCC 8483 on different arabinoxylan hydrolyzates and xylose. CJX-1P to BAF-6P: different 
AXH; XYL: xylose. 
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Figure 5.5. Growth curves of B. eggerthii DSM 20697 on different arabinoxylan hydrolyzates and xylose. CJX-1P to BAF-6P: 
different AXH; XYL: xylose. 
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Figure 5.6. Growth curves of B. intestinalis DSM 17393 on different arabinoxylan hydrolyzates and xylose. CJX-1P to BAF-6P: 
different AXH; XYL: xylose. 
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Figure 5.7. Growth curves of B. xylanisolvens XB1A on different arabinoxylan hydrolyzates and xylose. CJX-1P to BAF-6P: different 
AXH; XYL: xylose. 
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Figure 5.8. Average total growth of B. cellulosilyticus DSM 14830 on different arabinoxylan 
hydrolyzates (ANX-1 to BAF-6) and xylose. 
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Figure 5.9. Average total growth of B. ovatus 3_1_23 on different arabinoxylan hydrolyzates 
(ANX-1 to BAF-6) and xylose. 
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Figure 5.10. Average total growth of B. ovatus ATCC 8483 on different arabinoxylan 
hydrolyzates (ANX-1 to BAF-6) and xylose. 
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Figure 5.11. Average total growth of B. eggerthii DSM 20697 on different arabinoxylan 
hydrolyzates (ANX-1 to BAF-6) and xylose. 
 
 
 
 
 
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
A
N
X
-1
A
N
X
-2
A
N
X
-3
A
N
X
-4
A
N
X
-5
A
N
X
-6
A
N
X
-7
A
N
X
-8
A
N
X
-9
C
JX
-1
C
JX
-2
C
JX
-3
C
JX
-4
C
JX
-5
C
JX
-6
C
JX
-7
C
JX
-8
C
JX
-9
C
A
F-
1
C
A
F-
2
C
A
F-
3
C
A
F-
4
C
A
F-
5
C
A
F-
6
B
A
F-
1
B
A
F-
2
B
A
F-
3
B
A
F-
4
B
A
F-
5
B
A
F-
6
X
yl
o
se
A
ve
ra
ge
 t
o
ta
l g
ro
w
th
 (
Δ
O
D
6
0
0)
Substrate
B. eggerthi DSM 20697
 174 
 
 
Figure 5.12. Average total growth of B.intestinalis DSM 17393 on different arabinoxylan 
hydrolyzates (ANX-1 to BAF-6) and xylose. 
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Figure 5.13. Average total growth of B.xylanisolvens XB1A on different arabinoxylan 
hydrolyzates (ANX-1 to BAF-6) and xylose. 
The current study indicated that the Bacteroides species employed here were capable of 
fermenting a diverse array of structurally different wheat derived enzymatically tailored 
arabinoxylan hydrolyzates (AXH). B. cellulosilyticus DSM 14838 displayed the highest 
preference for wheat AXH while B. eggerthii DSM 20697 indicated the least preference for the 
wheat AXH. All the five strains except B. eggerthii DSM 20697 went through phase shifts 
during their growth on AXH. This suggests that these Bacteroides are capable of altering their 
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enzyme expression depending on the available substrate, grow at different rates on various 
regions of these complex molecules, or need to re-configure their cell envelope xylan foraging 
proteins to deal with variations in structures that are encountered during growth. Overall, the 
Bacteroides grew on all the AXH despite their structural differences. However, a general 
tendency to prefer less complex structures was observed for B. cellulosilyticus DSM 14838, B. 
ovatus ATCC 8483, B. ovatus 3-1-23 and B. xylanisolvens XB1A while B. xylanisolvens XB1A 
had a slight preference towards somewhat more complex AXH. The AXH, CJX-1 was a 
preferred substrate among most of the Bacteroides in this study. The work confirms the ability of 
Bacteroides to utilize structurally divers array of polysaccharides. The co-existence of these 
bacteria within the human intestinal tract could lead to maximum utilization of plant 
polysaccharides and in turn contribute to the many health benefits associated with plant 
polysaccharides. 
5.6. Future Research 
Although with some strains a strong structure function relationship was not obvious, it 
should not be considered as such right away. One reason for this could have been the narrow 
distribution range of some of the fine structural details among the AXH under investigation. 
Repeating the bacterial growth experiments employing AXH with much more obvious structural 
difference might give better insight into the structure function relationship between growth of 
Bacteroidetes on wheat AX. 
The current research was carried out using wheat derived AX polysaccharides. However, 
an interesting directionality would be to investigate how the wheat derived oligosaccharides 
would affect the growth of Bacteroidetes.  
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Bifidobacteria and Lactobacillus are commonly studied probiotic microbes. The effect of 
AXH on these beneficial bacterial strains need to be evaluated in the future. Due to the readily 
available resources investigating the effect of different fibers on the growth of these bacteria, it 
would be beneficial to evaluate the effect of wheat derived AXH on their growth, which might 
indicate how effective wheat derived AXH are as prebiotics compared to the commonly used 
prebiotics. 
Under normal physiological conditions, the colonic bacteria is under a dynamic system of 
diverse array of many different bacteria with many different hydrolysis capabilities. The 
degradation product of one species might be the preferred substrate for another bacteria. Thus, 
apart from the pure bacterial culture experiments, investigating the growth of combination of 
bacteria, may be using fecal cultures, or better yet, animal models would give better indication 
about the health benefits of structurally different AXH. 
The health benefits of polysaccharide fibers are not mealy due to their ability to act as 
food sources for the beneficial microbiota in the gut. The fermentation products of these 
microbiota, the microbiota it self and the polysaccharides are individually and collectively 
exerting effects on the intestinal epithelium acting as food sources to the enterocytes or inducing 
immunological outcomes. Future research exploring the collective effect of fiber and bacteria on 
the immune function of the gut is much encouraged. 
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APPENDIX A. SUPERIMPOSED CHROMATOGRAMS OF REFRACTIVE INDEX (RI) 
AND LIGHT SCATTERING DETECTOR OUTPUTS FOR AXH: (A) ANX-2, (B) CJX-2, (C) 
CAF-2 AND (D) BAF-2 
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APPENDIX B. THE TOTAL ION CHROMATOGRAM (TIC) AND THE MASS SPECTRUM 
OF THE CORRESPONDING PEAK IN THE TIC FOR ARABINOXYLAN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A
ra
f)
1

 
(X
y
lp
)1

 

4
(X
y
lp
)1

 
  
  
  
  
  
  
2
 

5
(A
ra
f)
1

 

4
(X
y
lp
)1

 

4
(X
y
lp
)1

 
  
  
  
  
  
  
3
 

4
(X
y
lp
)1

 
  
  
  
2
  
 3
 

5
(A
ra
f)
1

 
  
  
  
2
  
 3
 
 
(A
ra
f)
1

  
  
  
  
  
  
 
  
  
 3
 
 186 
 
 
 
 
 187 
 
 
 
 
 
 188 
 
 
 
 
 
 189 
 
 
 
 
 
 190 
 
 
 
 
 
 
 
 
 
